Form: 10-K

Annual report pursuant to section 13 and 15(d)

March 30, 2012



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-K
 
þ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 For the fiscal year ended December 31, 2011
or
o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
  For the transition period from ____________ to ____________
 
Commission File Number 0-29185
 
Save the World Air, Inc.
(Exact name of registrant as specified in its charter)
     
Nevada
52-2088326
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
 
735 State Street, Suite 500
Santa Barbara, California 93101
 (Address, including zip code, of principal executive offices)
 
 (805)-845-3581
 (Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Exchange Act: None.
 Securities registered pursuant to Section 12(g) of the Exchange Act: Common Stock, $0.001 par value.
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes o   No x
 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes o    No x
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes x   No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x   No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “small reporting company” in Rule 12b-2 of the Exchange Act.
 
Large Accelerated filer o
Accelerated filer o
Non-accelerated filer o
Smaller reporting company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes o    No x

The aggregate market value of the voting and non-voting common equity held by non-affiliates (excluding voting shares held by officers and directors) as of June 30, 2011 was $40,939,386.
 
The number of shares of the Registrant’s Common Stock outstanding as of March 15, 2012 was 123,304,914

DOCUMENTS INCORPORATED BY REFERENCE

Transitional Small Business Disclosure Format (Check one) Yes o    No x

 


 
 
 

 
 

 
SAVE THE WORLD AIR, INC.
FORM 10-K
INDEX
   
Page
PART I
Item 1
Business
  3  
Item 1A
Risk Factors
  17  
Item 1B
Unresolved Staff Comments
  23  
Item 2
Properties
  24  
Item 3
Legal Proceedings
  24  
Item 4
Mine Safety Disclosures
  24  
 
PART II
Item 5
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  25  
Item 6
Selected Financial Data
  26  
Item 7
Management’s Discussion and Analysis of Financial Condition and Results of Operations
  26  
Item 7A
Quantitative and Qualitative Disclosures About Market Risk 
  32  
Item 8
Financial Statements and Supplementary Data
  33  
Item 9
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
  33  
Item 9A
Controls and Procedures
  33  
Item 9B
Other Information
  35  
 
PART III
Item 10
Directors, Executive Officers and Corporate Governance
  37  
Item 11
Executive Compensation
  45  
Item 12
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
  48  
Item 13
Certain Relationships and Related Transactions, and Director Independence
  49  
Item 14
Principal Accounting Fees and Services
  49  
 
PART IV
Item 15
Exhibits, Financial Statement Schedules
  50  
SIGNATURES
  55  


 
 
2

 
 

 
PART I

Forward-Looking Statements

This Annual Report on Form 10-K contains forward-looking statements. These forward-looking statements include predictions regarding our future:
 
 
revenues and profits;
     
 
customers;
 
 
research and development expenses and efforts;
 
 
scientific and other third-party test results;
 
 
sales and marketing expenses and efforts;
 
 
liquidity and sufficiency of existing cash;
 
 
technology and products;
 
 
the outcome of pending or threatened litigation; and
 
 
the effect of recent accounting pronouncements on our financial condition and results of operations.
   
You can identify these and other forward-looking statements by the use of words such as “may,” “will,” “expects,” “anticipates,” “believes,” “estimates,” “continues,” or the negative of such terms, or other comparable terminology. Forward-looking statements also include the assumptions underlying or relating to any of the foregoing statements.
          
Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth below under the heading “Risk Factors.” All forward-looking statements included in this document are based on information available to us on the date hereof. We assume no obligation to update any forward-looking statements.

Item 1.    Business

The discussion of our business is as of the date of filing this report, unless otherwise indicated.

Overview

Save the World Air, Inc. (“STWA” or “Company” or “we” or “us”) designs, licenses and develops products to improve energy efficiency of large-scale energy production and improve diesel engine performance reducing emissions and improving fuel economy. We are a green technology company that leverages a suite of patented, patent-pending and licensed intellectual properties related to the treatment of fuels. Technologies patented by or licensed to us utilize either magnetic or uniform electrical fields to alter physical characteristics of fuels and are designed to create cleaner combustion. Cleaner combustion has been shown to improve performance, enhance fuel economy and/or reduce harmful emissions in laboratory testing.
 
We have two product lines; Applied Oil Technology (“AOT”) and ELEKTRA™.
 
Applied Oil Technology is transitioning from the research and development stage to full-scale commercial prototypes, and is in testing with the U.S. Department of Energy.  ELEKTRA is in the research and development stage.
 

 
 
3

 
 

We have two licenses (the “Licenses”) from Temple University for their patent-pending uniform electric field technology, which provide the intellectual property foundations upon which the AOT and ELEKTRA products are based.  The AOT technology consists of passing crude oil through an array of dynamically-controlled electrical fields to reduce the viscosity of the oil, making it easier to pump through oil pipelines.  The ELEKTRA technology consists of passing fuel through a dynamically-controlled electrical field to assist in the atomization of fuel via fuel injectors.  ELEKTRA introduces a uniform electrical field into the fuel flow to reduce the viscosity of diesel fuel, enabling smaller droplets to be released into the combustion chamber of a diesel engine. 
  
The Company holds the following patents:

US Patent #6901917, effective May 21, 2001 and updated on May 2, 2006 for “DEVICE FOR SAVING FUEL AND REDUCING EMISSIONS” covered in the United States, Australia, Canada, China, Russia, India, Indonesia, Japan and Mexico for the legacy technology.

US Patent #11/519168, effective May 13, 2005 for “METHOD AND APPARATUS FOR TREATMENT OF A FLUID” covered in the United States, China, Russia, Egypt, United Kingdom, Indonesia and Mexico.  This Patent has been transferred to Temple University.
 
We are also working with Temple University and numerous third-party entities to assist in the development of the commercial version of the AOT technology product line for oil refineries and pipelines.  The AOT product line uses the same dynamically-controlled strong electrical field concepts to reduce viscosity as ELEKTRA but is designed for pipeline applications that use thicker, more viscous fuels than the ELEKTRA market.  The AOT product is intended to improve the efficiency, and potentially the speed of highly viscous fluids such as crude oil traveling through pipelines.
 
We operate in a highly competitive industry.  Many of our activities are subject to governmental regulation.  We have taken aggressive steps to protect our intellectual property.  See “Competition”, “Government Regulation and Environmental Matters” and “Intellectual Property” below.
 
There are significant risks associated with our business, our Company and our stock.  See “Risk Factors” below.
 
We are a development stage Company that generated minimal revenues in 2006 and 2007. We did not generate any sales or revenues in 2008, 2009, 2010 or 2011. Our expenses to date have been funded primarily through the sale of stock and issuance of convertible debt, as well as proceeds from the exercise of stock purchase warrants and options. We raised capital in 2011 and will need to raise substantial additional capital in 2012, and beyond, to fund our sales and marketing efforts, continuing research and development, and certain other expenses, until our revenue base grows sufficiently to cover such expenditures.  See “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” below.

Our company was incorporated on February 18, 1998, as a Nevada corporation, under the name Mandalay Capital Corporation. We changed our name to Save the World Air, Inc. on February 11, 1999, following the acquisition of marketing and manufacturing rights of the ZEFS (legacy) technologies. Our mailing address is 735 State Street, Suite 500, Santa Barbara, California 93101. Our telephone number is (805) 845-3581. Our corporate website is www.stwa.com.  
 
Our common stock is quoted under the symbol “ZERO” on the Over-the-Counter Bulletin Board.
 
Recent Developments

In December, 2011 the Company signed a non-binding Letter of Intent with Beijing Heng He Xing Ye Technology Development Co., Ltd ("TDC") to distribute STWA's Applied Oil Technology™ (AOT™) into the Chinese market. TDC is a supplier of technology and oil pumping equipment to the Chinese oil industry.

In October, 2011 the U.S. Department of Energy published the test results for energy-efficiency improvement generated by the Company’s prototype AOT units.  The results were an energy-efficiency gain between 13.14% and 13.55%.  The results were published by the U.S. Department of Energy and generated industry awareness of the new technology (www.energy.gov).


 
 
4

 
 

In August, 2011 the Company renegotiated a new licensing agreement for the licensing of its intellectual property with Temple University. The new licensing agreement provides for a convergent, non-divisional relationship with Temple University based largely on the grant of exclusive rights and co-ownership of future Intellectual Property (IP) through co-development.

In July, 2011 the Company finished construction of the testing facility and began the testing protocols of the Company’s prototype Applied Oil Technology (AOT™) units.

In March 2011, the Company satisfied the last of the outstanding licensing agreement payments to Temple University, correcting its default status.

In January, 2011 the Company began design and construction of a custom-built crude oil testing facility together with the U.S. Department of Energy, at their Rocky Mountain Oilfield Testing Center, located on the Naval Petroleum Reserve #3 near Casper, Wyoming.

Our Business Strategy
 
Our business strategy is to provide the energy production and transportation industries with cost effective products to reduce their ongoing operation costs, and potentially reduce their initial capital expenditure costs.  In addition, our strategy is to provide the commercial transportation industry, military and other diesel-powered machinery operators with products to reduce their ongoing operation costs associated with fuel consumption, and potentially reduce their fuel consumption emissions.
     
We believe there is a large worldwide demand for products which can increase the efficiency of existing infrastructure associated with the production and transportation of hydrocarbon derived fuels.  We also believe that there is a large worldwide demand for products, which can increase the efficiency of existing infrastructure and assets associated with the maritime, military, construction, over the road and rail transportation, power generation and all other large diesel-powered systems and vehicles.
    
Our intent is to collaborate with established educational institutions such as Temple University, and industry partners to commercialize our technology, and leverage their facilities, expertise, sales channels, and infrastructure.  This will allow us to maximize the effectiveness of bringing our products to market while eliminating capital requirements and risk.  This model will allow us to accelerate all of our timelines, and retain a very competitive, and efficient corporate entity structure.
   
Our Products and Technologies

Applied Oil Technology (AOT)

New Technology to Reduce Oil Transportation Costs via Viscosity Reduction

There is a direct correlation between the time and expense of extracting and transporting crude oil with its viscosity. STWA’s Applied Oil Technology (AOT™) aims to provide a turnkey solution to change the way that oil explorers, drillers and wholesalers manage oil, thereby improving their efficiency and profitability.

AOT™ reduces the viscosity of crude oil, enabling it to travel through pipelines with reduced fluid drag exerted on the inside of the pipeline.  This translates into a direct reduction in the energy required per ton, per mile to move the product from point A to point B.

The U.S. Department of Energy published a report stating that they observed the operation of AOT™ under controlled conditions, which directly reduced the energy required to move the oil by 13.55%.

The Company believes that this 13.55% reduction in cost per mile is a very compelling figure for the domestic and international oil pipeline industry.


 
 
5

 
 

For example, a recent case study analysis determined that if the 13.55% reduction in energy consumption per ton/mile were to be implemented and realized by the Trans-Alaska Pipeline, it would result in ongoing energy cost savings of $9.377 million USD per year, for every pump station along the pipeline.

According to our research, there is forecasted to be substantial increases in oil and gas demand over the upcoming years.  Rapid, accelerating growth in Asia, notably, India and China are increasing the needs for new pipeline construction in order to handle increased demand.  The Company believes that new technological advancements such as the Company’s AOT™ will be needed to address the increases in demand.

An additional market driver for energy-efficiency technology such as STWA’s AOT, in 2011 was China’s government pledge in its 12th Five-Year Program to cut energy consumption per unit of Gross Domestic Product by 16% by 2015.  The Company believes that AOT™ may prove to be an important cornerstone for the Chinese Oil industry in this regard.

Our research indicates that the global market for new oil and gas pipelines, upgrades, extensions and maintenance was worth $62.6 billion in 2009.  Growth in this sector is expected to be substantial from 2010 up to 2020 as global energy demands increase, with Asia representing the majority of this growth.

Our AOT technology directly addresses this market, as it is designed to enable more efficient transportation costs per ton/mile, and it holds potential for faster throughput rates of crude oil, which would increase daily delivery capacities, while reducing operational direct expenses associated with crude oil transmission pipelines.

AOT’s market drivers are:
 
 
·
Increased Global Demand for Oil.
 
·
Emerging nations such as India and China are accelerating their demand for oil as their manufacturing sectors build new facilities to address expanding economies.
 
·
New drilling discoveries and techniques such Enhanced Oil Recovery, and horizontal drilling.
 
·
Emerging technological advancements enabling crude oil discoveries and supplies to be made in harsher climates and from more unconventional sources such as shale and oil sands.  Management believes that cold, remote oil fields stand to benefit greatly from efficient viscosity reduction technology, making them more competitive.
 
·
Oil and gas price organic demand and price increases.
 
·
As demand outpaces readily available supplies, new pipelines and pipeline technologies will be required to prevent supply shortages.  Greater price increases accelerate demand for additional pipelines and/or technology to improve delivery throughput capacities.
 
·
Accelerating destabilization in oil-rich regions such as the Middle-East, forcing developed nations to seek alternate supplies and supply routes to satisfy existing and future demand.
 
Applications for AOT include:
 
Crude oil pipeline pumping stations for transmission trunk lines.
Crude oil pipeline booster stations for transmission trunk lines.
Crude oil production gathering lines.
Crude oil refinery operational lines.

AOT™ relieves the amount of fluid-drag exerted between the fluid and the inner wall of the pipeline.  When installed directly after a crude oil pipeline pumping station, it immediately improves the ability of the crude oil to flow through the pipeline on its way to the next pipeline pumping station.  According to our research, the distance between pipeline pumping stations varies, but is within approximately 30-100 miles.

Crude oil pipeline pumping stations are extremely expensive to build, and extremely expensive to operate.  The Company believes that the implementation of the AOT™ product into service on the discharge side of existing, and/or newly built pipeline pumping stations would result in immediate operational cost savings for the pipeline operators.

The Company believes that the AOT™ can be implemented wherever crude oil is being pumped through pipelines of any size or length.  The Company believes that the efficiency gains realized by the customer improve with pipeline length and with heavier grades of oil being moved.

The Company believes that the AOT™ is potentially a high-margin, high-demand product.
 


 
 
6

 
 

AOT Competition:

There are three main other methods by which to reduce the viscosity of crude oil and/or to improve flow.  The commonly used practices are to heat the oil, by using either electrical or gas-powered heaters, add a chemical diluent, commonly using naphtha, natural gasoline, or chemical viscosity reduction agents, or by the use of chemical turbulence-suppression agents, known as drag reducing agents.  The purpose of each of the three methods is to improve the ability for crude oil to flow through the pipeline.
 
AOT has competitive advantages versus these existing methods of reducing viscosity.  In some cases it can replace existing methods, and in most cases it is a complimentary technology that reduces the overall cost of viscosity reduction.
 
History of AOT Development:

In 2004, STWA contacted Temple University with a research grant to expand on the Company’s legacy technology (ZEFS, MK IV, Mag ChargR and the ECO ChargR), with Dr. Rongjia Tao, Chairman, Temple University Physics Department, as principal investigator for the development and commercialization of improving oil flow using electric fields. We then assigned the original patent application for this technology “Method and Apparatus for a Treatment of a Fluid” to Temple University. In March 2008, Dr. Tao published Final Report Reducing the Viscosity of Crude Oil by Pulsed Electric and Magnetic Field disclosing a series of tests where crude oil viscosity was reduced by as much as 50%.  In 2009, we captured a series of tests on video and also demonstrated the technology to Colfax Corporation.  In August, 2010, chief scientist Dr. Tao had confirmed the technology’s effects using a neutron-scattering beam at the National Institute of Standards and Technology (NIST).  In November 2010, we announced that we had engaged Colfax Corporation to build a prototype to be tested at the US Department of Energy RMOTC in Casper, Wyoming. In January, 2011, we announced we were contracting with the Pipeline Research Council International for the testing of the Applied Oil Technology at the US Department of Energy.
 
ELEKTRA

New Emissions Reduction and Fuel Efficiency Technology
 
STWA’s patented and patent pending ELEKTRA™, co-developed with Temple University, improves diesel engine performance reducing emissions and improving fuel economy, by assisting in fuel atomization just prior to combustion. The ELEKTRA technology is designed to be installed in the fuel supply lines of vehicles and, because there are very few variations in the size and type of those lines, we anticipate that a relatively small number of variable capacity devices and a selection of installation adapters will cover most vehicle installations.

Using electromagnetism, Dr. Rongjia Tao, Chair, Department of Physics, Temple University expanded on STWA’s legacy technology with an innovative in-line device that introduces short, precise electric pulse bursts within the fluid flow, forcing the particulate matter to align in the field direction. When this happens, the particulate matters' natural tendency to combine into clusters is enhanced. This enables the total surface area per unit of dissolved particulate matter to decrease. This, in turn, provides more volume within the fluid for the suspended particles to move, thereby reducing particle rubbing and friction, which reduces the fuel’s viscosity.
  
We believe that the applications for products incorporating the ELEKTRA technology will include diesel, maritime diesel, aviation and military diesel, applications.  Subject to our cash flow and liquidity limitations, we are currently developing diesel tractor trailer applications and our present intention, subject to change, is to seek joint venture partners to commercialize the ELEKTRA technology in various applications.  

Research and Development

 The Company entered into a research and development agreement (R&D Agreement) in 2007 with Temple University to conduct further research on the AOT/ELEKTRA technology. Under the R&D Agreement Temple University agreed to conduct a 24-month research project towards expanding the scope of, and developing products utilizing, the technologies covered under the License Agreements (described below), including design and manufacture of prototypes utilizing electric fields to improve diesel, gasoline and kerosene fuel injection in engines using such fuels and a device utilizing a magnetic field to reduce crude oil viscosity for crude oil (paraffin and mixed base) and edible oil flow in pipelines. If the research project yields results within the scope of the technologies licensed pursuant to the Licenses, those results will be deemed included as rights licensed to the Company pursuant to the Licenses.


 
 
7

 
 

On August 9, 2011, Save The World Air, Inc. (the “Company”) and Temple University (“Temple”) entered into two (2) Exclusive License Agreements (collectively, the “License Agreements”) relating to Temple’s patent applications, patents and technical information pertaining to technology associated with an electric and/or magnetic field assisted fuel injector system (the “First Temple License”), and to technology to reduce crude oil viscosity (the “Second Temple License”).  The License Agreements are exclusive and the territory licensed to the Company is worldwide and replace previously issued License Agreements.
 
Pursuant to the two License Agreements, the Company agreed to pay Temple the following: (i) non-refundable license maintenance fee of $300,000; (ii) annual maintenance fees of $187,500; (iii) royalty fee ranging from 4% up to 7% from revenues generated from the License Agreements; and (iv) 25% of all revenues generated from sub-licensees to secure or maintain the sub-license or option thereon. Temple also agreed to cancel $37,500 of the amount due if the Company agrees to fund at least $250,000 in research or development of Temple’s patent rights licensed to the Company. The term of the licenses commences in August 2011 through the expiration of the patents contemplated thereunder, or unless sooner terminated under terms of the licensing agreements.
 
As of December 31, 2011, the Company recorded the entire $300,000 non-refundable license maintenance fee as part of its research and development costs, of which, $200,000 was paid in November 2011 and $100,000 was subsequently paid in February 2012. Further, the Company also accrued $78,125 of the annual maintenance fees of $187,500 which will become due in August 2012.
 
As of December 31, 2011, there were no revenues generated from these two License Agreements nor has the Company has made a determination to provide the $250,000 funding in research or development to Temple’s patent rights licensed to the Company. 
 
In 2010, the Company began pursuit of scaling-up the Applied Oil Technology from laboratory-scale to a fully functional field-scale prototype.  The purpose of this prototype is to validate and test functionality on a commercial scale.  The Company worked with numerous third-party vendors to accomplish the design, engineering and manufacture of the prototype beginning in the third quarter of 2010, and ending in the first quarter of 2011.  The prototype was delivered via freight to the U.S. Department of Energy RMOTC test facility on May 13th, 2011.

In 2010, the Company entered into a research and development (R&D) agreement with the U.S. Department of Energy to test the prototype at their Rocky Mountain Oilfield Testing Center, near Casper Wyoming.  The Company worked with numerous third-party vendors to retrofit a 4.5 mile subterranean oil pipeline flow loop originally built by Texaco and DeepSTAR, to test the new prototype under controlled-conditions.  The test facility construction was completed in June, 2011.

Numerous tests were conducted on the prototype at the aforementioned test facility, resulting in positive test results.  The U.S. Department of Energy RMOTC witnessed, and published a test report, confirming AOT generated 13.14% and 13.55% efficiency improvements on the pipeline during the test.

In 2007, The Company entered into a research and development agreement (R&D Agreement) with Temple University to conduct further research on the ELEKTRA / AOT technology. Under the R&D Agreement Temple University agreed to conduct a 24-month research project towards expanding the scope of, and developing products utilizing, the technologies covered under the License Agreements, including design and manufacture of prototypes utilizing electric fields to improve diesel, gasoline and kerosene fuel injection in engines using such fuels and a device utilizing a magnetic field to reduce crude oil viscosity for crude oil (paraffin and mixed base) and edible oil flow in pipelines.

Independent Laboratory and Scientific Testing
  
The Company is currently working with the U.S. Department of Energy to test its technology at the Department of Energy’s Rocky Mountain Oilfield Testing Center (RMOTC), near Casper, Wyoming.  This third-party testing is to establish independently verified data related to the Company’s technology as applied to commercial use in a controlled facility, using a commercial-scale prototype of the Applied Oil Technology (AOT).


 
 
8

 
 

On August 2 and 3, 2010, a group led by Dr. Rongjia Tao from Temple University conducted experiments, using the laboratory-scale Applied Oil Technology apparatus at the National Institute of Standards and Technology (NIST) Center for Neutron Research (CNR). NIST, an agency of the U.S. Department of Commerce, founded in 1901 in Gaithersburg, Maryland. It is the nation's first federal physical science research laboratory. 
  
Dr. Tao's team used the NG7 SANS (Small Angle Neutron Scattering) beam to investigate at a nano-scale level, the effects produced by STWA's Applied Oil Technology. The NG7 line was built as a joint effort between Exxon Corporation and the U.S. Government for fluid research, and uses the relatively new technique of neutron reflectometry to investigate the near-surface structure of many materials at the molecular level. The tests captured data and pictures with and without the field, confirming scientific evidence of its effect at a molecular level. The report can be found at the following link: http://www.stwa.com/STWA/whitepapers/STWA_Crude_Oil_Electrorheology_Neutron_Scattering_Test_at_NIST.pdf
   
Testing of the technology as applied to crude oil extraction and transmission has been conducted at Temple University in their Physics Department, in addition to the U.S. Department of Energy (US DOE), at their Rocky Mountain Oilfield Testing Center (RMOTC), located on the Naval Petroleum Reserve #3 Teapot Dome Oilfield, north of Casper, Wyoming.

Sales and Marketing
 
Applied Oil Technology

Product or Work Pipeline Industry’s Mission:
The pipeline industry is in the business of oil production and transportation.  Pipeline construction is highly expensive.  The Company’s AOT technology potentially reduces the pipe diameters and pump sizes needed for new pipeline construction dramatically saving on capital expenditure.

The Company believes that the practical implementation of the Applied Oil Technology will result in enormous financial savings to be realized by pipeline owners and operators.

Management believes that AOT will provide the same potential savings in constructing new pipelines, at much less cost to operate and much less environmental impact than DRA.  Additionally, for existing pipelines, this technology increases their daily revenue potential by moving more oil in a given time and pipe diameter and potentially postpones new construction.
    
Management believes that AOT will be an attractive option for producers and pipeline operators in its ability to reduce the operation costs associated with crude oil transport.  The oil industry is a very large, yet tightly-knit, focused community.  Management believes that the Company’s affiliation with Pipeline Research Council International (PRCI) will be beneficial in its ability to rapidly disseminate information pertaining to AOT’s effectiveness in improving pipeline efficiency.

PRCI is a community of the world’s leading pipeline companies, and the vendors, service providers, equipment manufacturers, and other organizations supporting the pipeline industry. Since 1952, PRCI has been recognized around the world as a unique forum within the energy pipeline industry delivering great value to its members and the industry,  both quantitative and qualitative, through the development and deployment of research solutions to the operational, maintenance, and regulatory challenges that face it.
  
The majority of the world’s largest oil and gas pipelines are fully-integrated companies, which are involved in all stages of petrochemical production from extraction to delivery.  The companies explore for and produce, own the pipelines for transport, and refine the petrochemicals for wholesale and retail sale.  Management believes that the Company’s AOT technology is of interest at every level of the extraction, production, transport and delivery to these ‘super major’ companies.

Management believes that the industry is actively seeking new and innovative cost-savings and throughput capacity improvement technology such as the Company’s Applied Oil Technology (AOT).  Management believes that targeted messaging to pipeline operators via trade journals and industry trade shows will create strong worldwide demand for the Company’s Applied Oil Technology.
 

 
 
9

 
 

Growing Markets:

China, a net importer of oil, and the world’s most populated country, is the second highest consumer of oil behind the US whose energy needs are forecast to be increasing 150% by 2020.  Its oil consumption rate is growing at seven times that of the US, and China is investing heavily in new oil pipelines and infrastructure to accommodate this ramp-up.  It is forecasted that 70% of Chinas imported oil will be coming from the Mid-East and Central Asia by 2015.  Management believes that The Company’s AOT technology holds the potential to provide advantages for the Chinese pipeline industry to assist in this growth.

India, a net importer of oil, is the second most populated country and is directly competing with China in securing oil supplies and infrastructure to fuel its own rapid growth.  India currently imports 70% of its oil, and is forecast to increase this number to 85% by 2020.  India is investing heavily in pipelines and infrastructure to accommodate this ramp-up. Management believes that the Company’s AOT technology holds the potential to provide advantages for the Indian pipeline industry to assist in this growth.

Asia boasts the global region with the largest growth forecasts and is expected to grow from $20.9Bn in 2010 to $32.1Bn in 2020.  Asia is a very promising region in that its growth is largely being fueled by state-owned companies under direction from their respective governments.  The total market forecast for this region is expected to be worth up to $306.5Bn from 2010 to 2020.  Management believes that there is the potential for strong interest in the Company’s AOT technology in these regions. According to the United States Energy Information Administration, “China consumed an estimated 9.2 million barrels per day (bbl/d) of oil in 2010, up nearly 900 thousand bbl/d, or over 10 percent from year-earlier levels. China's net oil imports reached about 4.8 million bbl/d in 2010 and it became the second-largest net oil importer in the world behind the United States in 2009. EIA forecasts that China's oil consumption will continue to grow during 2011 and 2012, and the anticipated growth of 1.1 million bbl/d between 2010 and 2012 would represent almost 40 percent of projected world oil demand growth during the 2-year period (– Source: www.eia.gov/countries/cab.cfm?fips=CH).

The US is currently the largest consumer of oil, yet its market forecast is not as strong over the 2010-2020 timeline as other regions, due to its markets being more closely linked to the financial markets, which suffered greatly in the 2008 economic downturn.  The MidEast, Asian, and European markets were more insulated to this exposure due to their industries being largely government backed.  North America does have a large number of new pipelines planned, yet their development has been halted until they become economically viable, pending economic recovery.  The North American market however is forecasted to see large growth rates as the economic recovery takes hold.  The North American market is forecasted to rise from $6.4Bn in 2010 to $16.9Bn in 2020 with the majority of growth from 2010-2015 of 23% CAGR and a decline in the 2015-2020 of -1.5% CAGR.  The total market forecast for this region is expected to be worth $162.3Bn from 2010-2020.  Management believes that there is the potential for strong interest in the Company’s AOT technology in this region.  

AOT Market Summary:

Our research indicates that the global use of fossil fuels will continue to be very strong into the foreseeable future.  Petrochemicals are forecasted to continue to be the mainstay of the global energy supply, until alternative and emerging energy sources are discovered and developed.  Management believes that the Company’s AOT technology will become a rapidly implemented and increasingly attractive option for producers and operators as they expand their operations to accommodate the rapidly rising demand for global crude oil supplies.  New pipelines are being constructed, new fields are being discovered, and new infrastructure is being built to handle the increasing demand around the globe.  Management believes that these new pipelines and infrastructure can benefit from the advantages the Company’s AOT technology can provide.
     
Market Drivers:

Management believes that there are a number of macroeconomic key leading indicators that point to an increase in demand for products that improve the flow characteristics and improve the efficiency per ton/mile of crude oil transport.  Our research indicates that there are two major key leading indicators that point to increased demand for products designed to improve pipeline flow assurance such as STWA’s AOT.


 
 
10

 
 

On the demand side of the equation, accelerated demand growth, notably in China and India are the major contributors to world oil demand, driving this demand for crude oil at an unprecedented rate.  According to the US Energy Information Administration, China’s demand for crude oil is growing from 2010-2012 by 1.1 million barrels per day, per year.  Our research also indicates that China imports roughly half of its oil, most of which comes into the country via tanker vessels, which commonly transition the Straits of Hormuz and the Straits of Malacca, en route to their destination ports serving Hong Kong, Shanghai, and Beijing.  Our research indicates that the Chinese Government is seeking ways to diversify these oil delivery routes in efforts to make their import delivery systems more secure.  Our research indicates that China is seeking ways to diversify their energy supply delivery system, and is investing heavily in cross-national pipeline networks to bring oil into the country from Russia, Kazakhstan, Myanmar, and potentially India.  The Chinese pipeline market is dominated by three major companies, all of which are directly linked to the Chinese central government.  Our research indicates that the Chinese pipeline network system is already running at full capacity, yet its demand growth continues to accelerate.   Management believes that products designed to improve the flow of oil, such as STWA’s AOT will be in great demand in the Chinese market alone, to increase the maximum flow rates of their pipelines throughout the country to satisfy the rapid crude oil demand growth.

Our research indicates that on the supply-side of the equation, new enhanced oil recovery “EOR” and production techniques and technology are improving the production capacity of oil wells beyond their previously attainable levels.  Regions such as the US and Canadian Bakken formation on the Montana / North Dakota / Saskatchewan border have realized rapid growth through the use of directional drilling and hydraulic fracturing, to enable each well to produce far more efficiently than every before.  Our research indicates that these recovery and production techniques are combining to make oil easier and faster to produce than ever before.  According to our research and information from industry contacts, the additional recovery and production rates for the Bakken region have already exceeded the physical carrying capacity of the pipelines servicing the region.  Our research indicates that the demand for additional pipeline capacity is growing rapidly for that region in particular, as producers seek ways to transport their new increased production volume capacities to market.  Management believes that products designed to improve the flow of oil, such as STWA’s AOT will be in great demand in the Bakken market alone, to increase the maximum flow rates of their pipelines servicing these regions.
   
Management believes that having the US DOE (US Department of Energy) test results verifying that AOT improves flow rates and reduces energy consumption will be the milestone that will allow the Company to begin closing sales of the product line.  Management believes that the AOT product line, integrated into the customers existing infrastructure may be able to yield higher throughput capacity and/or reduce energy requirements and transport costs per ton, per mile due to the pressure loss improvements generated by lowering the viscosity of the crude oil transported.

Upon completion of our tests and the results being published, management will seek contracts within the oil production and transportation industries and the selection of a manufacturing company as follows:

Selecting a Manufacturing Partner
 
We intend to outsource the manufacturing of the AOT technology. In consideration of qualified partners, here are examples of such criteria:
 
 
Existing proven, large-scale manufacturing and distribution for oil producers and transport hardware
 
 
Existing relationships with oil producers and pipeline operator decision-makers
 
 
Forward-looking proactive corporate vision looking to boldly expand their market share
   
STWA has contracted with a sub-manufacturing partner for developing its current AOT prototype.

ELEKTRA
 
Management believes that there is a large and active market for a product such as ELEKTRA that can reduce the fuel consumption of diesel engines.  Management believes that there is a viable market opportunity for the Elektra product within the commercial shipping industry, military and other off-highway commercial applications.
  

 
 
11

 
 

Subject to proper capitalization, we intend to embark upon additional research and development to scale up the Elektra product from laboratory research into preliminary prototypes, followed by commercial prototype units to prove our commercial sales viability. 

Our research indicates that there are a number of factors that will drive the need for products designed to improve efficiency and reduce emissions from diesel engines such as STWA’s Elektra product.  Our research indicates that the California Air Resources Board (CARB) has established regulations that are driving the need for new emissions reduction technologies.  CARB has established the following regulations on ship emissions:

“Requires use of cleaner fuels within 24 nautical mile zone of the California coastline

July 1, 2009
– use marine gas oil (averages 0.3% sulfur), or
– use marine diesel oil with a 0.5% sulfur limit

January 1, 2012
– use marine gas oil with a 0.1% sulfur limit, or
– use marine diesel oil with a 0.1% sulfur limit

Applies to main and auxiliary engines, and auxiliary boiler3

ARB will grant exemptions to vessels that apply for a temporary experimental or research exemption.

“Temporary Experimental or Research Exemption

Provided for research projects that will advance the state of knowledge of exhaust control technology or characterization of emissions

– Allows for the use of noncompliant fuel
– Applicant must provide progress reports and all test data and other project results
– Exemption possible for up to 3 years, with an extension possible
– Application process takes about 30 days”

Cargo ships primarily use a high-sulfur content, undistilled fuel known as Bunker-C or residual oil because it is inexpensive.  Low sulfur ship fuels such as Marine Diesel Oil (MDO) can cost up to six times as much as Bunker-C.  Additionally, ships have to shut down and clean out their fuel systems when switching from Bunker-C to MDO.  This can add an extra day to every inbound ocean voyage, greatly increasing the operating cost for ship fleets.  A technology that could deliver emissions reduction with Bunker-C and avoid shipping companies having to switch to MDO could avoid dramatic cost increases in shipping.

In the United States, California, through the California Air Resources Board (“CARB”), continues to set the strictest emission standards for the country and the United States Environmental Protection Agency (“EPA”) has indicated it may adopt more stringent emission standards, which would be applicable throughout the United States. The State of California has also announced its intent to seek greenhouse gas (“GHG”) legislation and the United States Congress is also considering GHG legislation.  
  
Foreign governments have recognized the serious effects caused by air pollution and many nations have enacted legislation to mandate that engine manufacturers be required to reduce exhaust emissions caused by their products. As evidenced by the overwhelming participation in the establishment of the Kyoto Accord, many nations are moving towards tighter GHG emissions control as well. The European Union (“EU”) currently requires all member nations to adopt EURO 3 emissions standards for motorcycles and EURO 4 emissions standards for automobiles and trucks. Some Eastern European countries contemplating EU admission, and certain Asian countries, have also announced gradual phase-in of EURO standards, including China, Indonesia, Vietnam, Thailand and India.
 

 
 
12

 
 

Management believes that US EPA, CARB and international governments will continue to lower emission standards below even these recent levels. Yet, the cost of adding emissions control devices to engines or vehicles has always been a challenge, since manufacturers shift the cost of such devices to the consumer.  In developing nations, where incomes are extremely low, economics and the lack of government resources have hampered progress.
 
Upon completion of our tests and the results being published, management will seek contracts within the maritime and military applications and the selection of a manufacturing company as follows:
 
Selecting a Manufacturing Partner
 
We intend to outsource the manufacturing of the ELEKTRA and are looking for three things in selecting a manufacturing partner. We are currently interviewing candidates.
  
 
Existing proven, large-scale manufacturer and distributor of Original Equipment Manufacturer for transportation
     
 
Existing relationships with fleet managers of large diesel truck operators
     
 
Forward-looking proactive corporate vision looking to boldly expand their market share
   
Competition

AOT
 
The oil transportation industry is highly competitive.  We are aware of only three currently available competitive technologies in widespread use for reducing the viscosity of oil throughout the world.  Many of our competitors have greater financial, research, marketing and staff resources than we do. For instance, oil pipeline operators use heat, diluents such as naphtha and/or natural gasoline, and/or chemical viscosity reduction additives, or chemical drag-reducing agents to improve flow in pipelines.  Our research indicates that these methods are either very energy-intensive, or costly to implement on a day to day basis.  Management believes that The Company’s AOT technology presents advantages over traditional methods, yet the industry’s willingness to experiment with said new technology may pose some challenges in acceptance.

We are not aware of any other technology using uniform electrical field crude oil viscosity reduction technology which has been proven to significantly improve pipeline operation efficiency.  Although we are unaware of any technologies that compete directly with our technologies, there can be no assurance that any unknown existing or future technology will be, superior to products incorporating the Applied Oil Technology which could provide the benefits of improved efficiency and increased flow rates.  Additionally, we believe that those aforementioned competing products that show benefit in more than one area demonstrate greater benefit in only one area and provide only minimal improvements in other areas.  Major domestic and international manufacturers and distributors of pipeline flow-improvement chemical solutions include Pemex, Petrotrin, Pluspetrol, Repsol, Glencore, Conoco-Philips, and Baker-Hughes. According to our research, heater skid manufacturers are generally local to the oilfield and pipeline regions, and are comprised of a large number of relatively small businesses in a fragmented industry. Major heater skid manufacturers are Parker, KW International, Thermotech Systems, LTD.

ELEKTRA

The maritime shipping industry is highly competitive. We have many competitors in the United States and throughout the world developing technologies to make engines more environmentally friendly and fuel-efficient. Many of our competitors have greater financial, research, marketing and staff resources than we do. For instance, engine and component manufacturers have already developed catalytic converters for engine exhaust systems in order to reduce emissions, but, as discussed above, this creates greenhouse gases and makes controlling emissions costly and complex. The industry has also proposed high-pressure fuel injection systems for gas and diesel applications but these modifications are extremely expensive.
 

 
 
13

 
 

Although we are unaware of any technologies that compete directly with our technologies, there can be no assurance that any unknown existing or future technology will be, superior to products incorporating the ELEKTRA technology which could provide the benefits of emission reductions, fuel efficiency and engine performance enhancement.  There are competing products which provide one or more of the beneficial attributes of our ELEKTRA technology, but not all three benefits.  Additionally, we believe that those competing products that show benefit in more than one area demonstrate greater benefit in only one area and provide only minimal improvements in other areas.
   
We are not aware of any other technology using uniform electrical field fuel treatments or products based on such technology which has been proven to significantly improve fuel mileage. There are many products currently on the market that claim to increase fuel efficiency. We believe that the majority of these products have not undergone or provided independent scientific validation from a recognized third party, or testing at a certified laboratory. High pressure fuel injection does improve fuel efficiency and performance, but is extremely expensive from the perspective of the developing nations of the world. Major domestic and international manufacturers and distributors of fuel injection systems include Delphi Corporation, Robert Bosch Corporation, Siemens Corporation, and a large number of smaller businesses in a fragmented industry.
 
We are not aware of any other technology using uniform electrical field fuel treatments or products based on such technology which has been proven to significantly improve engine performance. There are many products which a consumer can purchase to increase overall performance. All of the most effective such products, including forced induction, nitrous oxide injection and exotic exhaust, are very expensive, increase emissions, reduce fuel efficiency and shorter the life of the engine. Major domestic and international manufacturers and distributors of performance-enhancing systems include Holley Performance Products, Inc., Nitrous Express Inc., Paxton Automotive Corporation, Eaton Corporation, Vortec Engineering LLC, Flowmaster, Inc., Hedman Manufacturing, Inc., Gibson Performance, Inc. and a large number of smaller businesses in a fragmented industry.
 
Government Regulation and Environmental Matters

Our research and development activities are not subject to any governmental regulations that would have a significant impact on our business and we believe that we are in compliance with all applicable regulations that apply to our business as it is presently conducted. Our products, as such, are not subject to certification or approval by the EPA or other governmental agencies domestically or internationally. Instead, such agencies test and certify a sample engine fitted with our products.  Depending upon whether we manufacture or license our products in the future and in which countries such products are manufactured or sold, we may be subject to regulations, including environmental regulations, at such time.

Intellectual Property

ELEKTRA and APPLIED OIL TECHNOLOGY (AOT)
 
In addition to the License Agreements we have with Temple University (see Research and Development above), on May 14, 2004, we filed a patent application in Australia with respect to certain technology   (Method and Apparatus for a Treatment of a Fluid).  We entered into a license agreement with Temple University (the “2004 License Agreement”), for a research project with Dr. Rongjia Tao as principal investigator. That project and the related products involve the development and commercialization of underwater and cold temperature applications for improving oil flow under different temperature and pressure conditions. In connection with the 2004 License Agreement, we assigned the original patent application for this technology to Temple University and agreed to assign all subsequent patent applications for this technology to Temple University.  Under the 2004 License Agreement, we have the right to file additional patent applications, at our sole expense but for the benefit of Temple University, in various countries.  We have exclusive rights to this technology only in countries where we file patent applications.  In 2005, 2006 and 2007, we filed several additional patent applications in various countries.  As a result of Dr. Tao’s recently announced progress in reducing viscosity of crude oil with magnetic pulses, we believe that this technology may have commercial viability. We are maintaining the patent applications in the countries in which we have filed them, while we continue to explore the commercial benefits of pursuing this opportunity in these and possibly other countries.   


 
 
14

 
 

Method and Apparatus for Treatment of a Fluid

Cullen & Co Reference: 040540
 
Applicant:  Temple University of the Commonwealth System of Higher Education

Summary of Invention
Treating oils with magnetic fields to improve viscosity.

Claim 1 (PCT Application)

An apparatus for the magnetic treatment of a fluid which produces at least one magnetic field for a period of time, Tc at or above a critical magnetic field strength, Hc, the period Tc and the field strength Hc determined relative to one another and dependant upon the properties of the fluid. (All clear ISR)

Priority Date

The priority date is 14 May 2004 from Australian patent application 2004902563. (The GCC application was refiled and therefore the priority date for that application will be set at the actual filing date of the refiled application).

 
Country
Number
Filing date
Status
GCC *
GCC/P/2005/5066
22-August-2005
Application Allowed/Accepted – registration fees paid
Brazil
0510871-3
13-May-2005
Examination requested 29 April 2008 - awaiting report
Canada
2566739
13-May-2005
Examination requested - awaiting report
China (Method)
200580023369.3
13-May-2005
GRANTED
China (Apparatus)
20111022393.2
13 May 2005
Application filed – awaiting examination
Eurasia **
200602114
13-May-2005
GRANTED – Russia Only
Egypt
PCT 1087/2006
13-May-2005
GRANTED
United Kingdom
624025.3
13-May-2005
GRANTED
Indonesia
WO0200603429
13-May-2005
GRANTED
Libya
3560/2008
28-January-2008
Application filed - awaiting examination
Mexico
PA/a/2006/013206
13-May-2005
GRANTED
Norway
20065632
13-May-2005
Application filed – awaiting examination
United States
11/519168
13-May-2005
Under examination – response filed 20 December 2011
 

* Covers Kuwait, Oman, Qatar, Saudi Arabia, the United Arab Emirates, and Bahrain.
 


 
 
15

 
 

Legacy Technology

MAG ChargR™/ECO ChargR™, (legacy technology)

Our MAG ChargR™ and ECO ChargR™  products were designed to use fixed magnetic fields to alter some physical properties of fuel by incorporating our patented and patent-pending ZEFS and MK IV technologies.  We differentiate MAG ChargR and ECO ChargR products based on their differing attributes and marketing focus. ECO ChargR products were primarily designed to reduce harmful emissions and MAG ChargR products are primarily designed to enhance performance and fuel economy. Our ECO ChargR product was intended to reduce exhaust emissions in vehicle and small utility motors.  We intended that the ECO ChargR would be marketed primarily to original equipment manufacturers (“OEMs”) as well as to pilot and government-mandated emissions programs.  Our MAG ChargR product was intended to increase power and improve mileage. MAG ChargR was intended to apply to municipal fleets and to the specialty consumer accessories market for many types of vehicles, including but not limited to cars, trucks, motorcycles, scooters, all terrain vehicles (“ATVs”), snowmobiles, personal watercraft and small utility motors.  
 
Our first revenues in 2006 and 2007 were generated from initial sales in Asia for our ECO ChargR product in the motorcycle industry. We planned on commencing sales of ECO ChargR to customers in the United States in the motorcycle industry in second quarter of 2010. We also planned on commencing initial sales of our MAG ChargR in the United States in the automobile and motorcycle industry in the second quarter of 2010. On February 24, 2009, we received notice from the California Air Resources Board (CARB) that we have been issued an Executive Order (EO number D-659) approving the legacy technology for road-going applications.  A CARB Executive Order is recognized by the EPA, meaning the product can also be legally sold in all 50 states subject to any applicable state regulations.

The legacy technologies were instrumental in generating the impetus for the research grant to Temple University to investigate magnetic and electric field effects on motor fuels.  The legacy technologies have since been retired by management.
  
Non-Disclosure Agreements
 
To further protect our intellectual property, we have entered into agreements with certain employees and consultants, which limit access to, and disclosure or use of, our technology. There can be no assurance, however, that the steps we have taken to deter misappropriation of our intellectual property or third party development of our technology and/or processes will be adequate, that others will not independently develop similar technologies and/or processes or that secrecy will not be breached. In addition, although management believes that our technology has been independently developed and does not infringe on the proprietary rights of others, there can be no assurance that our technology does not and will not so infringe or that third parties will not assert infringement claims against us in the future. Management believes that the steps they have taken to date will provide some degree of protection; however, no assurance can be given that this will be the case.
   
Employees
 
As of December 31, 2011, we had nine full-time employees. As of such date, we also utilized the services of nineteen part-time consultants to assist us with various matters, including engineering, investment relations, public relations, accounting and sales and marketing. We intend to hire additional personnel to provide services when they are needed on a full-time basis. We recognize that our efficiency largely depends, in part, on our ability to hire and retain additional qualified personnel as and when needed and we have adopted procedures to assure our ability to do so.
  





 
 
16

 
 

Item 1A. Risk Factors

We have a history of losses, and we cannot assure you that we will ever become or remain profitable. As a result, you may lose your entire investment.
 
We generated our first revenues from operations in late 2006 and subsequently have not generated any revenues and we have incurred net losses every year since our inception in 1998. For the fiscal years ended December 31, 2011 and 2010, we had net losses of $10,856,547 and $9,494,906, respectively.  To date, we have dedicated most of our financial resources to research and development, general and administrative expenses and initial sales and marketing activities. We have funded all of our activities through sales of our securities, including equity and debt.  We anticipate net losses and negative cash flow to continue until such time as our products are brought to market in sufficient amounts to offset operating losses. We have significantly reduced both our research and development efforts, and our sales and marketing efforts, during the past year. Consequently, we will need to generate substantial additional funds, from a combination of revenue and external financing activities, to fund our operations. Our ability to achieve profitability is dependent upon our continuing research and development, product development, and sales and marketing efforts, to deliver viable products and the Company’s ability to successfully bring them to market. Although our management is optimistic that we will succeed in marketing products incorporating our AOT and ELEKTRA technologies, there can be no assurance that we will ever generate significant revenues or that any revenues that may be generated will be sufficient for us to become profitable or thereafter maintain profitability. If we cannot generate sufficient revenues or become or remain profitable, we may have to cease our operations and liquidate our business.
 
Our independent auditors have expressed doubt about our ability to continue as a going concern, which may hinder our ability to obtain future financing.
 
In their report dated March 30, 2012, our independent auditors stated that our consolidated financial statements for the year ended December 31, 2011 were prepared assuming that we would continue as a going concern. Our ability to continue as a going concern is an issue raised as a result of our recurring and accumulated deficit losses from operations since inception. We had an accumulated deficit of $69,289,467 as of December 31, 2011. Our ability to continue as a going concern is subject to our ability to obtain significant additional capital to fund our operations and to generate revenue from sales, of which there is no assurance. The going concern qualification in the auditor’s report could materially limit our ability to raise additional capital. If we fail to raise sufficient capital, we may have to liquidate our business and you may lose your investment.
  
Since we have not yet begun to generate positive cash flow from operations, our ability to continue operations is dependent on our ability to either begin to generate positive cash flow from operations or our ability to raise capital from outside sources.
 
We have not generated positive cash flow from operations and have relied on external sources of capital to fund operations. We had $617,797 in cash at December 31, 2011 and negative cash flow from operations of $4,723,952 for the year ended December 31, 2011.
 
We currently do not have credit facilities available with financial institutions or other third parties, and historically have relied upon best efforts third-party funding. Though we have been successful at raising capital on a best efforts basis in the past, we can provide no assurance that we will be successful in any future best-efforts financing endeavors. We will need to continue to rely upon financing from external sources to fund our operations for the foreseeable future. If we are unable to raise sufficient capital from external sources to fund our operations, we may need to curtail operations.
 
We will need substantial additional capital to meet our operating needs, and we cannot be sure that additional financing will be available.

As of December 31, 2011 and thereafter, our expenses ran, and are expected to continue to run, at a “burn rate” of approximately $280,000 per month, which amount could increase during 2012. We are not currently able to fund operations on a current basis, and we will require substantial additional capital in order to operate.  In order to fund some of our capital needs, we conducted private offerings of our securities in 2010 and 2011.   While discussion regarding additional interim and permanent financings are being actively conducted, management cannot predict with certainty that the equity line of credit will be available to provide adequate funds, or any funds at all, or whether any additional interim or permanent financings will be available at all or, if it is available, if it will be available on favorable terms. If we cannot obtain needed capital, our research and development, and sales and marketing plans, business and financial condition and our ability to reduce losses and generate profits will be materially and adversely affected. 
 

 
 
17

 
 

We will need additional capital to repay certain short-term debt as it matures.

As of December 31, 2011, we have $1,720,460 remaining principal amount of convertible subordinated notes, of which $1,516,504 will be due in December 2012.
  
Our business prospects are difficult to predict because of our limited operating history, early stage of development and unproven business strategy. Since our incorporation in 1998, we have been and continue to be involved in development of products using our technology, establishing manufacturing and marketing of these products to consumers and industry partners. Although we believe our technology and products in development have significant profit potential, we may not attain profitable operations and our management may not succeed in realizing our business objectives.
 
If we are not able to devote adequate resources to product development and commercialization, we may not be able to develop our products.
 
Our business strategy is to develop, manufacture and market products incorporating our AOT and ELEKTRA technologies.  We also intend to develop, manufacture and market products incorporating the ELEKTRA technology. We believe that our revenue growth and profitability, if any, will substantially depend upon our ability to:

 
raise additional needed capital for research and development;
 
 
complete development of our products in development; and
 
 
successfully introduce and commercialize our new products.
 
Certain of our products are still under various stages of development. Because we have limited resources to devote to product development and commercialization, any delay in the development of one product or reallocation of resources to product development efforts that prove unsuccessful may delay or jeopardize the development of other product candidates. Although our management believes that it can finance our product development through private placements and other capital sources, if we do not develop new products and bring them to market, our ability to generate revenues will be adversely affected.
 
The commercial viability of AOT technologies remains largely unproven and we may not be able to attract customers.
 
Despite the fact that we have entered into various discussions and received letters of intent, to the best of our knowledge, no consumer or pipeline manufacturer has used the products incorporating the AOT technologies to reduce crude oil viscosity to date. Accordingly, the commercial viability of our devices is not known at this time. If commercial opportunities are not realized from the use of products incorporating the AOT technologies, our ability to generate revenue would be adversely affected.  There can be no assurances that we will be successful in marketing our products, or that customers will ultimately purchase our products. Failure to have commercial success from the sale of our products will significantly and negatively impact our financial condition.
 
The commercial viability of the ELEKTRA technology remains largely unproven and we may not be able to attract customers.
 
To the best of our knowledge, no consumer or maritime engine manufacturer has used the products incorporating the ELEKTRA technology to reduce maritime vessel emissions to date. Accordingly, the commercial viability of our devices is not known at this time. If commercial opportunities are not realized from the use of products incorporating the ELEKTRA technology, our ability to generate revenue would be adversely affected.  There can be no assurances that we will be successful in marketing our products, or that customers will ultimately purchase our products. Failure to have commercial success from the sale
of our products will significantly and negatively impact our financial condition.


 
 
18

 
 

If our products and services do not gain market acceptance, it is unlikely that we will become profitable.
 
The market for products that reduce harmful motor vehicle emissions is evolving and we have many successful competitors. Engine component manufacturers have historically used various technologies, including catalytic converters, to reduce exhaust emissions caused by their products. At this time, our technology is unproven, and the use of our technology by others is limited. The commercial success of our products will depend upon the adoption of our technology by engine component manufacturers and consumers as an approach to reduce maritime vessel emissions. Market acceptance will depend on many factors, including:
 
 
the willingness and ability of consumers and industry partners to adopt new technologies;
 
 
the willingness and ability of consumers and industry partners to adopt new technologies;
 
 
the willingness of governments to mandate reduction of motor vehicle emissions;
     
 
our ability to convince potential industry partners and consumers that our technology is an attractive alternative to other technologies for reduction of motor vehicle emissions; 
     
 
our ability to manufacture products and provide services in sufficient quantities with acceptable quality and at an acceptable cost; and 
     
 
our ability to place and service sufficient quantities of our products. 
 
If our products do not achieve a significant level of market acceptance, demand for our products will not develop as expected and it is unlikely that we will become profitable.
 
We need to outsource and rely on third parties for the manufacture, sales and marketing of our products, and our future success will be dependent on the timeliness and effectiveness of the efforts of these third parties.
 
We do not have the required financial and human resources or capability to manufacture market and sell our products. Our business model calls for the outsourcing of the manufacture, and sales and marketing of our products in order to reduce our capital and infrastructure costs as a means of potentially improving our financial position and the profitability of our business. Accordingly, we must enter into agreements with other companies that can assist us and provide certain capabilities that we do not possess. We have entered into certain distribution agreements, but we may not be successful in entering into additional such alliances on favorable terms or at all. Even if we do succeed in securing additional distribution agreements, we may not be able to maintain them. Furthermore, any delay in entering into agreements could delay the development and commercialization of our products and reduce their competitiveness even if they reach the market. Any such delay related to our existing or future agreements could adversely affect our business.

If any party to which we have outsourced certain functions fails to perform its obligations under agreements with us, the development and commercialization of our products could be delayed or curtailed.
 
To the extent that we rely on other companies to manufacture, sell or market our products, we will be dependent on the timeliness and effectiveness of their efforts. If any of these parties do not perform its obligations in a timely and effective manner, the commercialization of our products could be delayed or curtailed because we may not have sufficient financial resources or capabilities to continue such development and commercialization on our own.
 



 
 
19

 
 

Any revenues that we may earn in the future are unpredictable, and our operating results are likely to fluctuate from quarter to quarter.
 
We believe that our future operating results will fluctuate due to a variety of factors, including:
  
 
delays in product development;
 
market acceptance of our new products;
 
changes in the demand for, and pricing, of our products;
 
competition and pricing pressure from competitive products;
 
●  
manufacturing delays; and
 
●  
expenses related to, and the results of, proceedings relating to our intellectual property.
 
A large portion of our expenses, including expenses for our facilities, equipment and personnel, is relatively fixed and not subject to further significant reduction. In addition, we expect our operating expenses will increase in 2012 as we continue our research and development and increase our production and marketing activities, among other activities. Although we expect to generate revenues from sales of our products, revenues may decline or not grow as anticipated and our operating results could be substantially harmed for a particular fiscal period. Moreover, our operating results in some quarters may not meet the expectations of stock market analysts and investors. In that case, our stock price most likely would decline.
 
Nondisclosure agreements with employees and others may not adequately prevent disclosure of trade secrets and other proprietary information.
 
In order to protect our proprietary technology and processes, we rely in part on nondisclosure agreements with our employees, licensing partners, consultants, agents and other organizations to which we disclose our proprietary information. These agreements may not effectively prevent disclosure of confidential information and may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. In addition, others may independently discover trade secrets and proprietary information, and in such cases we could not assert any trade secret rights against such parties. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret protection could adversely affect our competitive business position. Since we rely on trade secrets and nondisclosure agreements, in addition to patents, to protect some of our intellectual property, there is a risk that third parties may obtain and improperly utilize our proprietary information to our competitive disadvantage. We may not be able to detect unauthorized use or take appropriate and timely steps to enforce our intellectual property rights.
 
The manufacture, use or sale of our current and proposed products may infringe on the patent rights of others, and we may be forced to litigate if an intellectual property dispute arises.
 
If we infringe or are alleged to have infringed another party’s patent rights, we may be required to seek a license, defend an infringement action or challenge the validity of the patents in court. Patent litigation is costly and time consuming. We may not have sufficient resources to bring these actions to a successful conclusion. In addition, if we do not obtain a license, do not successfully defend an infringement action or are unable to have infringed patents declared invalid, we may:
  
 
incur substantial monetary damages;

 
encounter significant delays in marketing our current and proposed product candidates;

 
be unable to conduct or participate in the manufacture, use or sale of product

 
● 
candidates or methods of treatment requiring licenses;

 
lose patent protection for our inventions and products; or

 
find our patents are unenforceable, invalid, or have a reduced scope of protection.
 

 
 
20

 
 

Parties making such claims may be able to obtain injunctive relief that could effectively block our ability to further develop or commercialize our current and proposed product candidates in the United States and abroad and could result in the award of substantial damages. Defense of any lawsuit or failure to obtain any such license could substantially harm the company. Litigation, regardless of outcome, could result in substantial cost to and a diversion of efforts by the Company to operate its business.
 
We may face costly intellectual property disputes.
 
Our ability to compete effectively will depend in part on our ability to develop and maintain proprietary aspects of our technologies and either to operate without infringing the proprietary rights of others or to obtain rights to technology owned by third parties. Our pending patent applications, specifically patent rights of the MK IV, ELEKTRA and ATO technologies, may not result in the issuance of any patents or any issued patents that will offer protection against competitors with similar technology. Patents we have received for our technologies, and which we may receive, may be challenged, invalidated or circumvented in the future or the rights created by those patents may not provide a competitive advantage. We also rely on trade secrets, technical know-how and continuing invention to develop and maintain our competitive position. Others may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets.
 
We may not be able to attract or retain qualified senior personnel.
 
We believe we are currently able to manage our current business with our existing management team. However, as we expand the scope of our operations, we will need to obtain the full-time services of additional senior management and other personnel. Competition for highly-skilled personnel is intense, and there can be no assurance that we will be able to attract or retain qualified senior personnel. Our failure to do so could have an adverse effect on our ability to implement our business plan. As we add full-time senior personnel, our overhead expenses for salaries and related items will increase compensation packages, these increases could be substantial.
 
If we lose our key personnel or are unable to attract and retain additional personnel, we may be unable to achieve profitability.
 
Our future success is substantially dependent on the efforts of our senior management, particularly Cecil Bond Kyte, our Chief Executive Officer, Charles R. Blum, our President and Gregg Bigger our Chief Financial Officer. The loss of the services of members of our senior management may significantly delay or prevent the achievement of product development and other business objectives. Because of the scientific nature of our business, we depend substantially on our ability to attract and retain qualified marketing, scientific and technical personnel, including consultants. There is intense competition among specialized automotive companies for qualified personnel in the areas of our activities. If we lose the services of, or do not successfully recruit key marketing, scientific and technical personnel, the growth of our business could be substantially impaired. We do not maintain key man insurance for any of these individuals.  


 
 
21

 
 

Changes in stock option accounting rules may adversely affect our reported operating results, our stock price, and our ability to attract and retain employees.
 
In December 2004, the Financial Accounting Standards Board (“FASB”) published new rules that will require companies such as us to record all stock-based employee compensation as an expense. The new rules apply to stock options grants, as well as a wide range of other share-based compensation arrangements including restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As required by FASB, we adopted these rules effective January 1, 2006.  As a small company with limited financial resources, we have depended upon compensating our officers, directors, employees and consultants with such stock based compensation awards in the past in order to limit our cash expenditures and to attract and retain officers, directors, employees and consultants. Accordingly, if we continue to grant stock options or other stock based compensation awards to our officers, directors, employees, and consultants, our future earnings, if any, will be reduced (or our future losses will be increased) by the expenses recorded for those grants. These compensation expenses may be larger than the compensation expense that we would be required to record were we able to compensate these persons with cash in lieu of securities. Since we are a small company, the expenses we may have to record as a result of future options grants may be significant and may materially negatively affect our reported financial results.
 
Currently, there is only very limited trading in our stock, so you may be unable to sell your shares at or near the quoted bid prices if you need to sell your shares.
 
The shares of our common stock are thinly-traded on the OTC Bulletin Board, meaning that the number of persons interested in purchasing our common shares at or near bid prices at any given time may be relatively small or non-existent. This situation is attributable to a number of factors, including the fact that we are a small company engaged in a high risk business which is relatively unknown to stock analysts, stock brokers, institutional investors and others in the investment community that can generate or influence daily trading volume and valuation. Should we even come to the attention of such persons, they tend to be risk-averse and would be reluctant to follow an unproven, early stage company such as ours or purchase or recommend the purchase of our shares until such time as we became more seasoned and viable. As a consequence, there may be periods of several days or more when trading activity in our shares is minimal or non-existent, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous trading without negatively impacting our share price. We cannot provide any assurance that a broader or more active public trading market for shares of our common stock will develop or be sustained.  Due to these conditions, we cannot give any assurance that shareholders will be able to sell their shares at or near bid prices or at all.
 
The market price of our stock is volatile.
 
The market price for our common stock has been volatile during the last year, ranging from a closing price of $0.60 on January 3, 2011 to a closing price of $0.20 on August 8, 2011, and a closing price of $0.64 on March 15, 2012. Additionally, the price of our stock has been both higher and lower than those amounts on an intra-day basis in the last year. Because our stock is thinly traded, its price can change dramatically over short periods, even in a single day. The market price of our common stock could fluctuate widely in response to many factors, including:
 
 
developments with respect to patents or proprietary rights;

 
announcements of technological innovations by us or our competitors;

 
announcements of new products or new contracts by us or our competitors;

 
actual or anticipated variations in our operating results due to the level of development expenses and other factors;

 
changes in financial estimates by securities analysts and whether any future earnings of ours meet or exceed such estimates;

 
 
22

 
 
 

 
conditions and trends in our industry;

 
new accounting standards;

 
general economic, political and market conditions and other factors; and

 
the occurrence of any of the risks described in this Memorandum.
 
Substantial sales of common stock could cause our stock price to fall.
 
In the past year, there have been times when average daily trading volume of our common stock has been extremely low, and there have been many days in which no shares were traded at all. At other times, the average daily trading volume of our common stock has been high.  Nevertheless, the possibility that substantial amounts of common stock may be sold in the public market may adversely affect prevailing market prices for our common stock and could impair our ability to raise capital through the sale of our equity securities.
  
Potential issuance of additional shares of our common stock could dilute existing stockholders.
 
We are authorized to issue up to 200,000,000 shares of common stock. To the extent of such authorization, our Board of Directors has the ability, without seeking stockholder approval, to issue additional shares of common stock in the future for such consideration as the Board of Directors may consider sufficient. The issuance of additional common stock in the future will reduce the proportionate ownership and voting power of the common stock offered hereby.
 
Our common stock is subject to penny stock regulation, which may make it more difficult for us to raise capital.
 
Our common stock is considered penny stock under SEC regulations. It is subject to rules that impose additional sales practice requirements on broker-dealers who sell our securities. For example, broker-dealers must make a suitability determination for the purchaser, receive the purchaser’s written consent to the transaction prior to sale, and make special disclosures regarding sales commissions, current stock price quotations, recent price information and information on the limited market in penny stock. Because of these additional obligations, some broker-dealers may not effect transactions in penny stocks, which may adversely affect the liquidity of our common stock and shareholders’ ability to sell our common stock in the secondary market. This lack of liquidity may make it difficult for us to raise capital in the future.

Item 1B.  Unresolved Staff Comments
 
None
 

 
23

 
 
Item 2.  Properties
 
Our Executive Offices are located at 735 State Street, Suite 500, Santa Barbara, California 93101 and our engineering, production and testing facility is located at 235 Tennant Avenue, Morgan Hill, California 95037. In September 2005, the Company entered into a lease for the Morgan Hill facility for  the term September 1, 2005 through August 31, 2007 and carried an option to renew for two additional years at the then prevailing market rate. Monthly rent was $2,240 per month under this lease. The lease was amended in February 2006 for additional space. Monthly rate under the amended lease was $4,160 per month.  The Company renewed this lease on August 9, 2007 for an additional two-year term.  The rent is $4,640 per month for the first six months of the new term of the lease and $5,480 per month for the remaining eighteen months of the new term of the lease.  We believe that this space is adequate for our current and planned needs.
 
Leases
 
In March 2009, the Company entered into a sublease agreement for its executive offices in Santa Barbara, California. The term of the lease was for $3,520 per month from April 1, 2010 through December 31, 2010 and $3,630 per month from January 1, 2010 to December 31, 2010. In November 2010, the Company amended the lease agreement. Pursuant to the amendment, the term of the lease was for $5,830 per month from January 1, 2011 to December 31, 2013.
 
Total rent expense under this lease and other operating leases in effect during the years ended December 31, 2011 and 2010, was $138,840 and $112,320, respectively. The following is a schedule by years of future minimum rental payments required under the non-cancellable operating leases as of December 31, 2011.
   
Years Ending December 31,
     
2011
 
$
69,960
 
2012
   
69,960
 
2013
   
69,960
 
         
Total
 
$
209,880
 
     
Item 3.  Legal Proceedings
 
There is no other litigation of any significance with the exception of the matters that have arisen under, and are being handled in, the normal course of business.   

Litigation Involving Former Executive Officer
   
As previously reported, on April 7, 2010, Bruce McKinnon, the former CEO of the Company, and the Company entered into an Agreement Re: Collection on Judgment (“Judgment”) (the “Settlement Agreement”),  wherein McKinnon, among other things, agreed to cease further collection efforts on the Judgment, and the Company, among other things, agreed to satisfy the Judgment for, and McKinnon agreed to accept as full and final satisfaction of the Judgment, subject to certain payment waivers, a total amount of $360,000, plus interest of ten percent (10%) per annum from March 15, 2010, on the unpaid balance until paid, payable as follows:  $30,000 on April 7, 2010; $85,000 on or before April 15, 2010; and, $15,000 per month commencing on June 1, 2010, until paid.   As of December 31, 2011, all payments were made on time and the balance has been paid in full.
 
Item 4.   Mine Safety Disclosures.

None.
 




 
 
24

 
 

PART II
 
Item 5.    Market for Common Equity and Related Stockholder Matters

Through May 21, 2007, our common stock was traded on the Over the Counter Bulletin Board (the “OTCBB” under the symbol “ZERO”. Effective May 22, 2007, our common stock was removed from the OTCBB and placed on the “Pink Sheets”. Effective February 8, 2010, our common stock was reinstated and currently trades on the OTCBB. The following table sets forth the high and low bid prices of the Company’s common stock for the quarters indicated as quoted on the Pink Sheets or the OTCBB, as applicable, as reported by Yahoo Finance. These quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission, and may not represent actual transactions.
 
   
2011
   
2010
 
   
High
   
Low
   
High
   
Low
 
First Quarter
 
$
0.64
   
$
0.25
   
$
0.82
   
$
0.47
 
Second Quarter
 
$
0.44
   
$
0.30
   
$
0.74
   
$
0.32
 
Third Quarter
 
$
0.37
   
$
0.18
   
$
0.45
   
$
0.20
 
Fourth Quarter
 
$
0.43
   
$
0.20
   
$
0.54
   
$
0.28
 

According to the records of our transfer agent, we had 1,131 stockholders of record of our common stock at March 15, 2012. The Company believes that the number of beneficial owners is substantially higher than this amount.
 
We do not pay a dividend on our common stock and we currently intend to retain future cash flows to finance our operations and fund the growth of our business. Any payment of future dividends will be at the discretion of our Board of Directors and will depend upon, among other things, our earnings, financial condition, capital requirements, level of indebtedness, contractual restrictions in respect to the payment of dividends and other factors that our Board of Directors deems relevant.

Issuances of Unregistered Securities in Current Fiscal Year
 
2011 Winter Offering. From December 13, 2010 through February 28, 2011, we conducted a private offering (the “2011 Winter Offering”) and issued Convertible Notes in the aggregate face amount of $2,588,422.  These Notes were sold for an aggregate purchase price of $2,353,111 net proceeds.  The Notes are convertible into 10,353,688 shares of our common stock and in addition, investors received warrants entitling the holders to purchase up to 10,353,688 shares of our common stock.  (See “Details of Recent Financing Transactions.”)
 
2011 Spring Offering. From March 14, 2011 through May 31, 2011, we conducted a private offering (the “2011 Spring Offering”) and issued Convertible Notes in the aggregate face amount of $1,469,550.  These Notes were sold for an aggregate purchase price of $1,335,955 net proceeds.  The Notes are convertible into 5,878,200 shares of our common stock and in addition, investors received warrants entitling the holders to purchase up to 5,878,200 shares of our common stock.  (See “Details of Recent Financing Transactions.”) 
 
2011 Summer Offering. From June 24, 2011 through July 31, 2011, we conducted a private offering (the “2011 Summer Offering”) and issued Convertible Notes in the aggregate face amount of $487,783.  These Notes were sold for an aggregate purchase price of $443,439 net proceeds.  The Notes are convertible into 1,951,132 shares of our common stock and in addition, investors received warrants entitling the holders to purchase up to 1,951,132 shares of our common stock.  (See “Details of Recent Financing Transactions.”)
 
2011 Fall Offering. From August 30, 2011 through October 15, 2011, we conducted a private offering (the “2011 Fall Offering”) and issued Convertible Notes in the aggregate face amount of $170,720.  These Notes were sold for an aggregate purchase price of $155,200 net proceeds.  The Notes are convertible into 682,880 shares of our common stock and in addition, investors received warrants entitling the holders to purchase up to 682,880 shares of our common stock.  (See “Details of Recent Financing Transactions.”)
 
2011 Fall Offering #2. From October 24, 2011 through December 13, 2011, we conducted a private offering (the “2011 Fall Offering #2”) and issued Convertible Notes in the aggregate face amount of $1,516,504.  These Notes were sold for an aggregate purchase price of $1,378,640 net proceeds.  The Notes are convertible into 6,066,016 shares of our common stock and in addition, investors received warrants entitling the holders to purchase up to 6,066,016 shares of our common stock.  (See “Details of Recent Financing Transactions.”)
 
 
25

 
 
The sales of the securities described above were made in reliance on the exemptions from registration set forth in Section 4(2) of the Securities Act of 1933, as amended (the “Act”), or Regulations D or S promulgated thereunder.

Other Issuances

During the year ended December 31, 2011, we issued an aggregate of 22,710,276 shares of our common stock as follows:
 
 
During 2011, we issued 2,800,000 shares of our common stock for services valued in the aggregate at $862,000. We valued the shares at market prices at the date of the agreements ranging from $0.25 to $0.60 per share.

 
During 2011 we issued 19,861,478 shares of our common stock in exchange for conversion of $4,965,370 of Convertible Notes.  We valued the shares at $0.25 pursuant to the term of the convertible note.

 
During 2011, we issued 77,778 shares of our common stock for exercised options valued at $0.27 per share.

 
During 2011, we issued 81,020 shares of our common stock for cashless exercise of warrants.
  
Item 6.   Selected Financial Data
  
Not Applicable

Item 7.   Management’s Discussion and Analysis or Plan of Operation

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Consolidated Financial Statements and supplementary data referred to in Item 7 of this Form 10-K.
 
This discussion contains forward-looking statements that involve risks and uncertainties. Such statements, which include statements concerning future revenue sources and concentration, selling, general and administrative expenses, research and development expenses, capital resources, additional financings and additional losses, are subject to risks and uncertainties, including, but not limited to, those discussed above in Item 1 and elsewhere in this Form 10-K, particularly in “Risk Factors,” that could cause actual results to differ materially from those projected. Unless otherwise expressly indicated, the information set forth in this Form 10-K is as of December 31, 2011, and we undertake no duty to update this information.

Overview

We are a development stage company that generated its first initial revenues in the fourth quarter of 2006. Our focus is on research and development, and initial sales and marketing, of products incorporating our proprietary and patented technology, which is designed to reduce harmful emissions, and/or improve fuel efficiency and engine performance on equipment and vehicles driven by internal combustion engines. We have devoted the bulk of our efforts to the completion of the design, the development of our production models, testing of devices and the promotion of our products in the marketplace. We anticipate that these efforts will continue during 2012.
 
Our expenses to date have been funded primarily through the sale of shares of common stock and convertible debt, as well as proceeds from the exercise of stock purchase warrants. We raised capital in 2011 and will need to raise substantial additional capital in 2012, and possibly beyond, to fund our sales and marketing efforts, continuing research and development, and certain other expenses, until our revenue base grows sufficiently.
   
Results of Operation

There were no revenues and cost of sales for the fiscal year ended December 31, 2011 and 2010.
 
Operating expenses were $6,886,681 for the fiscal year ended December 31, 2011, compared to $4,293,631 for the fiscal year ended December 31, 2010, an increase of $2,593,050. This increase is attributable to increases in non-cash expenses of $1,773,975 and cash expenses of $819,075. Specifically, the increase in non-cash expenses is attributable to increases in valuation warrants and options given employees as compensation of $2,010,528, offset by a decrease in valuation of stocks and warrants given to consultants of $237,249. The increase in cash expenses is attributable to increases in consulting and professional fees of $373,722, salaries and benefits of 222,736, office and other expenses of $126,125, travel expenses of $53,626 and corporate expenses of $42,866.
 

 
 
26

 
 

Research and development expenses were $1,130,283 for the fiscal year ended December 31, 2011, compared to $427,982 for the fiscal year ended December 31, 2010, an increase of $702,301. This increase is primarily attributable to increases in product testing, research and supplies of $610,166 and contract fees of $118,635, offset by a decrease in travel expenses of $26,500.
 
Other expenses were $2,838,783 for the fiscal year ended December 31, 2011, compared to $4,772,493 for the fiscal year ended December 31, 2010, a decrease of $1,933,710. This decrease is attributable to decreases in the fair value of derivative liabilities of $1,607,031, cost of private placement of $1,129,212 which was not incurred in 2011, cost to induce conversion of certain notes of $168,340 which was not incurred in 2011, and increase in other income of $78,822, offset by an increase in interest and financing expense of $1,049,695.
 
We had a net loss of $10,856,547 or $0.10 loss per share for the fiscal year ended December 31, 2011 compared to a net loss of $9,494,906, or $0.12 loss per share for the fiscal year ended December 31, 2010.
  
Liquidity and Capital Resources

General

We have incurred negative cash flow from operations in the developmental stage since our inception in 1998. As of December 31, 2011, we had cash of $617,797 and an accumulated deficit of $69,289,467. Our negative operating cash flow in 2011 was funded primarily through the sale convertible notes.

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, we had a net loss of $10,856,547 and a negative cash flow from operations of $4,723,952 for the year ended December 31, 2011, and had a working capital deficiency (excluding our derivative liability) of $1,548,080 and a stockholders’ deficiency of $3,105,282 at December 31, 2011.  These factors raise substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern is dependent upon our ability to raise additional funds and implement our business plan. The consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

During 2011, we raised an aggregate of $5,360,070 in net proceeds from the issuance of Convertible Notes, as follows:
     
 
Net proceeds of $2,251,832 from the issuance of convertible notes and warrants in a 2011 Winter Offering.  The face amount of the notes is $2,588,422.
     
 
Net proceeds of $1,141,600 from the issuance of convertible notes and warrants in a 2011 Spring Offering.  The face amount of the notes is $1,469,550.
     
 
Net proceeds of $437,998 from the issuance of convertible notes and warrants in a 2011 Summer Offering.  The face amount of the notes is $487,783.
     
 
Net proceeds of $150,000 from the issuance of convertible notes and warrants in a 2011 Fall Offering.  The face amount of the notes is $170,720.
     
 
Net proceeds of $1,378,640 from the issuance of convertible notes and warrants in a 2010 Fall Offering #2.  The face amount of the notes is $1,516,504.

 

 
 
27

 
 

Details of Recent Financing Transactions

2011 Winter Offering

From December 13, 2010 through February 28, 2011, we  conducted a private offering (the “Winter 2011 Offering”) of up to $3,000,000 aggregate face amount of its convertible notes (the “Winter 2011  Notes”). A total of $2,588,422 aggregate face amount of the Winter 2011  Notes were sold for an aggregate purchase price of $2,353,111.  While there was no stated interest rate on the Winter 2011 Notes, the implied effective interest rate on the Winter 2011 Notes is 10% per annum. The Winter 2011 Notes mature on the first anniversary of their date of issuance. The Winter 2011 Notes are convertible, at the option of the note holder, into 10,353,688 shares of our common stock (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).
 
Each of the investors in the Winter 2011 Offering received, for no additional consideration, a warrant (the “Winter 2011 Warrants”), entitling the holder to purchase a number of shares of our common stock equal to 100% of the number of shares of common stock into which the Winter 2011 Notes are convertible (the “Warrant Shares”).  Each Winter 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 10,353,688 Warrant Shares are initially issuable to date on exercise of the Winter 2011 Warrants.
    
We received $2,251,032 in net proceeds in the 2011 Winter Offering which was used for general corporate purposes and working capital. The aggregate value of the 2011 Offering Warrants issued were valued at $1,368,888 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of 0.69; dividend yield of 0%; volatility factors of the expected market price of common stock of 120%; and an expected life of two years (statutory term) and vest immediately upon issuance.  We also determined that the notes contained a beneficial conversion feature valued at $984,223.  The aggregate value of the 2011 Winter Offering Warrants, the beneficial conversion feature and the implied discount and transaction fees of $235,311 are considered as debt discount and are being amortized over the life of the notes. The amortization recorded during the period amounted to $2,573,756.

As of December 31, 2011, investors have converted $2,500,422 of the Convertible Notes into 10,001,688 shares of our common stock. The outstanding balance at December 31, 2011 was $88,000.

2011 Spring Offering

From March 14, 2011 through May 31, 2011, we  conducted a private offering (the “Spring 2011 Offering”) of up to $1,000,000 aggregate face amount of its convertible notes (the “Spring 2011  Notes”). A total of $1,469,550 aggregate face amount of the Spring 2011 Notes were sold for an aggregate purchase price of $1,335,955.  While there was no stated interest rate on the Spring 2011 Notes, the implied effective interest rate on the Spring 2011 Notes is 10% per annum. The Spring 2011 Notes mature on the first anniversary of their date of issuance. The Spring 2011 Notes are convertible, at the option of the note holder, into 5,878,200 shares of our common stock (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).
 
Each of the investors in the Spring 2011 Offering received, for no additional consideration, a warrant (the “Spring 2011 Warrants”), entitling the holder to purchase a number of shares of our common stock equal to 100% of the number of shares of common stock into which the Spring 2011 Notes are convertible (the “Warrant Shares”).  Each Spring 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 5,878,200 Warrant Shares are initially issuable to date on exercise of the Spring 2011 Warrants.
    



 
 
28

 
 

We received $1,141,599 in net proceeds in the 2011 Spring Offering which was used for general corporate purposes and working capital. The aggregate value of the 2011 Spring Offering Warrants issued were valued at $726,787 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of 0.45; dividend yield of 0%; volatility factors of the expected market price of common stock of 119%; and an expected life of two years (statutory term) and vest immediately upon issuance.  We also determined that the notes contained a beneficial conversion feature valued at $609,168. The aggregate value of the 2011 Spring Offering Warrants, the beneficial conversion feature and the implied discount and transaction fees of $133,595 are considered as debt discount and are being amortized over the life of the notes or amortized in full upon conversion.  The amortization recorded during the period amounted to $1,469,550.

As of December 31, 2011, investors have converted $1,469,550 of the Convertible Notes into 5,878,200 shares of our common stock.  There was no outstanding balance at December 31, 2011.

2011 Summer Offering

From June 24, 2011 through July 31, 2011, we conducted a private offering (the “Summer 2011 Offering”) of up to $1,000,000 aggregate face amount of its convertible notes (the “Summer 2011  Notes”). A total of $487,783 aggregate face amount of the Summer 2011 Notes were sold for an aggregate purchase price of $443,439.  While there was no stated interest rate on the Summer 2011 Notes, the implied effective interest rate on the Summer 2011 Notes is 10% per annum. The Summer 2011 Notes mature on the first anniversary of their date of issuance. The Summer 2011 Notes are convertible, at the option of the note holder, into 1,951,132 shares of our common stock (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).
  
Each of the investors in the Summer 2011 Offering received, for no additional consideration, a warrant (the “Summer 2011 Warrants”), entitling the holder to purchase a number of shares of our common stock equal to 100% of the number of shares of common stock into which the Summer 2011 Notes are convertible (the “Warrant Shares”).  Each Summer 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 1,951,132 Warrant Shares are initially issuable to date on exercise of the Summer 2011 Warrants.
    
We received $437,999 in net proceeds in the 2011 Summer Offering which was used for general corporate purposes and working capital. The aggregate value of the 2011 Summer Offering Warrants issued were valued at $172,856 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of 0.36; dividend yield of 0%; volatility factors of the expected market price of common stock of 116%; and an expected life of two years (statutory term) and vest immediately upon issuance.  We also determined that the notes contained a beneficial conversion feature valued at $270,583.  The aggregate value of the 2011 Summer Offering Warrants, the beneficial conversion feature and the implied discount and transaction fees of $44,344 are considered as debt discount and were amortized in full upon conversion of the notes. The amortization recorded during the period amounted to $487,783.

As of December 31, 2011, investors have converted $487,783 of the Convertible Notes into 1,951,132 shares of our common stock.  There was no outstanding balance as of December 31, 2011.

2011 Fall Offering

From August 30, 2011 through October 15, 2011, we conducted a private offering (the “Fall 2011 Offering”) of up to $1,000,000 aggregate face amount of its convertible notes (the “Fall 2011  Notes”). A total of $170,720 aggregate face amount of the Fall 2011 Notes were sold for an aggregate purchase price of $155,200.  While there was no stated interest rate on the Fall 2011 Notes, the implied effective interest rate on the Fall 2011 Notes is 10% per annum. The Fall 2011 Notes mature on the first anniversary of their date of issuance. The Fall 2011 Notes are convertible, at the option of the note holder, into 682,880 shares of our common stock (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).
  
Each of the investors in the Fall 2011 Offering received, for no additional consideration, a warrant (the “Fall 2011 Warrants”), entitling the holder to purchase a number of shares of our common stock equal to 100% of the number of shares of common stock into which the Fall 2011 Notes are convertible (the “Warrant Shares”).  Each Fall 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 682,880 Warrant Shares are initially issuable to date on exercise of the Fall 2011 Warrants.


 
 
29

 
 

We received $150,000 in net proceeds in the 2011 Summer Offering which was used for general corporate purposes and working capital. The aggregate value of the 2011 Fall Offering Warrants issued were valued at $50,958 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of 0.28; dividend yield of 0%; volatility factors of the expected market price of common stock of 112%; and an expected life of two years (statutory term) and vest immediately upon issuance.  We also determined that the notes contained a beneficial conversion feature valued at $104,242.  The aggregate value of the 2011 Fall Offering Warrants, the beneficial conversion feature and the implied discount and transaction fees of $15,520 are considered as debt discount and are being amortized over the life of the note or amortized in full upon conversion of the notes. The amortization recorded during the period amounted to $87,992.

As of December 31, 2011, investors have converted $66,220 of the Convertible Notes into 264,880 shares of our common stock. The outstanding balance at December 31, 2011 was $104,500.

2011 Fall#2 Offering

From October 24, 2011 through December 13, 2011 we conducted a private offering (the “Fall#2 2011 Offering”) of up to $2,200,000 aggregate face amount of its convertible notes (the “Fall#2 2011  Notes”). A total of $1,516,504 aggregate face amount of the Fall#2 2011 Notes have been sold for an aggregate purchase price of $1,378,640.  While there is no stated interest rate on the Fall#2 2011 Notes, the implied effective interest rate on the Fall#2 2011 Notes is 10% per annum. The Fall#2 2011 Notes mature on the first anniversary of their date of issuance. The Fall#2 2011 Notes are convertible, at the option of the note holder, into 6,066,016 shares of our common stock (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).
  
Each of the investors in the Fall#2 2011 Offering will receive, for no additional consideration, a warrant (the “Fall#2 2011 Warrants”), entitling the holder to purchase a number of shares of our common stock equal to 100% of the number of shares of common stock into which the Fall#2 2011 Notes are convertible (the “Warrant Shares”).  Each Fall#2 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 6,066,016 Warrant Shares are initially issuable to date on exercise of the Fall#2 2011 Warrants.

We received $1,378,640 in net proceeds in the 2011 Fall#2 Offering which was used for general corporate purposes and working capital. The aggregate value of the 2011 Fall#2 Offering Warrants issued were valued at $650,823 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of 0.24; dividend yield of 0%; volatility factors of the expected market price of common stock of 112%; and an expected life of two years (statutory term) and vest immediately upon issuance.  We also determined that the notes contained a beneficial conversion feature valued at $727,817.  The aggregate value of the 2011 Fall#2 Offering Warrants, the beneficial conversion feature and the implied discount and transaction fees of $137,864 are considered as debt discount and are being amortized over the life of the note or amortized in full upon conversion of the notes. The amortization recorded during the period amounted to $63,188.

As of December 31, 2011, there was no note conversion to common stock. The outstanding balance at December 31, 2011 was $1,516,504.

Summary
 
At December we had cash on hand in the amount of $657,805 and since December 31, 2011, we have raised an additional $1,338,440 through the sale of Convertible Notes.  At December 31, 2011 the we had outstanding Convertible Notes amounting to $1,720,504 of which $1,051,440 have been converted into 4,205,760 shares of common stock.  We expect the balance of these notes and the notes issued after December 31, 2011will be converted into shares of common stock. It is possible that we may need additional funds to operate our business, including without limitation the expenses we will incur in connection with the license and research and development agreements with Temple University; costs associated with product development and commercialization of the AOT and the ELEKTRA technology; costs to manufacture and ship our products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, we have substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, certain severance payments to a former officer and consulting fees, during the remainder of 2012 and beyond.
   
No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company.
 

 
 
30

 
 

Contractual Obligations

The following table discloses our contractual commitments for future periods. Long-term commitments are comprised of operating leases and minimum guaranteed compensation payments under employment and other agreements.  See Note 10 to Notes to Consolidated Financial Statements, “Commitments and Contingencies”.

Year ending December 31,
 
Operating Leases (1)
   
Guaranteed Payments
 
2012
 
$
69,960
   
$
643,300
 (2)
2013
   
69,960
     
    498,300
 (3)
2014
   
     
    498,300
 (3)
2015
   
     
    498,300
 (3)
2016
   
     
  213,400
 (4)
Total
 
$
139,920
   
$
2,351,600
 
 

(1) 
Consists of rent for our Santa Barbara Facility expiring on December 31, 2013. (For description of this property, see Part 1, Item 2, and “Property”).
(2) 
Consists of an aggregate of  $310,800 in total compensation, including base salary and certain contractually-provided benefits, to an executive officer, pursuant to an employment agreement that expires on January 30, 2016, $287,500 in licensing  maintenance fees to Temple University and $45,000 in consulting fees to Irth Communications.
(3) 
Consists of an aggregate of $310,800 in total compensation, including base salary and certain contractually-provided benefits to an executive officer, pursuant to an employment agreement that expires on January 30, 2016 and $187,500 in licensing maintenance fees to Temple University.
(4)
Consists of an aggregate of $25,900 in total compensation, including base salary and certain contractually-provided benefits to an executive officer, pursuant to an employment agreement that expires on January 30, 2016 and $187,500 in licensing maintenance fees to Temple University.
 
Licensing Fees to Temple University.  For details of the licensing agreements with Temple University, see “Part I, Item 1, “Business - Our Business Strategy - Our Products and Technologies.”

Critical Accounting Policies and Estimates
 
Our discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, expenses, and related disclosure of contingent assets and liabilities. We evaluate, on an on-going basis, our estimates and judgments, including those related to the useful life of the assets. We base our estimates on historical experience and assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
  
The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the results that we report in our consolidated financial statements. The SEC considers an entity’s most critical accounting policies to be those policies that are both most important to the portrayal of a company’s financial condition and results of operations and those that require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about matters that are inherently uncertain at the time of estimation. . For a more detailed discussion of the accounting policies of the Company, see Note 2 of the Notes to the Consolidated Financial Statements, “Summary of Significant Accounting Policies”.
 
We believe the following critical accounting policies, among others, require significant judgments and estimates used in the preparation of our consolidated financial statements.
 

 
 
31

 
 

The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Certain significant estimates were made in connection with preparing our consolidated financial statements as described in Note 1 to Notes to Consolidated Financial Statements. Actual results could differ from those estimates.
  
Stock-Based Compensation
  
The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.
   
The fair value of the Company's common stock option grant is estimated using the Black-Scholes option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes option pricing model could materially affect compensation expense recorded in future periods.
 
Accounting for Warrants and Derivatives
 
The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations.  For stock-based derivative financial instruments, the Company uses probability weighted average series Black-Scholes Merton option pricing models to value the derivative instruments at inception and on subsequent valuation dates.
 
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.  Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Recent Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2011-4, which amends the Fair Value Measurements Topic of the Accounting Standards Codification (ASC) to help achieve common fair value measurement and disclosure requirements in U.S. GAAP and IFRS.  ASU No. 2011-4 does not require additional fair value measurements and is not intended to establish valuation standards or affect valuation practices outside of financial reporting.  The ASU is effective for interim and annual periods beginning after December 15, 2011. The Company will adopt the ASU as required.  The ASU will affect the Company’s fair value disclosures, but will not affect the Company’s results of operations, financial condition or liquidity.
 
In June 2011, the FASB issued ASU No. 2011-5, which amends the Comprehensive Income Topic of the ASC.  The ASU eliminates the option to present the components of other comprehensive income as part of the statement of changes in shareholders’ equity, and instead requires consecutive presentation of the statement of net income and other comprehensive income either in a continuous statement of comprehensive income or in two separate but consecutive statements.  ASU No. 2011-5 is effective for interim and annual periods beginning after December 15, 2011.  The Company will adopt the ASU as required.  It will have no affect on the Company’s results of operations, financial condition or liquidity.
 
 In September 2011, the FASB issued ASU 2011-08, “Testing Goodwill for Impairment”, an update to existing guidance on the assessment of goodwill impairment.  This update simplifies the assessment of goodwill for impairment by allowing companies to consider qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount before performing the two step impairment review process.  It also amends the examples of events or circumstances that would be considered in a goodwill impairment evaluation.  The amendments are effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted.  The Company is currently evaluating the affects adoption of ASU 2011-08 may have on its goodwill impairment testing. 
 
Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Item 7A.  Quantitative and Qualitative Disclosure About Market Risk

Not Applicable

 
 
32

 
 

Item 8.  Financial Statements

Our consolidated financial statements as of and for the years ended December 31, 2011 and 2010 are presented in a separate section of this report following Item 15 and begin with the index on page F-1.

Item 9.  Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A.  Controls and Procedures
 
Evaluation of Disclosure Controls and Procedures

Our management evaluated, with the participation of our Chief Executive Officer and Interim Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Annual Report on Form 10-K. Based on this evaluation, our Chief Executive Officer and Interim Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)  were ineffective as of December 31, 2011, due to a material weakness in our internal control over financial reporting described below.
 
Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.  Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including our Chief Executive Officer and Interim Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.  Internal control consists of procedures which are designed with the objective of providing reasonable assurance that our transactions are properly authorized, recorded and reported and our assets are safeguarded against unauthorized or improper use, to permit the preparation of our financial statements in conformity with generally accepted accounting principles.
 
We identified certain matters that constitute material weakness (as defined under the Public Company Accounting Oversight Board Auditing Standard No. 2) in our internal control over financial reporting as discussed on Management’s Annual Report on Internal Control Over Financial Reporting below.
 
In light of the material weakness in internal control over financial reporting described below, we performed additional analysis and other post-closing procedures to ensure that our financial statements were prepared in accordance with generally accepted accounting principles.  Despite the material weakness in our internal control over financial reporting, we believe that the financial statements included in our Form 10-K for the period ended December 31, 2011 fairly present, in all material respects, our financial condition, results of operations, changes in stockholders' deficiency and cash flows for the periods presented.
  
Management’s Annual Report on Internal Control over Financial Reporting.

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transaction and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
 

 
 
33

 
 

Because of its inherent limitation, internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives.
  
Our Chief Executive Officer, Interim Chief Financial Officer and Controller conducted an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2011 based on the framework in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).  A material weakness is a deficiency or a combination of deficiencies in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.
 
Based on that assessment, we have identified the following material weakness and have implemented remediation of material weakness in internal control over financial reporting.
   
Lack of documented and reviewed system of internal control
 
We have an internal control weakness due to the lack of a documented and reviewed system of internal control. We have determined that to perform the processes and remediate this internal control deficiency, we will either need to engage an internal control consultant or reassign existing personnel. We have started to enhance some of our key internal control systems surrounding purchasing and requisitions, and to document those changes; however, this process is on-going and the implementation of policies and procedures may take several quarters.
        
As a result of the material weaknesses described above, management concluded that, as of December 31, 2011, we did not maintain effective internal control over financial reporting based on the criteria established in Internal Control – Integrated Framework, issued by COSO.
 
We are conducting an evaluation to design and implement adequate systems of accounting and financial statement disclosure controls. We expect to complete a review during 2012 to comply with the requirements of the SEC.  We believe that the ultimate success of our plan to improve our internal control over financial reporting will require a combination of additional financial resources, outside consulting services, legal advice, additional personnel, further reallocation of responsibility among various persons, and substantial additional training of those of our officers, personnel and others, including certain of our directors such as our Chairman of the Board and committee chairs, who are charged with implementing and/or carrying out our plan.  It should also be noted that the design of any system of controls and procedures is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.
 
Our annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting and management’s report was not subject to attestation by our registered public accounting firm pursuant to rules of the SEC that permit us to provide only Management’s report in this annual report.
  



 
 
34

 
 
 
 
Item 9B.  Other Information
 
AOT Testing

In March 2012,we entered into a Cooperation Framework Agreement with TDC. This agreement relates to possible distribution of STWA’s Applied Oil Technology in China.

In March 2002, we entered into a non-binding Letter of Intent with LG Partners in connection with its proposed development of a 900 mile non-domestic pipeline. It is LG Partners desire to install STWA’s Applied Oil Technology on their pipeline.

In October, 2011 the U.S. Department of Energy published the test results for energy-efficiency improvement generated by our prototype AOT units.  The results were an energy-efficiency gain between 13.14% and 13.55%.  The results were published by the U.S. Department of Energy (US DOE) and generated industry awareness of the new technology.

In August, 2011 we renegotiated a new licensing agreement with Temple University for the licensing of its intellectual property. The new licensing agreement provides for a convergent, non-divisional relationship with Temple University based largely on the grant of exclusive rights and co-ownership of future Intellectual Property (IP) through co-development.

In July, 2011 we finished construction of the testing facility and began the testing protocols of the Company’s prototype Applied Oil Technology (AOT™) units.

In March, 2011 we satisfied in full all overdue fees to Temple University pursuant to licensing agreements obtained in prior years.
  
In January, 2011 we began design and construction of a custom-built crude oil testing facility together with the U.S. Department of Energy, at their Rocky Mountain Oilfield Testing Center, located on the Naval Petroleum Reserve #3 near Casper, Wyoming.

In 2010, we worked with third-party entities to assist in the product development of commercial prototypes of the AOT technology.  The initial prototype has been constructed and is being used for testing by the U.S. Department of Energy.

In 2010, we were approved for testing by the US Department of Energy for testing our AOT at the US DOE Rocky Mountain Oilfield Testing Center, at the US Naval Petroleum Reserve #3 near Casper, Wyoming.

In 2010, we contracted with Pipeline Research Council International (PRCI) for testing of our AOT technology.

In 2010, Dr. Rongjia Tao of Temple University confirmed the AOT technology’s effects at nano-scale level using a neutron-scattering beam at the US National Institute of Standards and Technology (NIST).

In 2010, we satisfied our research and development agreement obligations with Temple University.
 
 



 
 
35

 
 
 
2011 Fall#3 Offering

From December 19, 2011 through January 15, 2012, the Company  conducted a private offering (the “Fall#3 2011 Offering”) of up to $3,000,000 aggregate face amount of its convertible notes (the “Fall#3 2011  Notes”). A total of $1,020,734 aggregate face amount of the Fall#3 2011  Notes were sold for an aggregate purchase price of $927,940.  While the stated interest rate on the Fall#3 2011 Notes is 0%, the actual interest rate on the Fall#3 2011 Notes is 10% per annum. The Fall#3 2011 Notes mature on the first anniversary of their date of issuance. The Fall#3 2011 Notes are convertible, at the option of the noteholder, into 4,082,936 shares of common stock of the Company (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).
 
Each of the investors in the Fall#3 2011 Offering received, for no additional consideration, a warrant (the “Fall#3 2011 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 100% of the number of shares of common stock into which the Fall#3 2011 Notes are convertible (the “Warrant Shares”).  Each Fall#3 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 4,082,936 Warrant Shares are initially issuable to date on exercise of the Fall#3 2011 Warrants.

2012 Winter Offering

From January 24, 2012 through February 3, 2012, the Company  conducted a private offering (the “Winter 2012 Offering”) of up to $2,200,000 aggregate face amount of its convertible notes (the “Winter 2012  Notes”). A total of $451,550 aggregate face amount of the Winter 2012  Notes were sold for an aggregate purchase price of $410,500.  While the stated interest rate on the Winter 2012 Notes is 0%, the actual interest rate on the Winter 2012 Notes is 10% per annum. The Winter 2012 Notes mature on the first anniversary of their date of issuance. The Winter 2012 Notes are convertible, at the option of the noteholder, into 1,806,200 shares of common stock of the Company (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).

Each of the investors in the Winter 2012 Offering received, for no additional consideration, a warrant (the “Winter 2012 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 100% of the number of shares of common stock into which the Winter 2012 Notes are convertible (the “Warrant Shares”).  Each Winter 2012 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 1,806,200 Warrant Shares are initially issuable to date on exercise of the Winter 2012 Warrants.

Employment Agreement Chief Financial Officer

On February 1, 2012, the Company entered into an employment agreement with Greggory M. Bigger to serve as the Company’s Chief Financial Officer.  A copy of the agreement if attached to this report as Exhibit 10.101.

 

 

 
 
36

 
 

PART III

Item 10.  Directors, Executive Officers and Corporate Governance

Composition of Board of Directors
 
Our bylaws provide that the Board shall consist of between one and eight directors, as determined by the Board from time to time. The Board consisted of three (3) members elected by the holders of the common stock at the Company’s Meeting of Shareholders on May 13, 2011.  Our directors are elected by our stockholders at each annual meeting of stockholders and will serve until their successors are elected and qualified, or until their earlier resignation or removal. Officers are appointed by our Board of Directors and their terms of office are, except to the extent governed by an employment contract, at the discretion of our Board of Directors.  There are no family relationships among any of our current directors or our executive officers.  
 
Directors
 
The following constitutes the Board of Directors as of December 31, 2011:
 
Name 
 
Age
 
Position 
 
Director Since
             
Cecil B. Kyte (1) (3)
 
40
 
Chief Executive Officer, Chairman, Director 
 
2006
             
Charles R. Blum (2)
 
74
 
President, Director   
 
2007
             
Nathan Shelton (1) (2) (3)
 
63
 
Director 
 
2007
 
(1) 
Member of the Audit Committee
(2) 
Member of the Compensation Committee
(3) 
Member of the Nominating and Corporate Governance Committee
 
Biographical Information Regarding Directors
 
Cecil Bond Kyte has served as a director since February 21, 2006.  In December 2007, Mr. Kyte was elected by the Board of Directors to serve as Chairman of the Board. On January 30, 2010, he was appointed to serve as Chief Executive Officer, replacing Charles R. Blum.  For the past twenty years Mr. Kyte has been a pilot in various capacities and flight academy instructor.  From February 2000 to November 2002, Mr. Kyte was employed by United States regional carrier, Chautauqua Airways, including service as an airline Captain.  After retiring in December 2002, Mr. Kyte has been an investor in a number of businesses, including oil and gas and financial business consulting services.  He is a co-founder of SwissGuard International, GmbH, a financial consulting firm based in Zurich, Switzerland.  A recent auto-racing achievement, Mr. Kyte won the 2006 SCCA ITA Regional Championship and also “Rookie of the Year” award.  Mr., Kyte received a B.S. Degree in Accounting from Long Beach State University.
 
Charles R. Blum was appointed on July 25, 2007 to the Board of directors and engaged as the President and Chief Executive Officer of the Company. In January 2010, Mr. Blum resigned as Chief Executive Officer and continues to serve as President.  Mr. Blum spent 22 years as the President/CEO of the Specialty Equipment Market Association (SEMA).  SEMA is a trade group representing 6500 business members who are actively engaged in the manufacture and distribution of automotive parts and accessories. SEMA produces the world’s largest automotive aftermarket Trade Show which is held annually in Las Vegas, Nevada. Mr. Blum led the association as its members grew from a handful of small entrepreneurial companies into an industry membership that sells over 31 billion dollars of product at the retail level annually. Mr. Blum has a proven record of accomplishment as a senior executive and brings a broad knowledge of the automotive aftermarket to the Company.  Mr. Blum attended Rutgers University.
   

 
 
37

 
 

Nathan Shelton has served as our director since February 12, 2007. Mr. Shelton has a long and distinguished career with a number of diverse successful companies primarily related to the automotive industry, holding prominent positions.  In 1987 he joined K&N Engineering as President and part owner and built the company into an industry leader.  In 2002 he sold his interest in K&N Engineering and founded S&S Marketing, which is engaged in the automotive aftermarket parts rep business, which he currently operates. Mr. Shelton is the recipient of numerous industry related prestigious awards and in 1992, Specialty Equipment Market Association (SEMA) invited him to join its board of directors, which includes serving in capacity as its Chairman from 2002 to 2004.  In 2007 he was elected to the SEMA “Hall of Fame”.  Mr. Shelton served honorably in the United States Seabees from 1968 to 1972.  He attended Chaffey Junior College.

Executive Officers
 
The following table sets forth certain information regarding our executive officers as of December 31, 2010:
 
 
Name 
 
Age
 
Position 
   
               
 
Cecil Bond Kyte
 
40
 
Chief Executive Officer
   
               
 
Charles R. Blum
 
74
 
President 
   
               
 
Eugene E. Eichler
 
85
 
Interim Chief Financial Officer
   
 
For the biographies of Cecil Bond Kyte and Charles R. Blum, please see above under “Biographical Information Regarding Directors.”
 
Eugene E. Eichler, CPA, has served as our Interim Chief Financial Officer since October 2007.  On December 31, 2011, Mr. Eichler resigned as Interim Chief Financial Officer due to health and disability conditions.. He served as our Chief Executive Officer from October 2005 until November 2006, at which time he separated from the company due to medical disability. He served as our Chief Financial Officer since May 2002 until November 2006 and has been a director since May 2002. Mr. Eichler served as our President from March 2004 to October 2005 and as our Chief Operating Officer from October 2001 to March 2004. Mr. Eichler was the Chief Financial Officer and Firm Administrator of the law firm Masry & Vititoe from 1982 to October 2001. From 1974 to 1982, Mr. Eichler provided financial consulting services to Foundation for HMO’s, Acne Care Medical Clinics and Earth Foods, Inc. From 1960 to 1974, Mr. Eichler headed financial consulting services for Milburn Industries and Brown, Eichler & Company. From 1953 to 1960, he held the position of Chief Budgets and Forecasts at North American Aviation. From 1951 to 1953, Mr. Eichler held various audit positions at the Atomic Energy Commission. Mr. Eichler received a B.A. from University of Montana.  Mr. Eichler resigned his position as interim Chief Financial Officer, effective December 31, 2011.  Effective February 1, 2012, Greggory M. Bigger was retained by the Company to serve as its Chief Financial Officer.
  
Code of Business Conduct

CORPORATE GOVERNANCE
 
We maintain a corporate governance page on our corporate website at www.stwa.com, which includes information regarding the Company’s corporate governance practices. Our codes of business conduct and ethics, Board committee charters and certain other corporate governance documents and policies and code of business conduct will be posted on our website. In addition, we will provide a copy of any of these documents without charge to any stockholder upon written request made to Corporate Secretary, Save the World Air, Inc., 735 State Street, Suite 500, Santa Barbara, California 93101.  The information on our website is not, and shall not be deemed to be, a part of this proxy statement or incorporated by reference into this or any other filing we make with the Securities and Exchange Commission (the “SEC”).
 

 
 
38

 
 

Board of Directors
 
Director Independence
 
Our Board of Directors as of December 31, 2011 consisted of three (3) members.  As of that date, the Board has affirmatively determined that Mr. Shelton is an independent director.  Mr. Kyte, our Chief Executive Officer and Mr. Blum, our  President, are not considered independent.
  
Meetings of the Board
 
The Board held four (4) meetings during 2011, and held one (1) meeting in 2012. Each of the directors attended 75% or more of the aggregate number of meetings of the Board  and Committees on which the director served in 2011 and 2012.
 
Each of our directors is encouraged to attend the Company’s 2012 Annual Meeting, which has not yet been scheduled, and to be available to answer any questions posed by stockholders to such director. Because our Board holds one of its regular meetings in conjunction with our Annual Meeting of stockholders, we anticipate that all of the members of the Board will be present for the 2012 Annual Meeting.
  
Communications with the Board
 
The following procedures have been established by the Board in order to facilitate communications between our stockholders and the Board:
 
 
Stockholders may send correspondence, which should indicate that the sender is a stockholder, to the Board or to any individual director, by mail to Corporate Secretary, Save the World Air, Inc. 735 State Street, Suite 500, Santa Barbara, California, 93101 or by e-mail to questions @stwa.com.
     
 
Our Secretary will be responsible for the first review and logging of this correspondence and will forward the communication to the director or directors to whom it is addressed unless it is a type of correspondence which the Board has identified as correspondence which may be retained in our files and not sent to directors. The Board has authorized the Secretary to retain and not send to directors communications that: (a) are advertising or promotional in nature (offering goods or services), (b) solely relate to complaints by customers with respect to ordinary course of business customer service and satisfaction issues or (c) clearly are unrelated to our business, industry, management or Board or committee matters. These types of communications will be logged and filed but not circulated to directors. Except as set forth in the preceding sentence, the Secretary will not screen communications sent to directors.
     
 
The log of stockholder correspondence will be available to members of the Board for inspection. At least once each year, the Secretary will provide to the Board a summary of the communications received from stockholders, including the communications not sent to directors in accordance with the procedures set forth above.
 
Our stockholders may also communicate directly with the non-management directors, individually or as a group, by mail c/o Corporate Secretary, Save the World Air, Inc., 735 State Street, Suite 500, Santa Barbara, California 93101 or by e-mail to info@stwa.com.
 
The Audit Committee has established procedures, as outlined in the Company’s policy for Procedures for Accounting and Auditing Matters”,  for the receipt, retention and treatment of complaints regarding questionable accounting, internal controls, and financial improprieties or auditing matters. Any of the Company’s employees may confidentially communicate concerns about any of these matters by calling our toll-free number, (877) 872-7892. Upon receipt of a complaint or concern, a determination will be made whether it pertains to accounting, internal controls or auditing matters and if it does, it will be handled in accordance with the procedures established by the Audit Committee.  
   

 
 
39

 
 

Committees of the Board
 
The Board has a standing Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. Each of these committees operates under a written charter. Copies of these charters, and other corporate governance documents, are available on our website, www.stwa.com In addition, we will provide a copy of any of these documents without charge to any stockholder upon written request made to Corporate Secretary, Save the World Air Inc., 735 State Street, Suite 500, Santa Barbara, California 93101.
 
The composition, functions and general responsibilities of each committee are summarized below.
  
Audit Committee
 
The Audit Committee currently consists of Messrs. Kyte (chairperson) and Shelton. The Board has determined that Mr. Shelton is an audit committee financial expert, and is independent under rules of the SEC.   Mr. Kyte, our Chief Executive Officer is not considered independent.  The Audit Committee held a total of four (4) meetings during 2011 and a total of one (1) meeting to date during 2012.
 
The Audit Committee operates under a written charter. The Audit Committee’s duties include responsibility for reviewing our accounting practices and audit procedures. In addition, the Audit Committee has responsibility for reviewing complaints about, and investigating allegations of, financial impropriety or misconduct. The Audit Committee works closely with management and our independent auditors. The Audit Committee also meets with our independent auditors on a quarterly basis, following completion of their quarterly reviews and annual audit, to review the results of their work. The Audit Committee also meets with our independent auditors to approve the annual scope of the audit services to be performed.
     
As part of its responsibility, the Audit Committee is responsible for engaging our independent auditor, as well as pre-approving audit and non-audit services performed by our independent auditor in order to assure that the provision of such services does not impair the independent auditor’s independence.
 
Please see “Audit Committee Report” below, which provides further details of many of the duties and responsibilities of the Audit Committee.
  

 
 
40

 
 

AUDIT COMMITTEE REPORT
 
The Audit Committee is currently composed of two (2) directors, Messrs. Kyte (Chairperson), and Shelton.  The Board has determined that Mr. Shelton is an audit committee financial expert, and is independent within the rules of the SEC. The duties and responsibilities of a member of the Audit Committee are in addition to his duties as a member of the Board.
 
The Audit Committee operates under a written charter, which is available on the Company’s website. The Board and the Audit Committee believe that the Audit Committee charter complies with the current standards set forth in SEC regulations. There may be further action by the SEC during the current year on several matters that affect all audit committees. The Board and the Audit Committee continue to follow closely further developments by the SEC in the area of the functions of audit committees, particularly as it relates to internal controls for non-accelerated filers, and will make additional changes to the Audit Committee charter and the policies of the Audit Committee as required or advisable as a result of these new rules and regulations. The Audit Committee met four (4) times during 2011 and one (1) time to date during 2012.
 
The Audit Committee’s primary duties and responsibilities are to:
 
 
engage the Company’s independent auditor;
     
 
monitor the independent auditor’s independence, qualifications and performance;
     
 
pre-approve all audit and non-audit services;
     
 
provide an open avenue of communication among the independent auditor, financial and senior management of the Company and the Board; and
     
 
monitor the Company’s compliance with legal and regulatory requirements.
 
Management is responsible for the Company’s internal controls and the financial reporting process. The Company’s independent auditor is responsible for performing an independent audit of the Company’s financial statements in accordance with the standards of the Public Company Accounting Oversight Board and issuing a report thereon. The Audit Committee’s responsibility is to monitor and oversee these processes.
 
The Company is planning to form an internal management group, reporting to the Chief Executive Officer and the Audit Committee that is charged with guiding the Company in meeting the various requirements of Section 404 of the Sarbanes-Oxley Act of 2002. The Audit Committee has begun to implement procedures to ensure that during the course of each fiscal year it devotes the attention that it deems necessary or appropriate to each of the matters assigned to it under its charter.
 
In overseeing the preparation of the Company’s financial statements, the Audit Committee held meetings with the Company’s independent auditors, both in the presence of management and privately, to discuss the overall scope and plans for their audit, review and discuss all financial statements prior to their issuance, and discuss significant accounting issues. Management advised the Audit Committee that all financial statements were prepared in accordance with accounting principles generally accepted in the United States of America, and the Audit Committee discussed the statements with both management and the Company’s independent auditors. In accordance with Section 204 of the Sarbanes-Oxley Act and the Statement on Auditing Standards (“SAS”) No. 61 (Communication With Audit Committees) as amended by SAS No. 90 (Audit Committee Communications), the Audit Committee has discussed with the Company’s independent auditors all matters required under the Sarbanes-Oxley Act and the foregoing standards. 
     
With respect to the Company’s independent auditors, the Audit Committee, among other things, discussed with Weinberg & Co., P.A., matters relating to its independence, including the written disclosures made to the Audit Committee as required by the Independence Standards Board Standard No. 1 (Independence Discussions with Audit Committees). The Audit Committee also reviewed and approved the audit and non-audit fees of that firm.
 
On the basis of these reviews and discussions, the Audit Committee (i) appointed Weinberg & Co., P.A. as the independent registered public accounting firm for the 2011 fiscal year and (ii) recommended to the Board that the Board approve the inclusion of the Company’s audited financial statements in the 10-K for filing with the SEC. 
 
 
Respectfully submitted:
   
 
Cecil Bond Kyte  (Chairman)
 
Nathan Shelton

 
 
41

 
 

COMPENSATION COMMITTEE REPORT
 
The Compensation Committee has furnished this report on executive compensation for the 2011 fiscal year.
 
The Compensation Committee administers the Company’s executive compensation program. The Compensation Committee has the authority to review and determine the salaries and bonuses of the executive officers of the Company, including the Chief Executive Officer and the other executive officers named in the Summary Compensation Table (the “Named Executive Officers”) appearing elsewhere in this proxy statement, and to establish the general compensation policies for such individuals. The Compensation Committee also has the sole and exclusive authority to make discretionary option grants to all of the Company’s employees under the Company’s 2004 Stock Option Plan (the “2004 Plan”).
 
The Compensation Committee currently consists of Messrs. Blum (chairperson) and Shelton. The Board believes that Mr. Shelton meets the independence requirement.  None of our executive officers served on the compensation committee of another entity or on any other committee of the board of directors of another entity performing similar functions during 2011. The Compensation Committee held one (1) meeting during 2011 and has not met during 2012.
 
The Compensation Committee operates under a written charter. The charter reflects these various responsibilities, and the Committee is charged with periodically reviewing the charter. In addition, the Committee has the authority to engage the services of outside advisors, experts and others, including independent compensation consultants who do not advise the Company, to assist the Committee.
 
The Compensation Committee believes that the compensation programs for the Company’s executive officers should reflect the Company’s performance and the value created for the Company’s stockholders. In addition, the compensation programs should support the short-term and long-term strategic goals and values of the Company, reward individual contribution to the Company’s success and align the interests of the Company’s officers with the interests of its stockholders. The committee believes that the Company’s success depends upon its ability to attract and retain qualified executives through the competitive compensation packages it offers to such individuals.
 
The principal factors that were taken into account in establishing each executive officer’s compensation package for the 2011 fiscal year are described below. However, the Compensation Committee may in its discretion apply entirely different factors, such as different measures of financial performance, for future fiscal years. Moreover, all of the Company’s Named Executive Officers have entered into employment agreements with the Company and many components of each such person’s compensation are set by such agreements.
 
Equity-Based Compensation. The Committee believes in linking long-term incentives to an increase in stock value. Accordingly, it awards stock options under the 2004 Plan with an exercise price equal to the fair market value of the underlying stock on the date of grant that vest and become exercisable over time. The Committee believes that these options encourage employees to continue to use their best efforts and to remain in the Company’s employ. Options granted to executive officers under the 2004 Plan generally vest and become exercisable in annual 25% increments over a four-year period after grant.
 
The Committee relies substantially on management of the Company to make specific recommendations regarding which individuals should receive option grants and the amounts of such grants.
     
The Company grants stock options to executive officers with a cumulative option price of up to $100,000 as incentive stock options and the remainder as non-qualified stock options, both with an exercise price equal to the fair market value of the Company’s common stock on the date of grant. Accordingly, those stock options will have value only if the market price of the Company’s common stock increases after that date. In determining the size of stock option grants to executive officers, the Committee bases its decisions on such considerations as similar awards to individuals holding comparable positions in our comparative groups, company performance and individual performance, as well as the allocation of overall share usage attributed to executive officers.  

Compliance with Code Section 162(m). Section 162(m) of the Code disallows a tax deduction to publicly-held companies for compensation paid to certain of their executive officers, to the extent that compensation exceeds $1 million per covered officer in any fiscal year. The limitation applies only to compensation which is not considered to be performance based. Non-performance based compensation paid to the Company’s executive officers for the 2011 fiscal year did not exceed the $1 million limit per officer, and the Compensation Committee does not anticipate that the non-performance based compensation to be paid to the Company’s executive officers for the 2011 fiscal year will exceed that limit. Because it is unlikely that the cash compensation payable to any of the Company’s executive officers in the foreseeable future will approach the $1 million limit, the Compensation Committee has decided at this time not to take any action to limit or restructure the elements of cash compensation payable to the Company’s executive officers. The Compensation Committee will reconsider this decision should the individual cash non-performance based compensation of any executive officer ever approach the $1 million level.  
 
The Board did not modify any action or recommendation made by the Compensation Committee with respect to executive compensation for the 2011 fiscal year. It is the opinion of the Compensation Committee that the executive compensation policies and plans provide the necessary total remuneration program to properly align the Company’s performance and the interests of the Company’s stockholders through the use of competitive and equitable executive compensation in a balanced and reasonable manner, for both the short and long term. 
 
 
Respectfully submitted by:
   
 
Charles Blum, Chairman
 
 
42

 
 
  
Nominating and Corporate Governance Committee Report
   
The Nominating and Corporate Governance Committee currently consists of Messrs. Shelton (chairperson) and Kyte. The Board believes that Mr. Shelton meets the independence requirements under rules of the SEC.  The Nominating and Corporate Governance Committee did not meet during 2011 and has not yet met during 2012.
 
The Nominating and Corporate Governance Committee operates under a written charter. The Nominating and Corporate Governance Committee has the primary responsibility for overseeing the Company’s corporate governance compliance practices, as well as supervising the affairs of the Company as they relate to the nomination of directors. The principal ongoing functions of the Nominating and Corporate Governance Committee include developing criteria for selecting new directors, establishing and monitoring procedures for the receipt and consideration of director nominations by stockholders and others, considering and examining director candidates, developing and recommending corporate governance principles for the Company and monitoring the Company’s compliance with these principles and establishing and monitoring procedures for the receipt of stockholder communications directed to the Board.
 
The Nominating and Corporate Governance Committee is also responsible for conducting an annual evaluation of the Board to determine whether the Board and its committees are functioning effectively. In performing this evaluation, the Nominating and Corporate Governance Committee receives comments from all directors and reports annually to the Board with the results of this evaluation.
   
Director Nominations
 
The Nominating and Corporate Governance Committee seeks out appropriate candidates to serve as directors of the Company, and the Nominating and Corporate Governance Committee interviews and examines director candidates and makes recommendations to the Board regarding candidate selection. In considering candidates to serve as director, the Nominating and Corporate Governance Committee evaluates various minimum individual qualifications, including strength of character, maturity of judgment, relevant technical skills or financial acumen, diversity of viewpoint and industry knowledge, as well as the extent to which the candidate would fill a present need on the Board.      

The Nominating and Corporate Governance Committee will consider, without commitment, stockholder nominations for director. Nominations for director submitted to this committee by stockholders are evaluated according to the Company’s overall needs and the nominee’s knowledge, experience and background. A nominating stockholder must give appropriate notice to the Company of the nomination not less than 90 days prior to the first anniversary of the preceding year’s annual meeting. In the event that the date of the annual meeting is advanced by more than 30 days or delayed by more than 60 days from the anniversary date of the preceding year’s annual meeting, the notice by the stockholder must be delivered not later than the close of business on the later of the 60th day prior to such annual meeting or the tenth day following the day on which public announcement of the date of such annual meeting is first made.
  
 
43

 
 
 
The stockholders’ notice shall set forth, as to:
 
 
each person whom the stockholder proposes to nominate for election as a director:
     
 
the name, age, business address and residence address of such person,
     
 
the principal occupation or employment of the person,
     
 
the class and number of shares of the Company which are beneficially owned by such person, if any, and
     
 
any other information relating to such person which is required to be disclosed in solicitations for proxies for election of directors pursuant to Regulation 14A under the Exchange Act and the rules hereunder; and the stockholder giving the notice
     
 
the name and record address of the stockholder and the class and number of shares of the Company which are beneficially owned by the stockholder,
     
 
a description of all arrangements or understandings between such stockholder and each proposed nominee and any other person or persons (including their names) pursuant to which nomination(s) are to be made by such stockholder, 
     
 
a representation that such stockholder intends to appear in person or by proxy at the meeting to nominate the persons named in its notice,
     
 
any other information relating to such person which is required to be disclosed in solicitations for proxies for election of directors pursuant to Regulation 14A under the Exchange Act and the rules thereunder.
 
The notice must be accompanied by a written consent of the proposed nominee to be named as a director.
 
We have adopted codes of business conduct and ethics for our directors, officers and employees which we believe meet requirements of a code of ethics.  You can access the Company’s Code of Business Conduct and Ethics and our Code of Ethics for Senior Executives and Financial Officers on the Corporate Governance page of the Company’s website at www.stwa.com.  Any shareholder who so requests may obtain a printed copy of the Code of Conduct by submitting a request to the Company’s Corporate Secretary.
   
 
Respectfully submitted by:
   
 
Nathan Shelton, Chairman

 


 
 
44

 
 

Item 11. Executive Compensation
  
EXECUTIVE COMPENSATION
  
The following table sets forth certain information regarding the compensation earned during the last three fiscal years by the Named Executive Officers:
 
Summary Compensation Table
 
   
Long-Term Compensation Awards
 
       
Name and Principal Position
 
Fiscal
 Year
   
Annual
Compensation
 Salary ($)
   
Restricted
 Stock
Awards
 ($)
   
Securities
 Underlying 
Options
 (#)
   
   Full Value of Options
($)
   
All
 Other
Compensation
 ($)
 
 
Cecil Bond Kyte (1)(4)
 
2011
   
$
208,333
   
$
0
     
          17,600,000
    $ 6,834,231    
$
0
 
Chief Executive Officer
 
2010
   
$
200,000
   
$
0
     
0
           
$
0
 
   
2009
   
$
183,333
                                 
 
Charles R. Blum (2) (4)
 
2011
   
$
100,000
   
$
0
     
1,000,000
    $  245,970    
$
0
 
President
 
2010
   
$
100,000
   
$
0
     
0
           
$
0
 
   
2009
   
$
105,682
   
$
0
     
333,333
    $  87,998    
$
0
 
 
Eugene E. Eichler (3) (4)
 
2011
   
$
120,000
   
$
0
     
2,000,000
    $  615,340    
$
0
 
Interim Chief Financial Officer
 
2010
   
$
120,000
   
$
0
     
0
           
$
0
 
   
2009
   
$
90,000
   
$
0
     
0
           
$
0
 
  
(1)
Mr. Kyte was appointed Chief Executive Officer in January 2009.  In 2010, Mr. Kyte earned and was paid $200,000.  On December 1, 2011, Mr. Kyte’s salary was increased to $300,000 per year.  In addition, Mr. Kyte received $33,333 in accrued back pay and on December 8, 2011 he received a bonus of $54,505.  In connection with the Amendment to Mr. Kyte’s Employment Agreement dated March 1, 2011, Mr. Kyte received options for 17,600,000 shares of common stock, and, options for 181,118 shares of common stock previously granted, were cancelled. On December the Board approved Amendment Number 2 to Mr. Kyte’s Employment and increased his salary to $300,000 per year.
(2)
Mr. Blum was appointed President and Chief Executive Officer in July 2007.  In January 20, 2009 Mr. Blum resigned the position of Chief Executive Officer and continues to serve as President.  He does not have an “Employment Agreement” at this time.  In 2010, Mr. Blum earned  $100,000 all of which was unpaid and accrued.  In 2011, Mr. Blum earned $100,000, of which $33,333 was paid and $66,667 was accrued.
(3)
On October 18, 2007, Mr. Eichler was appointed Interim Chief Financial Officer.  He does not have an “Employment Agreement” at this time.  In 2010, Mr. Eichler was paid $80,000 and $40,000 was accrued and unpaid at December 31, 2010.  In 2011, Mr. Eichler received his full salary of $120,000 and $45,000 of accrued back pay.  At December 31, 2011 Mr. Eichler had a balance of $145,000 accrued back pay.
(4)
The number and value of vested restricted stock based upon the closing market price of the common stock at December 31, 2012 ($0.537 were as follows: Mr. Kyte 2,770,412 vested shares valued at $1,025,244, and Mr. Eichler, 1,071,429 vested shares valued at $396,429.
 
The portions of the salaries identified above that have been deferred will be paid subject to the Company’s future financial and cash position.

  

 
 
45

 
 

OPTION GRANTS IN LAST FISCAL YEAR
 
The following table sets forth information concerning the stock option grants made to each of the Named Executive Officers during the 2011 fiscal year. No stock appreciation rights were granted to any of the Named Executive Officers during the 2011 fiscal year.
   
   
Individual Grants
 
Name
 
Number of
 Securities
 Underlying
 Options
 Granted
   
Percent of
 Total Options
 Granted to
 Employees in
 Fiscal 2011
   
Exercise or
 Base Price
 Per Share
   
 
Expiration
 Date
Cecil Bond Kyte
   
17,600,000
     
85.4%
    $
0.25
   
01/30/2021
Charles R. Blum          1,000,000       4.9%     $ 0.30     10/01/2021
Eugene E. Eichler        2,000,000       9.7%     $ 0.30     12/31/2021
   
AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR
AND YEAR-END OPTION VALUES
 
No options were exercised by any of the Named Executive Officers during the 2011 fiscal year. The following table sets forth the number of shares of our common stock subject to exercisable and unexercisable stock options which the Named Executive Officers held at the end of the 2011 fiscal year.
 
   
Shares
   
Value
   
Number of Securities
 Underlying Unexercised
 Options at
 Fiscal Year-End (#)
   
Value of Unexercised
 In-the-Money Options ($)(1)
 
   
Acquired on
   
Realized
             
Name
 
Exercise (#)
   
($)
   
Exercisable
   
Unexercisable
   
Exercisable
   
Unexercisable
 
Cecil Bond Kyte
   
   
$
   
4,650,000
   
17,600,000
   
$
532,000
   
$
   2,112,000
 
Charles R. Blum
   
   
$
   
       1,922,012
   
     0
   
$
108,333
   
$
 0
 
Eugene E. Eichler
   
   
$
   
2,121,127
   
0
   
$
70,000
   
$
0
 

(1)  Market value of our common stock at fiscal year-end minus the exercise price. The closing price of our common stock on December 31, 2011 the last trading day of the year was $0.37 per share.

 

 
 
46

 
 

EQUITY COMPENSATION PLAN INFORMATION FOR 2011
 
The following table sets forth information regarding outstanding options and shares reserved for future issuance under our equity compensation plans as of December 31, 2011:
 
Plan Category
 
Number of Securities
to be Issued upon
Exercise of
 Outstanding Options,
 Warrants and Rights
   
Weighted-Average
Exercise Price of
Outstanding Options,
 Warrants and Rights
   
Number of Securities
 Remaining Available
for Future Issuance
 Under Equity
 Compensation Plans
 (Excluding Securities
 Reflected in the
 First Column)
 
                   
Equity compensation plans approved by security holders
   
4,267,892
   
$
0.52
     
2,732,108
 
                         
Equity compensation plans not approved by security holders
   
   19,800,000
   
$
0.26
     
N/A
 
                         
Total
   
24,067,892
   
$
0.30
     
N/A
 
 
Employment Agreements

Agreement with Cecil Bond Kyte. On January 30, 2009, (the “Effective Date”), the Company entered into an employment agreement with Cecil Bond Kyte, pursuant to which he serves as our Chief Executive Officer.  The initial term of the agreement became effective on January 30, 2009 and expires on January 30, 2010 and renews automatically for addition one-year periods unless either party has given notice of non-extension prior to October 30, 2010.  The agreement provides for a base compensation of $200,000 per year.  Mr. Kyte is eligible to participate in the Company’s incentive and benefit plans, including eligibility to receive grants of stock options under the 2004 plan.
 
Mr. Kyte shall be eligible to receive an annual cash bonus in an amount equal to 2% of the Company’s net profit, if any, for its most recently completed fiscal year, computed in accordance with generally accepted accounting principles applied consistently with prior periods.  The bonus shall be payable, if at all, on the anniversary date of employment each year of the term; provided that no bonus shall be paid if the Executive is not, on such payment date, in the employ of the Company.
 
Mr. Kyte shall also receive an option (the “Option”) to purchase a number of shares (the “Option Shares”) of the Company’s common stock equal to the result of (A) 100,000 divided by (B) the closing price per share of the Company’s Common Stock on the first anniversary of the Effective Date.  The Option shall be an incentive stock option, shall be exercisable at the closing price per share on the first anniversary of the Effective Date, shall be exercisable for ten years from the date of grant and shall vest on the second anniversary of the Effective Date.

Amendment To  Kyte Employment Agreement

On March 1, 2011, the Board of Directors of. the Company approved an amendment (the “Amendment”) to the Kyte employment agreement.  The Company and Kyte have agreed to an amendment of the Employment Agreement, providing for non-cash performance compensation in the form of nonqualified stock options.  Kyte has agreed to continue to serve in the role of CEO of the Company through at least January 29, 2016.


 
 
47

 
 

The Board determined to grant Kyte nonqualified stock options to acquire shares of common stock of the Company under the following terms and conditions:
 
Stock Option Grant (“Grant”) of 17,600,000 Shares at an Exercise Price of  $0.25 per share exercisable for 10 years, which will expire on January 30, 2021.  (See Note 9 of the Company’s Financial Statement.)
 
Twenty percent (20%) of the Option shall vest on the first anniversary of the Effective Date (i.e. January 30, 2011); twenty percent (20%) on the second anniversary of the Effective Date; twenty percent (20%) on the third anniversary of the Effective Date; twenty percent (20%) on the fourth anniversary of the Effective Date; and, twenty percent (20%) on the fifth anniversary of the Effective Date;

Amendment #2 to Kyte Employment Agreement

The Second Amendment to Kyte’s Employment Agreement was made and entered into by and between the Company and Kyte effective as of December 1, 2011.  Compensation for Kyte was increased to a base salary of $300,000.
     
Agreement with Greggory M. Bigger.  On February 1, 2012, the Company entered into an employment agreement with Greggory M. Bigger, pursuant to which he agreed to serve as the Company’s Chief Financial Officer.  The initial term of the agreement commenced February 1, 2012, and continues for one (1) year.  Thereafter, the agreement is renewable for successive one (1) year periods, unless either party gives written notice of non-renewal, no later than sixty (60) days prior to the renewal date.  The agreement provides for the payment of a one-time acceptance bonus of $10,000.  Base salary under the agreement is $10,000 per month, plus an automobile allowance of $900 per month and other benefits generally available to senior employees of the Company.  The agreement also provides Mr. Bigger with a stock option grant (“Grant”) under the following terms and conditions:

 
A. 
Effective Date of Grant:  February 1, 2012;
 
B. 
Vesting Commence Date:  February 1, 2012;
 
C. 
Exercise Price per Share:  $0.25;
 
D. 
Total Number of Shares Subject to the Option:  4,000,000;
 
E. 
Type of Option:  Non-Qualified.  Neither the Option nor the underlying Shares shall be registered with the Securities and Exchange Commission and the Option and Shares shall constitute “restricted” securities.
 
F. 
Exercise Term:  Ten (10) years from the Effective Date of Grant;
 
G. 
Vesting Schedule:  Subject to Executive’s continued employment with the Company, the Option may be exercised within the Exercise Term, in whole or in part, in accordance with the following vesting schedule:
 
 
i. 
500,000 Options shall vest on Effective Date of Grant;
 
ii. 
500,000 Options shall vest on February 1, 2013;
 
iii. 
1,000,000 Options shall vest on February 1, 2014;
 
iv. 
1,000,000 Options shall vest on February 1, 2015; and,
 
v. 
1,000,000 Options shall vest on February 1, 2016.
  
Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
 
The following table sets forth certain information regarding the beneficial ownership of our common stock as of December 31, 2011.
 
 
each person, or group of affiliated persons, known by us to be the beneficial owner of more than 5% of the outstanding shares of our common stock;
     
 
each of our directors;
     
 
our Chief Executive Officer and each of our two other most highly-compensated executive officers serving as such as of December 31, 2011 whose total annual salary and bonus exceeded $100,000, for services rendered in all capacities to the Company (such individuals are hereafter referred to as the “Named Executive Officers”); and* all of our directors and executive officers serving as a group.
   
Name and Address of Beneficial Owner (1) 
 
Number of Shares of
Common Stock
Beneficially Owned (2)
   
Percentage of
Shares Beneficially
Owned (2)
 
             
Named Executive Officers and Director
           
Cecil Bond Kyte, Chief Executive Officer, Director (3)     
   
7,890,412
     
6.62%
 
Charles R. Blum , President(4) 
   
1,922,012
     
1.67%
 
Eugene E. Eichler, Chief Financial Officer (5) 
   
4,877,346
     
4.10%
 
Shelton, Nathan – Director (6)  
   
496,937
     
.43%
 
All directors and executive officers as a group 
   
15,238,717
     
12.16%
 

(1)
Unless otherwise indicated, the address of each listed person is c/o Save the World Air, Inc., 735 State Street, Suite 500, Santa Barbara, California 93101.
 
(2)
Percentage of beneficial ownership is based upon 114,163,470 shares of our common stock outstanding as of December 31, 2011.  Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock subject to options and warrants currently exercisable or convertible, or exercisable or convertible within 60 days, are deemed outstanding for determining the number of shares beneficially owned and for computing the percentage ownership of the person holding such options, but are not deemed outstanding for computing the percentage ownership of any other person. Except as indicated by footnote, and subject to community property laws where applicable, the persons named in the table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them.

 
 
48

 
 

(3) 
Includes options to purchase 4,620,000 shares of our common stock exercisable currently and warrants  to purchase 500,000 shares of our common stock.
 
(4) 
Includes options to purchase 1,922,012 shares of our common stock exercisable currently.
 
(5) 
Includes options to purchase 2,121,127 shares of our common stock exercisable currently. and warrants to purchase 1,684,800 shares of our common stock.
 
(6) 
Includes options to purchase 304,585 shares of our common stock exercisable currently.
 
Item 13.  Certain Relationships and Related Transactions

Accounts Payable to related parties
 
As of December 31, 2011, the Company had accounts payable to related parties in the amount of $63,003, which was composed of $36,125 in unpaid Directors Fees and $26,878 in unreimbursed expenses incurred by officers and Directors.
   
Item 14.  Principal Accounting Fees and Services
 
The Audit Committee has selected Weinberg & Company, P.A. to audit our financial statements for the fiscal year ended December 31, 2011.
 
Weinberg & Company, P.A. was first appointed in fiscal year 2003, and has audited our financial statements for fiscal years 2002 through 2011.
 
Audit and Other Fees
 
The following table summarizes the fees charged by Weinberg & Company, P.A. for certain services rendered to the Company during 2011 and 2010.
 
   
Amount
 
Type of Fee
 
Fiscal
Year 2011
   
Fiscal
Year 2010
 
Audit(1)
 
$
83,162
   
$
87,883
 
Audit Related(2)
   
     
 
Taxes (3)
   
7,693
     
20,920
 
All Other (4)
   
 —
     
 
Total
 
$
90,855
   
$
108,803
 
  
(1) 
This category consists of fees for the audit of our annual financial statements included in the Company’s annual report on Form 10-K and review of the financial statements included in the Company’s quarterly reports on Form 10-Q. This category also includes advice on audit and accounting matters that arose during, or as a result of, the audit or the review of interim financial statements, statutory audits required by non-U.S. jurisdictions and the preparation of an annual “management letter” on internal control matters.
(2) 
Represents services that are normally provided by the independent auditors in connection with statutory and regulatory filings or engagements for those fiscal years, aggregate fees charged for assurance and related services that are reasonably related to the performance of the audit and are not reported as audit fees. These services include consultations regarding Sarbanes-Oxley Act requirements, various SEC filings and the implementation of new accounting requirements.
(3) 
Represents aggregate fees charged for professional services for tax compliance and preparation, tax consulting and advice, and tax planning.
(4) 
Represents aggregate fees charged for products and services other than those services previously reported.

 
 
49

 
 
  
PART IV

Item 15.  Exhibits, Financial Statement Schedules  

(a)           The following documents are filed as part of this Form 10-K.
 
Financial Statements:   

 Reference is made to the contents to the consolidated financial statements of Save the World Air, Inc. under Item 7 of this Form 10-K.
 
 
(b)
Exhibits:
 
The exhibits listed below are required by Item 601 of Regulation S-K.
 
Exhibit
No.
 
Description
3.1(1)
 
Articles of Incorporation, as amended, of the Registrant.
3.2(1)
 
Bylaws of the Registrant.
10.1(2)
 
Commercial Sublease dated October 16, 2003 between the Registrant and KZ Golf, Inc.
10.2(9)
 
Amendment dated June 15, 2004 to Exhibit 10.1
10.3 (10)
 
Amendment dated August 14, 2005 to Exhibit 10.1
10.4(10)
 
General Tenancy Agreement dated March 14, 2006 between the Registrant and Autumlee Pty Ltd.
10.5(3)
 
Agreement dated December 13, 2002 between the Registrant and RAND.
10.6(2)**
 
Agreement dated May 7, 2003 between the Registrant and RAND.
10.7(5)
 
Modification No. 1 dated as of August 21, 2003 to Exhibit 10.5
10.8(5)
 
Modification No. 2 dated as of October 17, 2003 to Exhibit 10.5
10.9(5)
 
Modification No. 3 dated as of January 20, 2004 to Exhibit 10.5
10.10(4)
 
Deed and Document Conveyance between the Trustee of the Property of Jeffrey Ann Muller and Lynette Anne Muller (Bankrupts).
10.11(4)
 
Assignment and Bill of Sale dated May 28, 2002 between the Registrant and Kevin Charles Hart.
10.12(11)†
 
Amended and Restated Employment Agreement dated October 5, 2005 between the Registrant and Eugene E. Eichler.
10.13(15)†
 
Severance Agreement dated November 8, 2006 between the Registrant and Eugene E. Eichler
10.14(11)†
 
Amended and Restated Employment Agreement dated October 5, 2005 between the Registrant and Bruce H. McKinnon.
10.15(6)
 
Save the World Air, Inc. 2004 Stock Option Plan
10.16(8)
 
Form of Incentive Stock Option Agreement under 2004 Stock Option Plan
10.17(8)
 
Form of Non-Qualified Stock Option Agreement under 2004 Stock Option Plan
10.18(8)
 
Consulting Agreement dated as of October 1, 2004 between the Registrant and John Fawcett
10.19(7)
 
License Agreement dated as of July 1, 2004 between the Registrant and Temple University – The Commonwealth System of Higher Education
10.20(8)
 
Consulting Agreement dated as of November 19, 2004 between the Registrant and London Aussie Marketing, Ltd.
10.21(13)
 
Amendment dated September 14, 2006 to Exhibit 10.20
10.22(8)†
 
Employment Agreement dated September 1, 2004 with Erin Brockovich
10.23(15)†
 
Amendment dated as of July 31, 2006 to Exhibit 10.22
10.24(8)
 
Assignment of Patent Rights dated as of September 1, 2003 between the Registrant and Adrian Menzell
10.25(8)
 
Global Deed of Assignment dated June 26, 2004 between the Registrant and Adrian Menzell
10.26(11)†
 
Amended and Restated Employment Agreement dated as of March 1, 2006 between the Registrant and John Richard Bautista III
 
 
50

 
 
10.27(9)
 
Lease dated August 15, 2005 between the Registrant and Thomas L. Jackson
10.28(10)
 
Amendment dated February 1, 2006 to Exhibit 10.27
10.29(10)
 
Form of 9% Convertible Note issued in the 2005 Interim Financing
10.30(10)
 
Form of Stock Purchase Warrant issued in the 2005 Interim Financing
10.31(10)
 
Form of Stock Purchase Warrant issued in the 2005 Bridge Financing
10.32(11)
 
Form of Stock Purchase Warrant issued in 2006 Regulation S financing
10.33(11)
 
Form of Stock Purchase Warrant issued in 2006 PIPE financing
10.34(12)
 
Commercial Sublease between the Registrant and KZG Golf dated January 1, 2006
10.35(12)
 
Investment Agreement dated September 15, 2006 between the Registrant and Dutchess Private Equities Fund
10.36(12)
 
Registration Rights Agreement dated September 15, 2006 between the registrant and Dutchess Private Equities Fund, LLP
10.37(17)
 
License Agreement between the Registrant and Temple University dated February 2, 2007
10.38(17)
 
License Agreement between the Registrant and Temple University dated February 2, 2007
10.39(17)
 
R&D Agreement between the Registrant and Temple University dated February 2, 2007
10.40(14)
 
Note Purchase Agreement dated December 5, 2006 between the registrant and Morale Orchards LLC
10.41(14)
 
Form of Stock Purchase Warrant issued to Morale Orchards LLC
10.42(14)
 
Form of Convertible Note issued to Morale Orchards LLC
10.43(16)
 
Consulting Agreement dated January 4, 2007 between the Registrant and Spencer Clarke LLC
10.44(15)
 
Agreement dated as of July 15, 2006 between the Company and SS Sales and Marketing Group
10.45(15)
 
Engagement Agreement between the Registrant and Charles K. Dargan II
10.46(15)
 
Form of 10% Convertible Note issued in 2007 PIPE Offering
10.47(15)
 
Form of Stock Purchase Warrant issued in 2007 PIPE Offering
10.48(18)
 
Appointment of New Directors, Nathan Shelton, Steven Bolio and Dennis Kenneally
10.49(19)
 
Issuance of RAND Final Report
10.50(20)
 
Delisting from OTCBB to OTC Pink Sheets
10.51(21)
 
Resignation of Director, Dennis Kenneally
10.52(22)
 
Resignation of Officer, Bruce H. McKinnon
10.53(23)
 
Form of 10% Convertible Note issued in 2007 Spring Offering
10.54(23)
 
Form of Stock Purchase Warrant issued in 2007 Spring Offering
10.55(24)
 
Termination of North Hollywood Lease
10.56(25)
 
Modification Agreement of 10% 2007 PIPE Convertible Notes
10.57(26)
 
Form of 10% Convertible Note issued in 2007 Summer Offering
10.58(26)
 
Form of Stock Purchase Warrant issued in 2007 Summer Offering
10.59(27)
 
Resignation of Director, J. Joseph Brown
10.60(28)
 
Resignation of Chief Financial Officer and Appointment of Interim Chief Financial Officer
10.61(29)
 
Severance Agreement dated June 15, 2007 between Registrant and Bruce H. McKinnon
10.62(30)
 
Resignation of Director, Bruce H. McKinnon
10.63(31)
 
Second Modification Agreement of 10% 2007 PIPE Convertible Notes
10.64(32)
 
Form of 10% Convertible Note issued in 2007 Fall Offering
10.65(32)
 
Form of Stock Purchase Warrant issued in 2007 Fall Offering
10.66(33)
 
Resignation of Director, Joseph Helleis
10.67(34)
 
Form of 10% Convertible Note issued in 2007/8 Winter Offering
10.68(34)
 
Form of Stock Purchase Warrant issued in 2007/8 Winter Offering
10.69(34)
 
Modification and Satisfaction Agreement of Convertible Notes with Morale Orchards, LLP and Matthews & Partners
 
 
51

 
 
 
10.70(35)
 
Termination of employment relationship with John Bautista
10.71(36)
 
Form of 10% Convertible Note issued in 2008 Summer Offering
   
Form of Stock Purchase Warrant issued in 2008 Summer Offering
10.72(37)
 
Form of 10% Convertible Note issued in 2008 Fall Offering
   
Form of Stock Purchase Warrant issued in 2008 Fall Offering
10.73(38)
 
Form of 10% Convertible Note issued in 2008 Winter Offering
   
Form of Stock Purchase Warrant issued in 2008 Winter Offering
10.74(39)
 
Letter Agreement with Temple University extending default date
10.75(40)
 
Notice of first payment to Temple University under Letter Agreement
   
Announcement of date of 2010 Annual Shareholder Meeting
   
Appointment of Cecil Bond Kyte as new Chief Executive Officer
10.76(41)
 
Form of 10% Convertible Note issued in 2009 Winter Offering
   
Form of Stock Purchase Warrant issued in 2009 Winter Offering
10.77(42)
 
Employment Agreement with Cecil Bond Kyte
10.78(43)
 
Form of 10% Convertible Note issued in 2009 Winter #2 Offering
   
Form of Stock Purchase Warrant issued in 2009 Winter #2 Offering 
10.79(44) 
 
Form of 10% Convertible Note issued in 2009 Spring Offering 
   
Form of Stock Purchase Warrant issued in 2009 Spring Offering 
10.80(45) 
 
Form of 7% Convertible Note issued in 2009 Summer Offering 
   
Form of Stock Purchase Warrant issued in 2009 Summer Offering 
10.81(46) 
 
Passing of Steven Bolio, Company Director 
10.82(47) 
 
Form of 7% Convertible Note issued in 2009 Wellfleet Offering 
   
Form of Stock Purchase Warrant issued in 2009 Wellfleet Offering 
10.83(48) 
 
Form of 7% Convertible Note issued in 2009 Fall Offering 
   
Form of Stock Purchase Warrant issued in 2009 Fall Offering 
10.84(49)
 
Letter to Shareholders
10.85(50)
 
Form of 10% Convertible Note issued in 2010 Winter Offering
Form of Stock Purchase Warrant  issued in 2010 Winter Offering
10.86(51)
 
Settlement of Bruce H. McKinnon Arbitration Award
10.87(52)
 
Form of 10% Convertible Note Issued in 2010 Spring Offering
Form of Stock Purchase Warrant issued in to2010 Spring Offering
10.88(53)
 
Form of 10% Convertible Note Issued in 2010 Summer Offering
Form of Stock Purchase Warrant issued in 2010 Summer Offering
10.89(54)
 
Form of 10% Convertible Note issued in 2010 Fall Offering
Form of Stock Purchase Warrant issued in 2010 Fall Offering
10.90(55)
 
Form of 10% Convertible Note issued in 2010 Fall Offering #2
Form of Stock Purchase Warrant issued in 2010 Fall Offering #2
10.91(56)
 
Resignation of Director John A. Price
10.92(57)
 
Form of 10% Convertible Note issued in 2011 Winter Offering
Form of Stock Purchase Warrant issued in 2011 Winter Offering
10.93(58)
 
Amendment to Employment Contract with Cecil Kyte
Announcement of date of 2011 Annual Shareholder Meeting
10.94(59)  
License Agreement between the Registrant and Temple University dated August 9, 2011
10.96(60)  
Form of 10% Convertible Note Issued in 2011 Spring Offering
Form of Stock Purchase Warrant issued in 2011 Spring Offering
 
 
52

 
 
10.97(61)
 
Form of 10% Convertible Note Issued in 2011 Summer Offering
Form of Stock Purchase Warrant Issued in 2011 Summer Offering
10.94(62)  
Form of 10% Convertible Note Issued in 2011 Fall Offering
Form of Stock Purchase Warrant Issued in 2011 Fall Offering
10.95(63)
 
Final Report of the Rocky Mountain Oilfield Testing Center of Viscosity Reduction Device (AOT)
10.96(64)  
Form of 10% Convertible Note Issued in 2011 Fall#2 Offering
Form of Stock Purchase Warrant Issued in 2011 Fall#2 Offering
10.97(65)
 
Letter of Intent between Registrant and Heng He Xing Ye Technology Development Co., Ltd. dated October 19,2011
10.98(66)
 
Announcement of resignation of Eugene E. Eichler, Interim Chief Financial Officer for health reasons.
10.99(67)
 
Form of 10% Convertible Note Issued in 2011 Fall#3 Offering
Form of Stock Purchase Warrant Issued in 2011 Fall#3 Offering
10.100(68)
 
Form of 10% Convertible Note Issued in 2012 Winter Offering
Form of Stock Purchase Warrant Issued in 2012 Winter Offering
10.101*
 
Employment Agreement with Gregg Bigger, Chief Financial Officer
10.102(69)
 
Letter of Intent between Registrant and LG Partners LLC (“LGP”)
10.103(70)
 
Cooperation Framework Agreement between Registrant and Heng He Xing Technology Development Co., Ltd (TDC) dated March 9, 2012
10.104*   U.S. Department of Energy Agreement dated February 6, 2012
 
21
 
List of Subsidiaries
24*
 
Power of Attorney (included on Signature Page)
31.1*
 
Certification of Chief Executive Officer of Annual Report Pursuant to Rule 13(a)—15(e) or Rule 15(d)—15(e).
31.2*
 
Certification of Chief Financial Officer of Annual Report Pursuant to 18 U.S.C. Section 1350.
32.1*
 
Certification of Chief Executive Officer and Chief Financial Officer of Annual Report pursuant to Rule 13(a)—15(e) or Rule 15(d)—15(e).
     
101.INS
XBRL Instance Document
101.SCH
XBRL Schema Document
101.CAL
XBRL Calculation Linkbase Document
101.DEF
XBRL Definition Linkbase Document
101.LAB
XBRL Label Linkbase Document
101.PRE
XBRL Presentation Linkbase Document
 

*
 
Filed herewith.
**
 
Confidential treatment previously requested.
 
Management contract or compensatory plan or arrangement. 
(1)
      
Incorporated by reference from Registrant’s Registration Statement on Form 10-SB (Registration Number 000-29185), as amended, filed on March 2, 2000.
(2)
 
Incorporated by reference from Registrant’s Form 10-KSB for the fiscal year ended December 31, 2002.
(3)
 
Incorporated by reference from Registrant’s Form 8-K filed on December 30, 2002.
(4)
 
Incorporated by reference from Registrant’s Form 8-K filed on November 12, 2002.
(5)
 
Incorporated by reference from Registrant’s Form 10-QSB for the quarter ended March 31, 2004.
(6)
 
Incorporated by reference from Appendix C of Registrant’s Schedule 14A filed on April 30, 2004, in connection with its Annual Meeting of Stockholders held on May 24, 2004.
(7)
 
Incorporated by reference from Registrant Form 8-K filed on July 12, 2004.
(8)
 
Incorporated by reference from registrant’s Form 10-KSB for the fiscal year ended December 31, 2004.
(9)
 
Incorporated by reference from Registrant’s Form 10-QSB for the quarter ended September 30, 2005
(10)
 
Incorporated by reference from Registrant’s Form 10-KSB for the fiscal year ended December 31, 2005
(11)
 
Incorporated by reference from Registrant’s Form SB-2 filed on June 28, 2006 (SEC File No. 333- 333-135415)
(12)
 
Incorporated by reference from Registrant’s Form 8-K filed on September 21, 2006
(13)
 
Incorporated by reference from Registrant’s Form SB-2 filed on October 6, 2006 (SEC File No. 333-137855)
(14)
 
Incorporated by reference from Registrant’s Form 8-K filed on December 11, 2006
(15)
 
Incorporated by reference from Registrant’s Form 10KSB for the fiscal year ended December 31, 2006
(16)
 
Incorporated by reference from Registrant’s form 8-K filed on January 10, 2007
(17) 
 
Incorporated by reference from Registrant’s form 8K filed on February 8, 2007 
(18) 
 
Incorporated by reference from Registrant’s form 8K filed on February 16, 2007 
(19) 
 
Incorporated by reference from Registrant’s form 8K filed on May 3, 2007 
(20) 
 
Incorporated by reference from Registrant’s form 8K filed on May 22 2007 
(21) 
 
Incorporated by reference from Registrant’s form 8K filed on June 8, 2007 
(22) 
 
Incorporated by reference from Registrant’s form 8K filed on June 15, 2007 
(23) 
 
Incorporated by reference from Registrant’s form 8K filed on July 2, 2007 
(24) 
 
Incorporated by reference from Registrant’s form 8K filed on July 18, 2007 
(25) 
 
Incorporated by reference from Registrant’s form 8K filed on August 30, 2007 
 
 
53

 
 
 
(26) 
 
Incorporated by reference from Registrant’s form 8K filed on October 9, 2007 
(27) 
 
Incorporated by reference from Registrant’s form 8K filed on October 23, 2007 
(28) 
 
Incorporated by reference from Registrant’s form 8K filed on November 9, 2007 
(29) 
 
Incorporated by reference form Registrant’s Form 10QSB for the nine months ended September 30, 2007 
(30) 
 
Incorporated by reference from Registrant’s form 8K filed on November 15, 2007 
(31) 
 
Incorporated by reference from Registrant’s form 8K filed on December 11, 2007 
(32) 
 
Incorporated by reference from Registrant’s form 8K filed on December 20, 2007 
(33) 
 
Incorporated by reference from Registrant’s form 8K filed on February 25, 2010 
(34)
 
Incorporated by reference from Registrant’s form 8K filed on March 11, 2010
(35)
 
Incorporated by reference from Registrant’s form 8K filed on March 27, 2010
(36)
 
Incorporated by reference from Registrant’s form 8K filed on September 3, 2010
(37)
 
Incorporated by reference from Registrant’s form 8K filed on November 6, 2010
(38)
 
Incorporated by reference from Registrant’s form 8K filed on December 11, 2010
(39)
 
Incorporated by reference from Registrant’s form 8K filed on January 13, 2010
(40)
 
Incorporated by reference from Registrant’s form 8K filed on January 27, 2010
(41)
 
Incorporated by reference from Registrant’s form 8K filed on January 26, 2010
(42)
 
Incorporated by reference from Registrant’s form 10K for the twelve months ended December 31, 2010
(43) 
 
Incorporated by reference from Registrant’s form 8K filed on March 12, 2010 
(45) 
 
Incorporated by reference from Registrant’s form 8K filed on September 30, 2010
(46) 
 
Incorporated by reference from Registrant’s form 8K filed on November 24, 2010 
(47) 
 
Incorporated by reference from Registrant’s form 8K filed on December 7, 2010 
(48) 
 
Incorporated by reference from Registrant’s form 8K filed on February 3, 2010 
(49)
(50)
(51)
(52)
(53)
(54)
(55)
(56)
(57)
(58)
(59)
(60)
(61)
(62)
(63)
(64)
(65)
(66)
(67)
(68)
(69)
(70)
 
 
 
Incorporated by reference from Registrant’s form 8K filed on March 22, 2010
Incorporated by reference from Registrant’s form 8K filed on April 8, 2010
Incorporated by reference from Registrant’s form 8K filed on April 13, 2010
Incorporated by reference from Registrant’s form 8K filed on May 7, 2010
Incorporated by reference from Registrant’s form 8K filed on August 11, 2010
Incorporated by reference from Registrant’s form 8K filed on November 11, 2010
Incorporated by reference from Registrant’s form 8K filed on December 6, 2010
Incorporated by reference from Registrant’s form 8K filed on February 25, 2011
Incorporated by reference form Registrant’s form 8K filed on March 7, 2011
Incorporated by reference from Registrant’s form 8K filed on March 9, 2011
Incorporated by reference from Registrant’s form 8K filed on August 11, 2011
Incorporated by reference from Registrant’s form 8K filed on June 9, 2011
Incorporated by reference from Registrant’s form 8K filed on August 10, 2011
Incorporated by reference from Registrant’s form 8K filed on October 21, 2011
Incorporated by reference from Registrant’s form 8K filed on October 25, 2011
Incorporated by reference from Registrant’s form 8K filed on December 14, 2011
Incorporated by reference from Registrant’s form 8K filed on December 27, 2011
Incorporated by reference from Registrant’s form 8K filed on January 4, 2012
Incorporated by reference from Registrant’s form 8K filed on January 23, 2012
Incorporated by reference from Registrant’s form 8K filed on February 8, 2012
Incorporated by reference from Registrant’s form 8K filed on March 16, 2012
Incorporated by reference from Registrant’s form 8K filed on March 20, 2012

 
  

 
 
54

 
 

  
SIGNATURES
 
In accordance with Section 13 or 15(d) of the Exchange Act, the Registrant has caused this report to be signed on its behalf by the undersigned, hereunto duly authorize.


 
Save The World Air, Inc.
 
       
Date: March 30, 2012
By:
/s/ CECIL BOND KYTE
 
   
Cecil Bond Kyte
 
   
Chief Executive Officer
 
       
 
 
POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints, jointly and severally, Cecil Bond Kyte and Greggory Bigger, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934 this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

NAME
 
TITLE
 
DATE
         
/s/ CECIL BOND KYTE
 
Chief Executive Officer and Chairman of the Board of Directors
 
 March 30, 2012
Cecil Bond Kyte
       
         
/s/ CHARLES R. BLUM
 
President and Director
 
 March 30, 2012
Charles R. Blum
       
         
/s/ GREGGORY BIGGER
 
Chief Financial Officer
 
March 30, 2012
Greggory Bigger
       
         
/s/ NATHAN SHELTON
 
Director
 
March 30, 2012
Nathan Shelton
       

 
   

 
 
55

 
 


 
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

SAVE THE WORLD AIR, INC. AND SUBSIDIARY
(A DEVELOPMENT STAGE ENTERPRISE)
DECEMBER 31, 2011 AND 2010

 
 
Page
   
Report of Independent Registered Public Accounting Firm
F-2
   
Consolidated balance sheets
F-3
   
Consolidated statements of operations
F-4
   
Consolidated statements of stockholders’ deficiency
F-5
   
Consolidated statements of cash flows
F-6
   
Notes to consolidated financial statements
F-15

 
   
 
 
 
 

 
 
F-1

 
 

  
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of:
Save The World Air, Inc. and Subsidiary

We have audited the accompanying consolidated balance sheets of Save The World Air, Inc. and Subsidiary (a development stage enterprise) (the “Company”) as of December 31, 2011 and 2010, and the related consolidated statements of operations, stockholders’ deficiency and cash flows for the years then ended and for the period from February 18, 1998 (inception) through December 31, 2011.  These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.  An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Save The World Air, Inc. and Subsidiary as of December 31, 2011 and 2010, and the results of their operations and their cash flows for the years then ended and for the period from February 18, 1998 (inception) through December 31, 2011, in conformity with accounting principles generally accepted in the United States of America.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has incurred recurring losses from operations since its inception. These matters raise substantial doubt about the Company's ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ Weinberg & Company, P.A.

 
Weinberg & Company, P.A.

Los Angeles, California
March 30, 2012
   

 
 
F-2

 
 
   
SAVE THE WORLD AIR, INC.
(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED BALANCE SHEETS
 
   
December 31,
 
   
2011
   
2010
 
ASSETS
Current assets
           
Cash
 
$
617,797
   
$
101,645
 
Other current assets
   
77,907
     
29,425
 
Total current assets
   
695,704
     
131,070
 
Property and Equipment, net
   
75,609
     
78,083
 
Other assets
   
10,330
     
8,020
 
Total assets
 
$
781,643
   
$
217,173
 
 
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
 
                 
Current liabilities
               
Accounts payable- related parties
 
$
63,003
   
$
241,176
 
Accounts payable – license agreements
   
178,125
     
721,785
 
Accounts payable- other
   
478,402
     
450,411
 
Accrued expenses
   
1,060,162
     
959,827
 
Accrued professional fees
   
294,552
     
431,704
 
Loan payable- related party and shareholders
   
     
86,947
 
Convertible debentures, net-of-discount
   
169,542
     
76,947
 
Fair value of derivative liabilities
   
1,643,139
     
3,664,675
 
Total liabilities
   
3,886,925
     
6,633,472
 
                 
Commitments and contingencies
               
                 
Stockholders’ deficiency
               
Common stock, $.001 par value: 200,000,000 shares authorized, 114,273,470 and 91,453,194 shares issued and outstanding at December 31, 2011 and 2010, respectively
   
114,274
     
91,453
 
Additional paid-in capital
   
66,069,911
     
51,925,168
 
Deficit accumulated during the development stage
   
(69,289,467
)
   
(58,432,920
)
Total stockholders’ deficiency
   
(3,105,282
)
   
(6,416,299
)
Total liabilities and stockholder’s deficiency
 
$
781,643
   
$
217,173
 

 
  
See notes to consolidated financial statements.  

 
 
F-3

 
 
  
SAVE THE WORLD AIR, INC.
(A DEVELOPMENT STAGE ENTERPRISE)
 
CONSOLIDATED STATEMENTS OF OPERATIONS
       
   
Years Ended December 31,
   
Inception
(February 18,
1998) to
 December 31,
 
   
2011
   
2010
   
2011
 
                   
Net sales
 
$
   
$
   
$
69,000
 
Cost of goods sold
   
     
     
24,120
 
Gross profit
   
     
     
44,880
 
Operating expenses
   
6,886,681
  
   
4,293,631
  
   
44,144,635
 
Research and development expenses
   
1,130,283
     
427,982
     
7,444,997
 
Non-cash patent settlement cost
   
     
     
1,610,066
 
Loss before other income (expense)
   
(8,016,964
)
   
(4,721,613
)
   
(53,154,818
)
Other income (expense)
                       
Other income (loss)
   
48,000
     
145,112
     
191,972
 
Interest income
   
     
     
16,342
 
Interest and financing expense
   
(5,084,253
   
(4,034,558
   
(16,676,617
)
Change in fair value of derivative liabilities
   
2,021,536
     
414,505
     
2,128,201
 
Costs of private placement
   
     
(1,129,212
   
(1,640,715
)
Costs to induce conversion of notes
   
     
(168,340
)
   
(469,043
)
Loss on disposition of equipment
   
     
     
(14,426
)
Settlement of Debt Due Morale/ Matthews
   
     
     
(927,903
Settlement of litigation and debt
   
175,934
     
     
1,265,022
 
Loss before provision for income taxes
   
(10,855,747
)
   
(9,494,106
)
   
(69,281,985
)
Provision for income taxes
   
  800
     
  800
     
7,482
 
Net loss
 
$
 (10,856,547
)
 
$
 (9,494,906
)
 
$
(69,289,467
)
                         
Net loss per common share, basic and diluted
 
$
(0.10
)
 
$
(0.12
)
       
Weighted average common shares outstanding, basic and diluted
   
104,103,109
     
81,910,267
         

 
 
See notes to consolidated financial statements. 

 





 
 
F-4

 
 
 
SAVE THE WORLD AIR, INC.
(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY
FROM FEBRUARY 18, 1998 (INCEPTION) TO DECEMBER 31, 2011
  
   
Price per
   
Common Stock
   
Common
Stock
to be
   
Additional
Paid-in
   
Deferred
   
Deficit
Accumulated
During the
Development
   
Total
Stockholders
 
   
Share
   
Shares
   
Amount
   
Issued
   
Capital
   
Compensation
   
Stage
   
Deficiency
 
Balance, February 18, 1998 date of inception)
         
   
$
   
$
   
$
   
$
   
$
 —
   
$
 
Issuance of common stock on April 18, 1998
   
.0015 - .01
     
10,030,000
     
10,030
     
     
14,270
     
     
     
24,300
 
Net loss
           
     
     
     
     
     
(21,307
)
   
(21,307
)
Balance, December 31, 1998
           
10,030,000
   
$
10,030
   
$
     
14,270
   
$
   
$
(21,307
)
 
$
2,993
 
Issuance of common stock on May 18, 1999
   
1.00 - 6.40
     
198,003
     
198
     
     
516,738
     
     
     
516,936
 
Issuance of common stock for ZEFS on September 14, 1999
   
.001
     
5,000,000
     
5,000
     
     
     
     
     
5,000
 
Stock issued for professional services on May 18, 1999
   
0.88
     
69,122
     
69
     
     
49,444
     
     
     
49,513
 
Net loss
           
     
     
     
     
     
(1,075,264
)
   
(1,075,264
)
Balance, December 31, 1999
           
15,297,125
   
$
15,297
   
$
   
$
580,452
   
$
   
$
(1,096,571
)
 
$
(500,822
)
 
 
(continued)
 
 
 
 
 
  

 
 
F-5

 
 
  
SAVE THE WORLD AIR, INC.
(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY (continued)
FROM FEBRUARY 18, 1998 (INCEPTION) TO DECEMBER 31, 2011
  
   
Price per
   
Common Stock
   
Common
Stock
to be
   
Additional
Paid-in
   
Deferred
   
Deficit
Accumulated
During the
Development
   
Total
Stockholders
 
   
Share
   
Shares
   
Amount
   
Issued
   
Capital
   
Compensation
   
Stage
   
Deficiency
 
Balance, December 31, 1999
         
15,297,125
   
$
15,297
   
$
   
$
580,452
   
$
   
$
(1,096,571
 
$
(500,822
Issuance of common stock for services
 
$0.38 - $5.31
     
305,810
     
306
     
     
588,704
     
     
     
589,010
 
Stock issued for employee compensation on February 8, 2000
 
$1.03-$5.31
     
42,000
     
42
     
     
137,378
     
     
     
137,420
 
Stock issued for directors fees
 
$3.38-$4.44
     
56,000
     
56
     
     
195,584
     
     
     
195,640
 
Common stock cancelled
         
(55,000
   
(55
           
(64,245
                   
(64,300
Net loss
         
     
     
     
     
     
(1,270,762
)
   
(1,270,762
Balance, December 31, 2000
         
15,645,935
     
15,646
     
     
1,437,873
     
     
(2,367,333
)
   
(913,814
Issuance of common stock for services
 
$0.25-$1.65
     
1,339,912
     
1,340
     
     
1,031,231
     
     
     
1,032,571
 
Stock issued for directors fees
 
$0.60-$0.95
     
1,100,000
     
1,100
             
1,008,900
                     
1,010,000
 
Intrinsic value of options issued to employees
                                 
2,600,000
     
(2,600,000)
             
 
Fair value of options issued to non-employees
                                 
142,318
                     
142,318
 
Amortization of deferred compensation
                                         
191,667
             
191,667
 
Net loss
                                                 
(2,735,013
   
(2,735,013
Balance, December 31, 2001
         
18,085,847
   
$
18,086
   
$
   
$
6,220,322
   
$
(2,408,333
 
$
(5,102,346
)
 
$
(1,272,271
 
 
(continued)



 
 
F-6

 
 
 
SAVE THE WORLD AIR, INC.
(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY (continued)
FROM FEBRUARY 18, 1998 (INCEPTION) TO DECEMBER 31, 2011
  
   
Price per
   
Common Stock
   
Common
Stock
to be
   
Additional
Paid-in
   
Deferred
   
Deficit
Accumulated
During the
Development
   
Total
Stockholders
 
   
Share
   
Shares
   
Amount
   
Issued
   
Capital
   
Compensation
   
Stage
   
Deficiency
 
Balance, December 31, 2001
         
18,085,847
   
$
18,086
   
$
   
$
6,220,322
   
$
(2,408,333
 
$
(5,102,346
 
$
(1,272,271
Stock issued for directors fees
   
0.40
     
2,150,000
     
2,150
     
     
857,850
     
     
     
860,000
 
Common stock sold (2,305,000 shares)
   
0.15-0.25
     
     
     
389,875
     
     
     
     
389,875
 
Fair value of options issued to non-employees for services
           
     
     
     
54,909
     
(54,909
)
   
     
 
Amortization of deferred compensation
           
     
     
     
     
891,182
     
     
891,182
 
Net loss
           
     
     
     
     
     
(2,749,199
)
   
(2,749,199
)
Balance, December 31, 2002
           
20,235,847
     
20,236
     
389,875
     
7,133,081
     
(1,572,060
   
(7,851,545
)
   
(1,880,413
)
Common stock issued previously paid for
   
0.15-0.25
     
2,305,000
     
2,305
     
(433,750
)
 
 
431,445
     
     
     
 
Sale of common stock
 
$
0.25
     
9,504,000
     
9,504
             
2,366,439
     
     
     
2,375,943
 
Issuance of common stock for services
 
$
0.55
     
83,414
     
83
     
     
45,794
     
     
     
45,877
 
Common stock issued for convertible debt
 
$
0.25
     
2,000,000
     
2,000
             
498,000
     
     
     
500,000
 
Finders’ fees related to stock issuances
           
     
     
43,875
     
(312,582
)
   
     
     
(268,707
)
Common stock sold (25,000 shares)
   
0.25
     
     
     
6,250
     
     
     
     
6,250
 
Amortization of deferred compensation
           
     
     
     
     
863,727
     
     
863,727
 
Net loss
                                                   
(2,476,063
   
(2,476,063
Balance, December 31, 2003
           
34,128,261
   
$
34,128
   
$
6,250
   
$
10,162,177
   
$
(708,333
 
$
(10,327,608
)
 
$
(833,386
)
 
 
(continued)
   

 
 
F-7

 
 
  
SAVE THE WORLD AIR, INC.
(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY (continued)
FROM FEBRUARY 18, 1998 (INCEPTION) TO DECEMBER 31, 2011
  
   
Price per
   
Common Stock
   
Common
Stock
to be
   
Additional
Paid-in
   
Deferred
   
Deficit
Accumulated
During the
Development
   
Total
Stockholders
 
   
Share
   
Shares
   
Amount
   
Issued
   
Capital
   
Compensation
   
Stage
   
Deficiency
 
       
Balance, December 31, 2003
         
34,128,261
   
$
34,128
   
$
6,250
   
$
10,162,177
   
$
(708,333
 
$
(10,327,608
)
 
$
(833,386
Common stock issued previously paid for
 
$
.25
     
25,000
     
25
     
(6,250)
     
6,225
                     
 
Sale of common stock
 
$
1.00
     
1,272,500
     
1,273
     
119,000
     
1,271,227
     
     
     
1,391,500
 
Stock issued for services
 
$
.15-$1.70
     
1,268,560
     
1,268
             
1,388,663
                     
1,389,931
 
Stock issued for directors fees
 
$
1.50
     
50,000
     
50
     
     
74,950
     
     
     
75,000
 
Common stock issued for convertible debt
 
$
1.53
     
60,000
     
60
             
91,740
     
     
     
91,800
 
Common stock issued upon exercise of warrants and options
 
$
.20 -$.40
     
960,500
     
960
     
     
193,240
     
     
     
194,200
 
Common stock issued for patent settlement
 
$
1.24
     
20,000
     
20
             
24,780
                     
24,800
 
Fair value of warrants issued
                                   
1,614,138
                     
1,614,138
 
Fair value of options issued to employees
           
     
     
     
248,891
     
(248,891
)
   
     
 
Fair value of options issued to non-employees
           
     
     
     
55,381
     
(55,381
)
   
     
 
Amortization of deferred compensation
           
     
     
     
     
936,537
     
     
936,537
 
Finders’ fees related to stock issuances
                                   
(88,384
                       
Net loss
           
     
     
     
     
     
(6,803,280
)
   
(6,803,280
)
Balance, December 31, 2004
           
37,784,821
   
$
37,784
   
$
119,000
   
$
15,043,028
   
$
(76,068
 
$
(17,130,888
)
 
$
(2,007,144
)
   
 
(continued)

 
 
F-8

 
 
 
SAVE THE WORLD AIR, INC.
(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY (continued)
FROM FEBRUARY 18, 1998 (INCEPTION) TO DECEMBER 31, 2011
   
     
Price per
   
Common Stock
   
Common
Stock
to be
 
Additional
Paid-in
   
Deferred
   
Deficit
Accumulated
During the
Development
   
Total
Stockholders
 
     
Share
   
Shares
   
Amount
   
Issued
 
Capital
   
Compensation
   
Stage
   
Deficiency
 
Balance, December 31, 2004
           
37,784,821
   
$
37,784
   
$
119,000
 
$
15,043,028
   
$
(76,068
 
$
(17,130,888
)
 
$
(2,007,144
Common stock issued previously paid for
   
$1.00
     
119,000
     
119
     
(119,000
 
118,881
     
     
     
 
Sale of common stock
   
$1.00
     
1,530,500
     
1,530
           
1,528,970
     
     
     
1,530,500
 
Common stock issued upon exercise of warrants
   
$.40 - $1.00
     
500
     
1
     
   
199
     
     
     
200
 
Common stock to be issued for settlement of payables
                           
612,521
                           
612,521
 
Fair value of options issued for settlement costs
                                 
31,500
                     
31,500
 
Fair value of warrants issued
                                 
18,462
                     
18,462
 
Fair value of warrants issued and intrinsic value of beneficial conversion associated with convertible notes
                                 
1,453,181
                     
1,453,181
 
Fair value of options issued to employees
           
     
     
   
243,750
     
(243,750
)
   
     
 
Amortization of deferred compensation
           
     
     
   
     
177,631
     
     
177,631
 
Finders’ fees related to stock issuances
                                 
(109,840
                   
(109,840
Common stock cancelled
           
(8,047,403
   
(8,047
         
8,047
                     
 
Net loss
           
     
     
   
     
     
(3,115,186
)
   
(3,115,186
)
Balance, December 31, 2005
           
31,387,418
   
$
31,387
   
$
612,521
 
$
18,336,178
   
$
(142,187
 
$
(20,246,074
)
 
$
(1,408,175
)
 
 
(continued)
 

 
 
F-9

 
 
 
SAVE THE WORLD AIR, INC.
(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY (continued)
FROM FEBRUARY 18, 1998 (INCEPTION) TO DECEMBER 31, 2011   
 
   
Price per
   
Common Stock
   
Common
Stock
to be
   
Additional
Paid-in
   
Deferred
   
Deficit
Accumulated
During the
Development
   
Total
Stockholders
 
   
Share
   
Shares
   
Amount
   
Issued
   
Capital
   
Compensation
   
Stage
   
Deficiency
 
Balance, December 31, 2005
         
31,387,418
   
$
31,387
   
$
612,521
   
$
18,336,178
   
$
(142,187)
   
$
(20,246,074
)
 
$
(1,408,175
Common stock issued paid for previously
         
846,549
     
847
     
(612,521
   
611,674
     
     
     
 
Sale of common stock
 
$1.00 - $1.89
     
1,360,537
     
1,360
     
60,000
     
2,401,048
     
     
     
2,462,408
 
Common stock issued upon exercise of warrants
 
$.50 - $1.50
     
2,583,533
     
2,584
     
     
1,794,944
     
     
     
1,797,528
 
Common stock to be issued for convertible debt
 
$.70
     
3,416,186
     
3,417
             
2,356,449
                     
2,359,866
 
Common stock to be issue for out of line of credit
 
$.55 - $1.22
     
487,483
     
487
             
379,610
                     
380,097
 
Fair value of options issued to employees
         
     
     
     
2,253,263
             
     
2,253,263
 
Fair value of options issued for settlement costs
                                 
31,500
                     
31,500
 
Fair value of warrants issued for services
                                 
463,627
                     
463,627
 
Fair value of warrants issued and intrinsic value of beneficial conversion associated with convertible notes
                                 
1,259.696
                     
1,259,696
 
Write off of deferred compensation
         
     
     
     
(142,187
   
142,187
     
     
 
Finders’ fees related to stock issuances
                                 
(284,579
                   
(284,579
Fees paid on equity line of credit
                                 
(30,402
                   
(30,402
Net loss
         
     
     
     
     
     
(10,181,523
)
   
(10,181,523
)
Balance, December 31, 2006
         
40,081,757
   
 
40,082
   
$
60,000
   
$
29,430,821
   
$
   
$
(30,427,597
)
 
$
(896,694
)
 
 
(continued)


 
 
F-10

 
 
 
SAVE THE WORLD AIR, INC.
(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY (continued)
FROM FEBRUARY 18, 1998 (INCEPTION) TO DECEMBER 31, 2011
 
   
Price per
   
Common Stock
   
Common
Stock
to be
   
Additional
Paid-in
   
Deficit
Accumulated
During the
Development
   
Total
Stockholders
 
   
Share
   
Shares
   
Amount
   
Issued
   
Capital
   
Stage
   
Deficiency
 
Balance, December 31, 2006
          40,081,757     $ 40,082     $ 60,000     $ 29,430,821     $ (30,427,597 )   $ (896,694 )
Common stock issued previously paid for
          2,597,524       2,598       (60,000     57,402              
Common stock to be issued for convertible debt
  $ .17 - $.53       1,910,711       1,911               524,569               526,480  
Common stock issued for put of line of credit
  $ .27 - $.73       1,880,421       1,880               990,175               992,055  
Common stock granted for services
                            4,000                       4,000  
Fair value of options issued to employees
                              67,592             67,592  
Fair value of warrants issued for services
                                    35,340               35,340  
Fair value of warrants issued and intrinsic value of beneficial conversion associated with convertible notes
                                    1,253,548               1,253,548  
Fees paid on equity line of credit
                                    (79,364             (79,364
Net loss
                                    (6,262,743 )     (6,262,743 )
Balance, December 31, 2007
            46,470,413     $ 46,471     $ 4,000     $ 32,280,083     $ (36,690,340 )   $ (4,359,786 )
Common stock issued for convertible debt
  $ .17 - $.53       5,575,082       5,574       16,500       1,936,171             1,958,245  
Common stock issued for Morale/ Matthews settlement
  $ .38       7,421,896       7,422             2,776,289             2,783,711  
Common stock issued for services
  $ .17 - $.49       2,398,850       2,399             516,230             518,629  
Common stock issued upon exercise of warrants
  $ .50       1,064,650       1,065             531,260             532,325  
Fair value of options issued as compensations
                            645,745             645,745  
Fair value of warrants issued and intrinsic value of beneficial conversion with convertible notes
                            1,323,077             1,323,077  
Fair value of warrants issued to PIPE holders
                            116,913             116,913  
Common stock issued for services
  $ .17       10,000       10       (4,000 )     3,990              
 Net loss for the year ended
    December 31, 2008
                                  (6,052,724 )     (6,052,724
Balance, December 31, 2008
            62,940,891       62,941       16,500       40,129,758       (42,743,064     (2,533,865
 
(continued)
 
 
F-11

 
 
 
SAVE THE WORLD AIR, INC.
(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY (continued)
FROM FEBRUARY 18, 1998 (INCEPTION) TO DECEMBER 31, 2011
 
 
   
Price per
   
Common Stock
   
Common
Stock
to be
   
Additional
Paid-in
   
Deficit
Accumulated
During the
Development
   
Total
Stockholders
 
   
Share
   
Shares
   
Amount
   
Issued
   
Capital
   
Stage
   
Deficiency
 
Balance, December 31, 2008
          62,940,891       62,941       16,500       40,129,758       (42,743,064     (2,533,865
Common stock and warrants issued to induce conversion of notes
  $ .15-.50       459,732       460               300,243             300,703  
Common stock issued for previously converted notes
  $ .17       97,059       97       (16,500     16,403              
Common stock issued for services
  $ .33-.51       1,482,000       1,482             595,438             596,920  
Common stock issued for settlement of accounts payable
  $ .20-.38       495,615       496             128,986             129,482  
Fair value of warrants issued to shareholder for loan
                            1,248             1,248  
Fair value of options issued as compensation
                            89,802             89,802  
Common stock issued upon exercise of options
  $ .27       83,333       83             22,417             22,500  
Fair value of warrants and beneficial conversion feature of issued convertible notes
                            540,324             540,324  
Net loss for the year ended December 31, 2009
                                    (6,194,950     (6,194,950
Balance, December 31, 2009
            71,289,396       71,289             43,255,773       (48,938,014     (5,610,952
Common stock issued for convertible debt
  $ .15-$.50       15,851,272       15,851             4,401,566             4,417,417  
Common stock issued to induce conversion of convertible debt
  $ .53       224,751       225             118,893             119,118  
Fair value of warrants issued to induce conversion of convertible debt
                            49,222             49,222  
Common stock issued for services
  $ .43-$.48       3,710,099       3,710             1,381,427             1,385,137  
Common stock issued as compensation
  $ .52-$.55       170,000       170             91,530             91,700  
Common stock issued for settlement of accounts payable
  $ .34       12,121       12             4,109             4,121  
Fair value of options issued as compensation
                            138,733             138,733  
Common stock issued upon exercise of options
  $ .27       195,555       196             52,604             52,800  
Fair value of warrants issued for services
                            126,000             126,000  
Fair value of warrants and beneficial conversion feature of issued convertible notes
                            2,305,311             2,305,311  
Net loss for the year ended December 31, 2010
                                    (9,494,906     (9,494,906
Balance, December 31, 2010
            91,453,194       91,453             51,925,168       (58,432,920 )     (6,416,299 )
 
(continued)
 
 
F-12

 
 
SAVE THE WORLD AIR, INC.
(A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY (continued)
FROM FEBRUARY 18, 1998 (INCEPTION) TO DECEMBER 31, 2011
 
     
Price per
   
Common Stock
   
Common
Stock
to be
   
Additional
Paid-in
   
Deficit
Accumulated
During the
Development
   
Total
Stockholders
 
     
Share
   
Shares
   
Amount
   
Issued
   
Capital
   
Stage
   
Deficiency
 
 
Balance, December 31, 2010
              91,453,194     $ 91,453     $     $ 51,925,168     $ (58,432,920 )   $ (6,416,299
Common stock issued and to be issued for convertible debt
    $ .25       19,861,478       19,862             4,945,508             4,965,370  
Common stock issued upon exercise of warrants
    $ .47       81,020       81             (81 )            
Common stock issued for services
    $ .25-$.60       2,800,000       2,800             859,200             862,000  
Fair value of options and warrants issued as compensation
                              2,240,961             2,240,961  
Common stock issued upon exercise of options
    $ .27       77,778       78             20,922             21,000  
Fair value of warrants issued to consultants
                              411,888             411,888  
Fair value of warrants and beneficial conversion feature of issued convertible notes
                              5,666,345             5,666,345  
Net loss for the year ended December 31, 2011
                                      (10,856,547     (10,856,547 )
Balance, December 31, 2011
              114,273,470     $ 114,274     $     $ 66,069,911     $ (69,289,467 )   $ (3,105,282 )
  
 
See notes to consolidated financial statements.
 
 

 
 
 
F-13

 
 
 
SAVE THE WORLD AIR, INC.
 (A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF CASH FLOWS
 
 
    Years Ended December 31,    
Inception
(February 18, 1998)
to December 31,
 
    2011     2010     2011  
Cash flows from operating activities
                 
Net Loss
 
$
(10,856,547
)
 
$
(9,494,906
)
 
$
(69,289,467
)
Adjustments to reconcile net loss to net cash used in operating activities:
                       
Write off of intangible assets
   
     
     
505,000
 
Settlement of litigation and debt
   
(175,934
)
   
(145,112
)
   
(1,338,254
)
Settlement of Debt Due Morale/Matthews
   
     
     
927,903
 
Stock based compensation expense
   
2,240,961
     
230,433
     
6,176,117
 
Issuance of common stock for services
   
862,000
     
1,385,137
     
8,034,788
 
Issuance of options for legal settlement
   
     
     
31,500
 
Issuance of warrants for legal settlement
   
     
     
4,957
 
Issuance of warrants for financing fees
   
     —
     
     —
     
153,501
 
Issuance of warrants for consulting fees
   
411,888
     
126,000
     
537,888
 
Increase in convertible notes related to default
   
2,795
     
37,138
     
299,274
 
Interest on related party loans
   
     
     
22,305
 
Patent acquisition cost
   
     
     
1,610,066
 
Amortization of issuance costs and original issue debt discounts including beneficial conversion feature-part of interest expense
   
5,069,446
     
3,971,577
     
16,134,077
 
Fair value of common stock and warrants issued to induce conversion of notes
   
     
168,340
     
469,043
 
Costs of private placement convertible notes
   
     
1,129,212
     
1,640,715
 
Change in fair value of derivative liability
   
(2,021,536
   
(414,505
   
(2,128,201
Amortization of deferred compensation
   
     
     
3,060,744
 
Loss on disposition of assets
   
     
     
14,426
 
Depreciation and amortization of leasehold improvements
   
34,717
     
34,022
     
494,899
 
Bad debt
   
     
     
1,300
 
Changes in operating assets and liabilities:
                       
Accounts receivable
   
     
     
(1,380
)
Prepaid expenses and others
   
(48,481
   
(12,972
   
(77,826
)
Other assets
   
(2,310
   
3,000
     
(10,330
)
Accounts payable and accrued expenses
   
415,519
     
71,899
     
5,027,850
 
Accounts payable – license agreements
   
(478,297
   
(284,599
   
(473,012
)
Accounts payable – related parties
   
(178,173
   
52,356
     
(30,000
Net cash used in operating activities
   
(4,723,952
)
   
(3,142,980
)
   
(28,202,117
)
Cash flows from investing activities
                       
Purchase of equipment
   
(32,243
)
   
(11,235
)
   
(598,862
)
Proceeds from sale of equipment
   
     
     
17,478
 
Net cash used in investing activities
   
(32,243
   
(11,235
   
(581,384
)
Cash flows from financing activities
                       
Net proceeds under equity line of credit
   
     
     
1,262,386
 
(Decrease) increase in loans from related parties and shareholders
   
(86,947
   
(10,786
   
536,979
 
Advances from founding executive officer
   
     
     
517,208
 
Net proceeds from issuance of convertible notes and warrants
   
5,360,070
     
3,217,735
     
16,565,048
 
Repayment of convertible notes
   
(14,276
   
     
(296,397
)
Proceeds from exercise of warrants
   
13,500
     
15,300
     
10,816,074
 
Net cash provided by financing activities
   
5,272,347
     
3,222,249
     
29,401,298
 
Net increase in cash
   
516,152
     
68,034
     
617,797
 
Cash, beginning of period
   
101,645
     
33,611
     
 
Cash, end of period
 
$
617,797
   
$
101,645
   
$
617,797
 
 
 
 
F-14

 
 
SAVE THE WORLD AIR, INC.
 (A DEVELOPMENT STAGE ENTERPRISE)

CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
 
     
Years Ended December 31,
     
Inception
(February 18, 1998)
to December 31,
 
     
2011
     
2010
     
2011
 
 
Supplemental disclosures of cash flow information
                       
Cash paid during the year for:
                       
Interest
 
$
12,014
   
$
21,294
   
$
171,380
 
Income taxes
 
$
800
   
$
800
   
$
7,482
 
Non-cash investing and financing activities
                       
Acquisition of intangible asset through advance from related party and issuance of common stock
 
$
   
$
   
$
505,000
 
Deferred compensation for stock options issued for services
   
     
     
3,202,931
 
Purchase of property and equipment financed by advance from related party
   
     
     
3,550
 
Conversion of related party debt to equity
   
     
     
515,000
 
Issuance of common stock in settlement of payable
   
     
4,121
     
247,584
 
Cancellation of stock
   
     
     
8,047
 
Conversion of accounts payable and accrued expenses to common stock
   
     
     
612,521
 
Conversion of accounts payable and accrued expenses to convertible debentures
   
306,275
     
331,200
     
637,475
 
Conversion of related party debt to convertible debentures
   
     
27,500
     
72,500
 
Conversion of convertible debentures to common stock
   
4,965,370
     
4,417,417
     
15,751,351
 
Issuance of shares for settlement of loans and other payable to Morale/Matthews
   
     
     
2,783,711
 
Write off of deferred compensation
   
     
     
142,187
 
Fair value of derivative liability recorded as note discount
   
     
1,243,625
     
2,130,625
 
Proceeds of exercise of options applied to accounts payable
   
7,500
     
37,500
     
67,500
 
Fair value of warrants and beneficial conversion feature associated with issued convertible notes
   
5,666,345
     
2,305,311
     
13,912,733
 

 

See notes to consolidated financial statements.
  
 

 
 
F-15

 
 
 
SAVE THE WORLD AIR, INC. AND SUBISIDARY
(A DEVELOPMENT STAGE ENTERPRISE)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2011 AND 2010
AND FOR THE PERIOD INCEPTION (FEBRUARY 18, 1998) TO DECEMBER 31, 2011
 
1.     
Description of business

Description of business

Save The World Air, Inc. (“STWA”, “Company”) was incorporated on February 18, 1998, as a Nevada Corporation under the name Mandalay Capital Corporation. The company changed its name to Save the World Air, Inc. on February 11, 1999, following the acquisition of the marketing and manufacturing rights of the ZEFS technologies. Our executive offices are at 735 State Street, Suite 500, Santa Barbara, California 93101. The telephone number is (805) 845-3561. Our research and development facility is at 235 Tennant Avenue, Morgan Hill, California 95037. The telephone number is (408) 778-0101. The Company’s common stock is quoted under the symbol “ZERO” on the Over-the-Counter Bulletin Board. More information including the Company’s fact sheet, logos and media articles are available at our corporate website, www.stwa.com.

The Company develops and commercializes energy efficiency technologies that assist in meeting the increasing global energy demands, improving the economics of oil extraction and transport, and reducing greenhouse gas emissions. The Company’s intellectual property portfolio includes 24 domestic and international patents and patents pending, which have been developed in conjunction with and exclusively licensed from Temple University. The Company’s technology has two commercial applications; Applied Oil Technology (AOT) and ELEKTRA™ and legacy technologies of ZEFS and MK IV. The AOT and ELEKTRA are technologies, which use electric fields to alter some physical properties of petrochemical fluids to reduce viscosity of the fluids.

Our AOT technology is designed to allow pipeline operators to temporarily reduce the viscosity of the crude oil within their pipeline(s) to reduce the fluid-drag (also known as friction-loss) between the fluid and the pipeline. By reducing the friction loss, pipeline operators’ pump systems require less energy to maintain a constant flow rate, thereby directly reducing daily operation costs. AOT has been proven in U.S. Department of Energy tests to increase the energy efficiency of oil pipeline pump stations by over 13%. We intend to market our AOT products primarily to pipeline operators as well as to pilot and government mandated delivery programs.

Our ELEKTRA products are intended to increase fuel efficiency and reduce emissions. ELEKTRA Will be marketed primarily to specialty consumer accessories market for many types of diesel-fueled vehicles, including but not limited to trucks, trains, maritime, military and aviation.

Consolidation policy

The accompanying consolidated financial statements of Save the World Air, Inc. and Subsidiary include the accounts of Save the World Air, Inc. (the Parent) and its wholly owned subsidiary STWA Asia Pte. Limited, incorporated on January 17, 2006.  Intercompany transactions and balances have been eliminated in consolidation.

2.     
Summary of significant accounting policies

Development stage enterprise

The Company is a development stage enterprise.  All losses accumulated since the inception of the Company have been considered as part of the Company’s development stage activities.
  
The Company’s focus is on product development and marketing of proprietary devices that are designed to reduce operation costs of petrochemical pipeline transport and fuel efficiency of diesel engines and has not yet generated meaningful revenues.  The Company is currently in the mid-late stages of developing its AOT™ and ELEKTRA™ technologies for commercial applications.  Expenses have been funded though the sale of company stock, convertible notes and the exercise of warrants for cash.  The Company has taken actions to secure the intellectual property rights to the AOT™ and ELEKTRA™ technologies and is the worldwide exclusive licensee for patent pending technologies associated with the development of AOT™ and ELEKTRA™.

 
 
F-16

 
 

Going concern

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, the Company had a net loss of $10,856,547 and a negative cash flow from operations of $4,723,952 for the year ended December 31, 2011, and had a working capital deficiency (excluding derivative liabilities) of $1,548,082 and a stockholders’ deficiency of $3,105,282 at December 31, 2011. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

At December 31, 2011 we have cash on hand totaling $617,797 and subsequent to December 31, 2011, the Company raised an additional $1,215,440 through the issuance of its convertible notes. (see "Note 12").   In order to fund our operations and the repayment of our outstanding notes, we may have to raise additional funds. At December 31, 2011, these notes included,  the Fall 2009 Notes due in January 2012, the Winter 2011 Notes due in February 2012, the Fall 2011 Notes in October 2012 and the Fall 2011#2 Notes due in December 2012  These Notes total $1,720,460 and we expect substantially all of these Notes will be converted into stock. In addition to the funds required to continue to operate our business, including without limitation the expenses we will incur in connection with the license and research and development agreements with Temple University, costs associated with product development and commercialization of the AOT and ELEKTRA technologies, costs to manufacture and ship our products, costs to design and implement an effective system of internal controls and disclosure controls and procedures, costs of maintaining our status as a public company by filing periodic reports with the SEC, costs to settle a certain law suit, and costs required to protect our intellectual property. In addition, we have substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, certain severance payments to a former officer and consulting fees, during 2012 and beyond.
 
No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. At present, we have relatively few financing options available to us.
 
 Revenue Recognition Policy

The Company recognizes revenue based upon meeting four criteria:

 
Persuasive evidence of an arrangement exists;
 
Delivery has occurred or services rendered;
 
The seller’s price to the buyer is fixed or determinable; and
 
Collectability is reasonably assured.

The Company co-develops with, and licenses from, its intellectual property as a joint-agreement with Temple University of Philadelphia, PA.  The Company’s business model is to contract with suppliers and manufacturers of oilfield equipment to sell into the oilfield pipeline market. The Company negotiates an initial contract with the customer fixing the terms of the sale and then receive a letter of credit or full payment in advance of shipment. Upon shipment, the Company will recognize the revenue associated with the sale of the products to the customer.
 
Property and equipment and depreciation
 
Property and equipment are stated at cost. Depreciation is computed using the straight-line method based on the estimated useful lives of the assets, generally ranging from three to ten years. Expenditures for major renewals and improvements that extend the useful lives of property and equipment are capitalized. Expenditures for repairs and maintenance are charged to expense as incurred. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the lease term.



 
F-17

 

Impairment of long-lived assets  

Our long-lived assets, such as property and equipment, are reviewed for impairment at least annually, or when events and circumstances indicate that depreciable or amortizable long lived assets might be impaired and the undiscounted cash flows estimated to be generated by those assets are less than the carrying amount of those assets. When specific assets are determined to be unrecoverable, the cost basis of the asset is reduced to reflect the current value.
  
We use various assumptions in determining the current fair value of these assets, including future expected cash flows and discount rates, as well as other fair value measures. Our impairment loss calculations require us to apply judgment in estimating future cash flows, including forecasting useful lives of the assets and selecting the discount rate that reflects the risk inherent in future cash flows.

If actual results are not consistent with our assumptions and judgments used in estimating future cash flows and asset fair values, we may be exposed to future impairment losses that could be material to our results.  Based upon management’s annual review, no impairments were recorded for the years ended December 31, 2011 and December 31, 2010.

Loss per share

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the loss of the Company. In computing diluted loss per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. For the years ended December 31, 2011 and 2010, the dilutive impact of outstanding stock options of 24,067,892 and 4,837,488; outstanding warrants of 49,106,280, and 22,979,068 and notes convertible into 6,836,016 and 1,839,763 shares respectively, have been excluded because their impact on the loss per share is anti-dilutive.
 
Income taxes

Income taxes are recognized for the amount of taxes payable or refundable for the current year and deferred tax liabilities and assets are recognized for the future tax consequences of transactions that have been recognized in the Company’s financial statements or tax returns. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax asset will not be realized.
   
Stock-Based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.
   
The fair value of the Company's common stock option grant is estimated using the Black-Scholes option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes option pricing model could materially affect compensation expense recorded in future periods.  
 
 
 
F-18

 

 
Accounting for Warrants and Derivatives
 
The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations.  For stock-based derivative financial instruments, the Company uses probability weighted average series Black-Scholes Merton option pricing models to value the derivative instruments at inception and on subsequent valuation dates.
 
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.  Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
 
Business and credit concentrations

The Company’s cash balances in financial institutions at times may exceed federally insured limits. As of December 31, 2011 and 2010, before adjustments for outstanding checks and deposits in transit, the Company had $597,581 and $111,223, respectively, on deposit with two banks. The deposits are federally insured up to $250,000 on each bank.
 
Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Certain significant estimates were made in connection with preparing the Company’s financial statements. Actual results could differ from those estimates.
 
Fair value of financial instruments

Effective January 1, 2008, fair value measurements are determined by the Company's adoption of authoritative guidance issued by the FASB, with the exception of the application of the statement to non-recurring, non-financial assets and liabilities as permitted. The adoption of the authoritative guidance did not have a material impact on the Company's fair value measurements.  Fair value is defined in the authoritative guidance as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:
 
Level 1—Quoted prices in active markets for identical assets or liabilities.
 
Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.
 
Level 3—Unobservable inputs based on the Company's assumptions.
 
The Company is required to use of observable market data if such data is available without undue cost and effort.
 
The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s consolidated balance sheets on a recurring basis and their level within the fair value hierarchy as of  December 31, 2011 and 2010.
 
     
Level 1
     
Level 2
   
Level 3
   
Total
 
 
Fair value of Derivative Liability-2011
$
-
    $
-
   
1,643,139
   
$
1,643,139
 
 
Fair value of Derivative Liability-2010
$
 
    $
 
   
3,664,675
   
$
3,664,675
 
 
 
 
F-19

 
 

Recent Accounting Pronouncements
  
In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) No. 2011-04, “Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs”.  ASU No. 2011-4 does not require additional fair value measurements and is not intended to establish valuation standards or affect valuation practices outside of financial reporting.  The ASU is effective for interim and annual periods beginning after December 15, 2011. The Company will adopt the ASU as required.  The ASU will affect the Company’s fair value disclosures, but will not affect the Company’s results of operations, financial condition or liquidity.
 
In June 2011, the FASB issued ASU No. 2011-05, “Presentation of Comprehensive Income”.  The ASU eliminates the option to present the components of other comprehensive income as part of the statement of changes in shareholders’ equity, and instead requires consecutive presentation of the statement of net income and other comprehensive income either in a continuous statement of comprehensive income or in two separate but consecutive statements.  ASU No. 2011-5 is effective for interim and annual periods beginning after December 15, 2011.  The Company will adopt the ASU as required.  It will have no effect on the Company’s results of operations, financial condition or liquidity.
 
In September 2011, the FASB issued ASU 2011-08, “Testing Goodwill for Impairment”, an update to existing guidance on the assessment of goodwill impairment.  This update simplifies the assessment of goodwill for impairment by allowing companies to consider qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount before performing the two step impairment review process.  It also amends the examples of events or circumstances that would be considered in a goodwill impairment evaluation.  The amendments are effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted.  The Company is currently evaluating the affects adoption of ASU 2011-08 may have on its goodwill impairment testing.
 
Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the Securities Exchange Commission (the "SEC") did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

3.     
Certain relationships and related transactions

Loans from related parties

In May of 2007, a former officer and incumbent director of the Company loaned $31,404 to pay a company obligation and in August 2007, the same party loaned $50,000 to the Company so that it could pay certain operating expenses. These amounts are unsecured, bear interest at 6% per annum and are due on demand.  At December 31, 2011 and 2010, the balance of these loans including interest was $0 and $86,947, respectively.
 
Accounts Payable to related parties
 
As of December 31, 2011, the Company had accounts payable to related parties in the amount of $63,003, which was composed of $36,125 in unpaid Directors Fees and $26,878 in unreimbursed expenses incurred by Officers and Directors. As of December 31, 2010, the amount payable to related parties was $241,176.
  
4.     
Property and Equipment
 
At December 31, 2011 and 2010, property and equipment consists of the following:

   
December 31,
 
   
2011
   
2010
 
             
Office equipment
 
$
75,685
   
$
45,133
 
Furniture and fixtures
   
15,589
     
13,898
 
Machinery and equipment
   
49,986
     
49,986
 
Testing equipment
   
147,312
     
147,312
 
Subtotal
   
288,572
     
256,329
 
Less accumulated depreciation
   
(212,963
)
   
(178,246
)
Total
 
$
75,609
   
$
78,083
 

Depreciation expense for the years ended December 31, 2011 and 2010 was $34,717 and $34,022, respectively.  Depreciation expense for the period from inception February 18, 1998 through December 31, 2011 was $494,899.


 
 
F-20

 
 

5.     
Convertible notes and warrants

Convertible debentures consist of the following:
 
 
 
Maturity dates
 
December 31,
2011
   
December 31, 
2010
 
2008 Winter Offering
December 5, 2009
   
     —
     
     6,697
 
2009  Spring Offering
April 30, 2010
   
     
6,455
 
2009 Wellfleet Offering 
September 28, 2012
   
     
27,011
 
2009 Fall Offering
January 15, 2012
   
11,456
     
37,409
 
2010 Fall Offering #2
November 30, 2011
   
     
386,760
 
2011 Winter Offering
February 28, 2012
   
88,000
     
 
2011 Spring Offering
May 31, 2012
   
     
 
2011 Summer Offering
July 31, 2012
   
     
 
2011 Fall Offering #1
October 15, 2012
   
104,500
     
 
2011 Fall Offering #2
December 15, 2012
   
1,516,504
     
         —
 
Sub-total 
     
 1,720,460
     
 464,332
 
Less, debt discount
     
  (1,550,918
   
  (387,385
Convertible debentures, net
   
$
   169,542
   
$
   76,947
 
 
2008 Winter Offering

From November 24, 2008 to December 5, 2008, the Company conducted an offering (the “2008 Winter Offering”) of up to $500,000 aggregate face amount of its Convertible Notes.  A total of $524,700 aggregate face amount of the 2008 Winter Notes were sold for an aggregate purchase price of $477,000 net proceeds.  Therefore, while the stated interest on the 2008 Winter Notes is 0%, the implied interest rate on the 2008 Winter Notes is 10%.  The 2008 Winter Notes will mature on the first anniversary of the date of issuance.  The 2008 Winter Notes are convertible, at the option of the noteholders, into shares of common stock of the Company (the “Conversion Shares”) at a conversion price equal to the average of the closing bid price of the Company’s common stock for the five trading days preceding the closing date of the 2008 Winter Offering (the “Conversion Price”).  Up to 3,086,470 Conversion Shares are issuable at a Conversion Price of $0.17 per share.
  
Each of the investors in the 2008 Winter Offering received, for no additional consideration, a warrant (the “ 2008 Winter Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 50% of the number of shares of common stock into which the ( 2008 Winter Notes) are convertible (the “2008 Winter Warrant Shares”). Each 2008 Winter Warrant is exercisable on a cash basis only at a price of $0.30 per share, and is exercisable for a period of two years from the date of issuance.  Up to 1,543,235 2008 Winter Warrant Shares are initially issuable upon exercise of the 2008 Winter Warrants.

The aggregate value of the Winter 2008 Offering Warrants issued in connection with the December 5, 2008 closing were valued at $168,925 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of 3.42%; dividend yield of 0%; volatility factors of the expected market price of common stock of 153.56%; and an expected life of two years (statutory term) and vest immediately upon issuance.  The Company also determined that the notes contained a beneficial conversion feature of $308,075.  The value of the Winter 2008 Offering Warrants, the beneficial conversion feature, and the transaction fees of $47,700 are considered as debt discount and were amortized over the life of the Note.
   
As of December 31, 2011, investors have converted $524,700 of the Convertible Notes into 3,086,470 shares of the Company’s common stock.  As of December 31, 2011, there was no outstanding balance.
 
  
 
F-21

 
 

2009 Spring Offering

From March 17, 2009 to April 30, 2009, the Company conducted and concluded a private offering (the “Spring 2009 Offering”) of up to $300,000 aggregate face amount of its convertible notes (the “Spring 2009 Notes”) with 11 accredited investors. A total of $181,500 aggregate face amount of the Spring 2009 Notes were sold for an aggregate purchase price of $165,000.  The Spring 2009 Notes mature on the first anniversary of their date of issuance, are convertible, at the option of the noteholder, into up to 672,222 shares of common stock of the Company at a conversion price of $0.27 per share.
 
Each of the investors in the Spring 2009 Offering received, for no additional consideration, a warrant (the “Spring 2009 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 50% of the number of shares of common stock into which the Spring 2009 Notes are convertible (the “Warrant Shares”).  Each Spring 2009 Warrant is exercisable on a cash basis only at an initial price of $0.50 per share, and is exercisable for a period of two years.  Up to 336,111 Warrant Shares are initially issuable on exercise of the Spring 2009 Warrants.
     
The Company received $165,000 in net proceeds in the Spring 2009 Offering which was used for general corporate purposes and working capital. The aggregate value of the Spring 2009 Offering Warrants issued in connection with the April 30, 2009 closing were valued at $39,994 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of 0.94%; dividend yield of 0%; volatility factors of the expected market price of common stock of 156.39%; and an expected life of two years (statutory term) and vest immediately upon issuance.  The Company also determined that the notes contained a beneficial conversion feature of $96,827.  The value of the Spring 2009 Offering Warrants, the beneficial conversion feature, and the transaction fees of $16,500 are considered as debt discount and were amortized over the life of the Note.
 
As of December 31, 2011, investors have converted $181,500 of the Convertible Notes plus penalty and interest of $7,538 into 679,768 shares of the Company’s common stock.  As of December 31, 2011, there was no balance outstanding
   
2009 Wellfleet Offering

On November 20, 2009, the Company completed a private financing of $75,000 principal amount of 7% Convertible Promissory Notes (the “Notes”) and 300,000 Common Stock Purchase Warrants exercisable at $.30 per share (the “Warrants”), pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) with 3 accredited investors (the “Note Offering”), through Sandgrain Securities, Inc., as placement agent.
 
The Notes are initially convertible into the Company’s common stock at a price of $.25 per share and accrue interest at 7% per year with a default rate of 10%, payable quarterly in cash.  Interest payments are payable in stock at the sole discretion of the Note holders, or, in the event that shares issuable thereon are registered under the Securities Act of 1933, as amended (the “Act”), or otherwise freely tradable pursuant to Rule 144, at the discretion of the Company as well. The Notes and any unpaid interest are due and fully payable on September 28, 2012.  The conversion price of the Notes is adjustable for corporate events such as merger, reclassification or stock splits.
 
Pursuant to the terms of the Purchase Agreement, and among other terms, in the event the Company conducts any subsequent financings (each, a “Follow On Offering”) of any kind other than an offering of securities substantially similar to the Notes and Warrants or certain other exempted issuances enumerated in the Notes, the Notes may, at the discretion of each holder thereof,  be exchanged in whole or in part to the extent of outstanding principal and/or interest in such Note, into the securities offered in the Follow On Offering, by applying and exchanging the outstanding principal and interest of such Notes towards the purchase price of the securities offered in such Follow On Offering, at the same price and terms of the Follow On Offering.
 
The Company paid a placement agent fee of (i) $6,000 in cash, (ii) 24,000 shares of Common Stock constituting 8% of the number of Conversion Shares initially issuable upon exercise of the Notes, and (iii) 24,000 warrants, substantially similar to the Warrants sold to investors (the “Placement Agent Warrants”), in connection with the Note Offering, in addition to legal fees.
 
Each of the warrant agreements included an anti-dilution provision that allowed for the automatic reset of the exercise price upon any future sale of common stock or warrants at or below the current exercise price.  The Company considered the current Financial Accounting Standards Board guidance of “Determining Whether an Instrument Indexed to an Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability or whether or not within the issuers’ control, means the instrument is not indexed to the issuers own stock. Accordingly, the Company determined that as the strike price of these warrants contain exercise prices that may fluctuate based on the occurrence of future offerings or events, and as such is not a fixed amount..  As a result, the Company determined that these warrants are not considered indexed to the Company’s own stock and characterized the fair value of these warrants as derivative liabilities upon issuance.
 

 
 
F-22

 
 

The Company determined that the fair value of the warrant liability at issuance on November 20, 2009 to be $75,000 based upon a weighted average Black-Sholes-Merton calculation. The Company recorded the full value of the derivative as a liability at issuance with an offset to valuation discount.  The fair value of the warrant liability as of December 31, 2010 was $129,000 (see Note 7).
 
As of December 31, 2011 investors have converted $75,000 of the Convertible Notes plus $1,750 of accrued interest into 307,000 shares of the Company’s common stock.   At December 31, 2011 there was no outstanding balance.
 
2009 Fall Offering
 
From October 2, 2009 to January 15, 2010, the Company conducted and completed a private offering (the “Fall 2009 Offering”) consisting of an aggregate of $1,588,125 of 7% Convertible Promissory Notes (the “Notes”) with interest compounded quarterly at the annual rate of 7% payable at maturity, and warrants to purchase an aggregate of 6,352,500 shares of our common stock (the “Fall 2009 Warrants”).  The Company received $1,284,425 net proceeds, of which $344,500 was received as of December 31, 2009.  The Fall 2009 Notes mature on the second anniversary of the closing of this offering and will be convertible, at the option of the noteholder, into up to 6,352,500 shares of our common stock at a conversion price of $0.25 per share.  The Fall 2009 Warrants are for a term of three years at an exercise price of $0.30 per share.
 
Each of the warrant agreements included an anti-dilution provision that allowed for the automatic reset of the exercise price upon any future sale of common stock or warrants at or below the current exercise price.  The Company considered the current Financial Accounting Standards Board guidance of “Determining Whether an Instrument Indexed to an Entity’s Own Stock” which indicates that any adjustment to the fixed amount (either conversion price or number of shares) of the instrument regardless of the probability or whether or not within the issuers’ control, means the instrument is not indexed to the issuers own stock. Accordingly, the Company determined that as the strike price of these warrants contain exercise prices that may fluctuate based on the occurrence of future offerings or events, and as such is not a fixed amount. As a result, the Company determined that these warrants are not considered indexed to the Company’s own stock and characterized the fair value of these warrants as derivative liabilities upon issuance.
 
The Company determined that the fair value of the warrant liability at issuances to be $3,027,815 based upon a weighted average Black-Scholes-Merton calculation (See Note 8), of which, $654,978 was recorded on December 31, 2009 and $2,372,837 was recorded on January 15, 2010.  The Company recorded the full value of the derivative of $2,372,837 as a liability at issuance with an offset to valuation discount. As the fair value of the liability of $2,372,837 exceeded the note value of $1,243,625, the excess of the liability over the note amount of $1,129,212 was considered to be cost of the private placement and was recorded during the period.  The fair value of the warrant liability as of December 31, 2011 was $1,251,773 (see Note 7).
    
As of December 31, 2011, investors have converted $1,578,125 of the Convertible Notes plus interest of $11,502 into 6,358,507 shares of the Company’s common stock.  The outstanding balance at December 31, 2011 was $11,456 which includes $1,456 in accrued interest.

2010 Winter Offering

From February 15, 2010 to March 31, 2010, the Company conducted a private offering (the “Winter 2010 Offering”) consisting of an aggregate of $885,863 face amount of its Convertible Promissory Notes (the “Winter 2010  Notes”) have been sold for an aggregate purchase price of $805,330.  While the stated interest rate on the Winter 2010 Notes is 0%, the implied interest rate on the Winter 2010 Notes is 10% per annum. The Winter 2010 Notes mature on the first anniversary of their date of issuance. The Winter 2010 Notes are convertible, at the option of the noteholder, into 2,214,657 shares of common stock of the Company (the “Conversion Shares”) at an initial conversion price of $0.40 per share (the “Conversion Price”).

Each of the investors in the Winter 2010 Offering received, for no additional consideration, a warrant (the “Winter 2010 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 100% of the number of shares of common stock into which the Winter 2010 Notes are convertible (the “Warrant Shares”).  Each Winter 2010 Warrant is exercisable on a cash basis only at an initial price of $0.40 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 2,214,657 Warrant Shares are initially issuable to date on exercise of the Winter 2010 Warrants.


 
 
F-23

 
 

The Company received $805,330 in net proceeds in the Winter 2010 Offering which was used for general corporate purposes and working capital. The aggregate value of the Winter 2010 Offering Warrants issued were valued at $476,268 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of 1.02; dividend yield of 0%; volatility factors of the expected market price of common stock of 135%; and an expected life of two years (statutory term) and vest immediately upon issuance.  The Company also determined that the notes contained a beneficial conversion feature of $329,062.  As of December 31, 2011, the aggregate value of the Winter 2010 Offering Warrants, the beneficial conversion feature and the transaction fees of $80,533 are considered as debt discount and were fully amortized in conjunction with the conversion of the notes.

As of December 31, 2011, investors have converted $885,863 of the Convertible Notes into 2,214,657 shares of the Company’s common stock.  There was no outstanding balance at December 31, 2011.

2010 Spring Offering

From April 15, 2010 to April 30, 2010, the Company conducted a private offering (the “Spring 2010 Offering”) consisting of an aggregate of $143,000 face amount of its Convertible Promissory Notes (the “Spring 2010  Notes”) have been sold for an aggregate purchase price of $130,000.  While the stated interest rate on the Spring 2010 Notes is 0%, the actual interest rate on the Spring 2010 Notes is 10% per annum. The Spring 2010 Notes mature on the first anniversary of their date of issuance. The Spring 2010 Notes are convertible, at the option of the noteholder, into 357,500 shares of common stock of the Company (the “Conversion Shares”) at an initial conversion price of $0.40 per share (the “Conversion Price”).

Each of the investors in the Spring 2010 Offering received, for no additional consideration, a warrant (the “Spring 2010 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 100% of the number of shares of common stock into which the Spring 2010 Notes are convertible (the “Warrant Shares”).  Each Spring 2010 Warrant is exercisable on a cash basis only at an initial price of $0.40 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 357,500 Warrant Shares are initially issuable to date on exercise of the Spring 2010 Warrants.

The Company received $130,000 in net proceeds in the Spring 2010 Offering which was used for general corporate purposes and working capital. The aggregate value of the Spring 2010 Offering Warrants issued were valued at $62,730 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of .41; dividend yield of 0%; volatility factors of the expected market price of common stock of 110%; and an expected life of two years (statutory term) and vest immediately upon issuance.  The Company also determined that the notes contained a beneficial conversion feature of $67,270.  As of December 31, 2011, the aggregate value of the Spring 2010 Offering Warrants, the beneficial conversion feature and the transaction fees of $13,000 are considered as debt discount and were fully amortized in conjunction with the conversion of the notes.

As of December 31, 2011, investors have converted $143,000 of the Convertible Notes into 357,000 shares of the Company’s common stock.  There was no outstanding balance at December 31, 2011.
  
2010 Summer Offering

From June 14, 2010 to July 31, 2010, the Company conducted and concluded a private offering (the “Summer 2010 Offering”) consisting of up to $500,000 aggregate face amount of its convertible notes (the “ Summer 2010 Notes). A total of $392,150 Summer 2010 Notes were sold to twenty six accredited investors for an aggregate purchase price of $356,500.  While the stated interest rate on the Summer 2010 Notes is 0%, the actual interest rate on the Summer 2010 Notes is 10% per annum. The Summer 2010 Notes mature on the first anniversary of the closing of this offering and will be convertible, at the option of the noteholder, into up to 1,568,600 shares of our common stock at a conversion price of $0.25 per share (the “Conversion Price”).

Each of the investors in the Summer 2010 Offering will receive, for no additional consideration, a warrant (the “Summer 2010 Warrants”), entitling the holder to purchase a number of shares of our common stock equal to 100% of the number of shares of common stock into which the Summer 2010 Notes are convertible (the “Warrant Shares”).  Each Summer 2010 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable  for a period of twenty four months.  Up to 1,568,600 Warrant Shares are initially issuable on exercise of the Summer 2010 Warrants.


 
 
F-24

 
 

The Company received $356,500 in net proceeds in the Summer 2010 Offering which was used for general corporate purposes and working capital. The aggregate value of the Summer 2010 Offering Warrants issued were valued at $209,512 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of .55; dividend yield of 0%; volatility factors of the expected market price of common stock of 132%; and an expected life of two years (statutory term) and vest immediately upon issuance.  The Company also determined that the notes contained a beneficial conversion feature of $146,988.  As of December 31, 2011, the aggregate value of the Summer 2010 Offering Warrants, the beneficial conversion feature and the transaction fees of $35,650 are considered as debt discount and were fully amortized in conjunction with the conversion of the notes.

As of December 31, 2011, investors have converted $392,150 of the Convertible Notes into 1,568,600 shares of the Company’s common stock.  There was no outstanding balance at December 31, 2011.

2010 Fall Offering

From August 10, 2010 to September 30, 2010, the Company conducted and concluded a private offering (the “Fall 2010 Offering”) consisting of up to $600,000 aggregate face amount of its convertible notes (the “Fall 2010 Notes). A total of $174,482 Fall 2010 Notes were sold to ten accredited investors for an aggregate purchase price of $158,620.  While the stated interest rate on the Fall 2010 Notes is 0%, the actual interest rate on the Fall 2010 Notes is 10% per annum. The Fall 2010 Notes mature on the first anniversary of the closing of this offering and will be convertible, at the option of the noteholder into 697,928 shares of the Company’s common stock at a conversion price of $0.25 per share (the “Conversion Price”).

Each of the investors in the Fall 2010 Offering will receive, for no additional consideration, a warrant (the “Fall 2010 Warrants”), entitling the holder to purchase a number of shares of our common stock equal to 100% of the number of shares of common stock into which the Fall 2010 Notes are convertible (the “Warrant Shares”).  Each Fall 2010 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable for a period of twenty four months.  Up to 697,928 Warrant Shares are initially issuable on exercise of the Fall 2010 Warrants.
  
The Company received $158,620 in net proceeds in the Fall 2010 Offering which was used for general corporate purposes and working capital. The aggregate value of the Fall 2010 Offering Warrants issued were valued at $88,113 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of .42; dividend yield of 0%; volatility factors of the expected market price of common stock of 135%; and an expected life of two years (statutory term) and vest immediately upon issuance.  The Company also determined that the notes contained a beneficial conversion feature of $70,507.  As of December 31, 2011, the aggregate value of the Fall 2010 Offering Warrants, the beneficial conversion feature and the transaction fees of $15,862 are considered as debt discount and were fully amortized in conjunction with the conversion of the notes.

As of December 31, 2011, investors have converted $174,482 of the Convertible Notes into 697,928 shares of the Company’s common stock.  At December 31, 2011 there was no outstanding balance.

2010 Fall Offering #2

From October 4, 2010 to November 30, 2010, the Company conducted and concluded a private offering (the “Fall 2010 Offering #2”) consisting of up to $3,000,000 aggregate face amount of its convertible notes (the “ Fall 2010 Notes). A total of $940,347 Fall 2010 #2 Notes were sold to ten accredited investors for an aggregate purchase price of $854,861.  While the stated interest rate on the Fall 2010 #2 Notes is 0%, the actual interest rate on the Fall 2010 #2 Notes is 10% per annum. The Fall 2010 #2 Notes mature on the first anniversary of the closing of this offering and will be convertible, at the option of the noteholder into 3,761,386 shares of the Company’s common stock at a conversion price of $0.25 per share (the “Conversion Price”).

Each of the investors in the Fall 2010 #2 Offering will receive, for no additional consideration, a warrant (the “Fall 2010 #2 Warrants”), entitling the holder to purchase a number of shares of our common stock equal to 100% of the number of shares of common stock into which the Fall 2010 #2 Notes are convertible (the “Warrant Shares”).  Each Fall 2010 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable for a period of twenty four months.  Up to 3,761,386 Warrant Shares are initially issuable on exercise of the Fall 2010 #2 Warrants.
   


 
 
F-25

 
 

The Company received $854,861 in net proceeds in the Fall 2010 #2 Offering which was used for general corporate purposes and working capital. The aggregate value of the Fall 2010 #2 Offering Warrants issued were valued at $436,986 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of .27; dividend yield of 0%; volatility factors of the expected market price of common stock of 121%; and an expected life of two years (statutory term) and vest immediately upon issuance.  The Company also determined that the notes contained a beneficial conversion feature of $417,875.  As of December 31, 2011, the aggregate value of the Fall 2010 #2 Offering Warrants, the beneficial conversion feature and the transaction fees of $85,486 are considered as debt discount and will be amortized over the life of the notes.

As of December 31, 2011, investors have converted $940,347 of the Convertible Notes into 3,761,386 shares of the Company’s common stock.  There was no outstanding balance at December 31, 2011.

2011 Winter Offering

From December 13, 2010 through February 28, 2011, the Company  conducted a private offering (the “Winter 2011 Offering”) of up to $3,000,000 aggregate face amount of its convertible notes (the “Winter 2011  Notes”). A total of $2,588,422 aggregate face amount of the Winter 2011  Notes were sold for an aggregate purchase price of $2,353,111.  While there was no stated interest rate on the Winter 2011 Notes, the implied effective interest rate on the Winter 2011 Notes is 10% per annum. The Winter 2011 Notes mature on the first anniversary of their date of issuance. The Winter 2011 Notes are convertible, at the option of the note holder, into 10,353,688 shares of common stock of the Company (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).
 
Each of the investors in the Winter 2011 Offering received, for no additional consideration, a warrant (the “Winter 2011 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 100% of the number of shares of common stock into which the Winter 2011 Notes are convertible (the “Warrant Shares”).  Each Winter 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 10,353,688 Warrant Shares are initially issuable to date on exercise of the Winter 2011 Warrants.
    
The Company received $2,353,111 in net proceeds in the 2011 Winter Offering which was used for general corporate purposes and working capital. The aggregate value of the 2011 Offering Warrants issued were valued at $1,368,888 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of .25; dividend yield of 0%; volatility factors of the expected market price of common stock of 130%; and an expected life of two years (statutory term) and vest immediately upon issuance.  The Company also determined that the notes contained a beneficial conversion feature valued at $984,223.  The aggregate value of the 2011 Winter Offering Warrants, the beneficial conversion feature and the implied discount and transaction fees of $235,311 are considered as debt discount and are being amortized over the life of the notes. The amortization recorded during the period amounted to $2,497,076.

As of December 31, 2011, investors have converted $2,500,422 of the Convertible Notes into 10,001,688 shares of the Company’s common stock. The outstanding balance at December 31, 2011 was $88,000.

2011 Spring Offering

From March 14, 2011 through May 31, 2011, the Company  conducted a private offering (the “Spring 2011 Offering”) of up to $1,000,000 aggregate face amount of its convertible notes (the “Spring 2011  Notes”). A total of $1,469,550 aggregate face amount of the Spring 2011 Notes were sold for an aggregate purchase price of $1,335,955.  While there was no stated interest rate on the Spring 2011 Notes, the implied effective interest rate on the Spring 2011 Notes is 10% per annum. The Spring 2011 Notes mature on the first anniversary of their date of issuance. The Spring 2011 Notes are convertible, at the option of the note holder, into 5,878,200 shares of common stock of the Company (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).
 
Each of the investors in the Spring 2011 Offering received, for no additional consideration, a warrant (the “Spring 2011 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 100% of the number of shares of common stock into which the Spring 2011 Notes are convertible (the “Warrant Shares”).  Each Spring 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 5,878,200 Warrant Shares are initially issuable to date on exercise of the Spring 2011 Warrants.
    

 
 
F-26

 
 

The Company received $1,335,955 in net proceeds in the 2011 Spring Offering which was used for general corporate purposes and working capital. The aggregate value of the 2011 Spring Offering Warrants issued were valued at $726,787 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of .45; dividend yield of 0%; volatility factors of the expected market price of common stock of 119%; and an expected life of two years (statutory term) and vest immediately upon issuance. The Company also determined that the notes contained a beneficial conversion feature valued at $609,168. The aggregate value of the 2011 Spring Offering Warrants, the beneficial conversion feature and the implied discount and transaction fees of $133,595 are considered as debt discount and are being amortized over the life of the notes. The amortization recorded during the period amounted to $1,425,861.

As of December 31, 2011, investors have converted $1,469,550 of the Convertible Notes into 5,878,200 shares of the Company’s common stock.  There was no outstanding balance at December 31, 2011.

2011 Summer Offering

From June 24, 2011 through July 31, 2011, the Company conducted a private offering (the “Summer 2011 Offering”) of up to $1,000,000 aggregate face amount of its convertible notes (the “Summer 2011  Notes”). A total of $487,783 aggregate face amount of the Summer 2011 Notes were sold for an aggregate purchase price of $443,439.  While there was no stated interest rate on the Summer 2011 Notes, the implied effective interest rate on the Summer 2011 Notes is 10% per annum. The Summer 2011 Notes mature on the first anniversary of their date of issuance. The Summer 2011 Notes are convertible, at the option of the note holder, into 1,951,132 shares of common stock of the Company (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).
  
Each of the investors in the Summer 2011 Offering received, for no additional consideration, a warrant (the “Summer 2011 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 100% of the number of shares of common stock into which the Summer 2011 Notes are convertible (the “Warrant Shares”).  Each Summer 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 1,951,132 Warrant Shares are initially issuable to date on exercise of the Summer 2011 Warrants.
    
The Company received $443,439 in net proceeds in the 2011 Summer Offering which was used for general corporate purposes and working capital. The aggregate value of the 2011 Summer Offering Warrants issued were valued at $172,856 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of .20; dividend yield of 0%; volatility factors of the expected market price of common stock of 115%; and an expected life of two years (statutory term) and vest immediately upon issuance.  The Company also determined that the notes contained a beneficial conversion feature valued at $270,583.  The aggregate value of the 2011 Summer Offering Warrants, the beneficial conversion feature and the implied discount and transaction fees of $44,344 are considered as debt discount and were amortized in full upon conversion of the notes. The amortization recorded during the period amounted to $487,783.

As of December 31, 2011, investors have converted $487,783 of the Convertible Notes into 1,951,132 shares of the Company’s common stock.  There was no outstanding balance as of December 31, 2011.

2011 Fall Offering

From August 30, 2011 through October 15, 2011, the Company conducted a private offering (the “Fall 2011 Offering”) of up to $1,000,000 aggregate face amount of its convertible notes (the “Fall 2011  Notes”). A total of $170,720 aggregate face amount of the Fall 2011 Notes were sold for an aggregate purchase price of $155,200.  While there was no stated interest rate on the Fall 2011 Notes, the implied effective interest rate on the Fall 2011 Notes is 10% per annum. The Fall 2011 Notes mature on the first anniversary of their date of issuance. The Fall 2011 Notes are convertible, at the option of the note holder, into 682,880 shares of common stock of the Company (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).
  
Each of the investors in the Fall 2011 Offering received, for no additional consideration, a warrant (the “Fall 2011 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 100% of the number of shares of common stock into which the Fall 2011 Notes are convertible (the “Warrant Shares”).  Each Fall 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 682,880 Warrant Shares are initially issuable to date on exercise of the Fall 2011 Warrants.


 
 
F-27

 
 

The Company received $155,000 in net proceeds in the 2011 Fall Offering which was used for general corporate purposes and working capital. The aggregate value of the 2011 Falll Offering Warrants issued were valued at $50,958 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of .28; dividend yield of 0%; volatility factors of the expected market price of common stock of 112%; and an expected life of two years (statutory term) and vest immediately upon issuance.  The Company also determined that the notes contained a beneficial conversion feature valued at $104,242.  The aggregate value of the 2011 Fall Offering Warrants, the beneficial conversion feature and the implied discount and transaction fees of $15,520 are considered as debt discount and were amortized in full upon conversion of the notes. The amortization recorded during the period amounted to $87,992.

As of December 31, 2011, investors have converted $66,220 of the Convertible Notes into 264,880 shares of the Company’s common stock. The outstanding balance at December 31, 2011 was $104,500.
 
2011 Fall#2 Offering

From October 24, 2011 through December 13, 2011, the Company conducted a private offering (the “Fall#2 2011 Offering”) of up to $2,200,000 aggregate face amount of its convertible notes (the “Fall#2 2011  Notes”). A total of $1,516,504 aggregate face amount of the Fall#2 2011 Notes have been sold for an aggregate purchase price of $1,378,640. While there is no stated interest rate on the Fall#2 2011 Notes, the implied effective interest rate on the Fall#2 2011 Notes is 10% per annum. The Fall#2 2011 Notes mature on the first anniversary of their date of issuance. The Fall #2 2011 Notes are convertible, at the option of the note holder, into 6,066,016 shares of common stock of the Company (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).
  
Each of the investors in the Fall#2 2011 Offering will receive, for no additional consideration, a warrant (the “Fall#2 2011 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 100% of the number of shares of common stock into which the Fall#2 2011 Notes are convertible (the “Warrant Shares”).  Each Fall#2 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 6,066,016 Warrant Shares are initially issuable to date on exercise of the Fall#2 2011 Warrants.

The Company received $1,378,640 in net proceeds in the 2011 Fall#2 Offering which was used for general corporate purposes and working capital. The aggregate value of the 2011 Fall#2 Offering Warrants issued were valued at $650,823 using the Black-Scholes-Merton option valuation model with the following assumptions; risk-free interest rate of .24; dividend yield of 0%; volatility factors of the expected market price of common stock of 112%; and an expected life of two years (statutory term) and vest immediately upon issuance.  The Company also determined that the notes contained a beneficial conversion feature valued at $727,817.  The aggregate value of the 2011 Fall#2 Offering Warrants, the beneficial conversion feature and the implied discount and transaction fees of $137,864 are considered as debt discount and were amortized in full upon conversion of the notes. The amortization recorded during the period amounted to $63,188.

As of December 31, 2011, there was no note conversion to common stock. The outstanding balance at December 31, 2011 was $1,516,504.

6.     
Research and Development

The Company has a research and development testing facility in Midwest, Wyoming, located at the U.S. Department of Energy Rocky Mountain Oilfield Testing Center, Naval Petroleum Reserve #3.  The Company constructs the AOT technology prototypes with the help of various third party entities, located in Casper, Wyoming.  The Company has purchased test equipment, pipeline pumping equipment, crude oil tank batteries, viscometers, SCADA systems, computer equipment and other related equipment for the purposes of evaluating and testing its AOT prototypes.

The Company has research and development facilities in Morgan Hill, California. The Company has tested ELEKTRA technologies and legacy products incorporating our ZEFS, MK IV for multiple makes and models diesel engines, motorbikes, boats, generators, lawnmowers and other small engines.  The Company has purchased test vehicles, test engines and testing equipment. The Company incurred expenses of $1,130,283 and $427,982 for the years ended December 30, 2011 and 2010, respectively, on its research and development activities, and $7,444,997 from February 18, 1998 (inception) to December 31, 2011.
 


 
 
F-28

 
 

Temple University License Agreements

The Company has entered into a research and development agreement (R&D Agreement) with Temple University to conduct further research on the ELEKTRA technology. Under the R&D Agreement Temple University will conduct a 24-month research project towards expanding the scope of, and developing products utilizing, the technologies covered under the License Agreements, including design and manufacture of prototypes utilizing electric fields to improve diesel, gasoline and kerosene fuel injection in engines using such fuels and a device utilizing a magnetic field to reduce crude oil viscosity for crude oil (paraffin and mixed base) and edible oil flow in pipelines. If the research project yields results within the scope of the technologies licensed pursuant to the License Agreements, those results will be deemed included as rights licensed to the Company pursuant to the License Agreements. If the research project yields results outside of the scope of the technologies covered by the License Agreements, the Company has a six-month right of first negotiation to enter into a new worldwide, exclusive license agreement with Temple University for the intellectual property covered by those results. Pursuant to the R & D Agreement, the Company will make payments to Temple University in the aggregate amount of $500,000. At December 31, 2011 the Company has completed payment in full of $500,000 under the R & D Agreement.
 
On August 9, 2011, Save The World Air, Inc. (the “Company”) and Temple University (“Temple”) entered into two (2) Exclusive License Agreements (collectively, the “License Agreements”) relating to Temple’s patent applications, patents and technical information pertaining to technology associated with an electric and/or magnetic field assisted fuel injector system (the “First Temple License”), and to technology to reduce crude oil viscosity (the “Second Temple License”).  The License Agreements are exclusive and the territory licensed to the Company is worldwide and replace previously issued License Agreements.

Pursuant to the two licensing agreements, the Company agreed to pay Temple the following: (i) non-refundable license maintenance fee of $300,000; (ii) annual maintenance fees of $187,500; (iii) royalty fee ranging from 4% up to 7% from revenues generated from the licensing agreements; and (iv) 25% of all revenues generated from sub-licensees to secure or maintain the sub-license or option thereon. Temple also agreed to cancel $37,500 of the amount due if the Company agrees to fund at least $250,000 in research or development of Temple’s patent rights licensed to the Company. The term of the licenses commences in August 2011 through the expiration of the patents contemplated thereunder, or unless sooner terminated under terms of the licensing agreements.

As of December 31, 2011, the Company recorded the entire $300,000 non-refundable license maintenance fee as part of its research and development costs, of which, $200,000 was paid in November 2011 and $100,000 was subsequently paid in February 2012. Further, the Company also accrued $78,125 of the annual maintenance fees of $187,500 which will become due in August 2012.
   
As of December 31, 2011, there were no revenues generated from these two licenses nor the Company has made a determination to provide the $250,000 funding in research or development to Temple’s patent rights licensed to the Company.
     
 
 
F-29

 
 
    
7.     
Derivative liability
 
In June 2010, the FASB issued authoritative guidance on determining whether an instrument (or embedded feature) is indexed to an entity’s own stock.  Under the authoritative guidance, effective January 1, 2010, instruments which do not have fixed settlement provisions are deemed to be derivative instruments.  The strike price of the warrants issued by the Company, in connection with certain convertible note offerings made during 2009 and 2010, in the aggregate of 8,522,500 warrants, exercisable at $.30 per share, contain exercise prices that may fluctuate based on the occurrence of future offerings or events.  As a result, theses warrants are not considered indexed to the Company’s own stock.  The Company characterized the fair value of these warrants as derivative liabilities upon issuance.  The FASB’s guidance requires the fair value of these liabilities be re-measured at the end of every reporting period with the change in value reported in the statement of operations.
 
The derivative liabilities were valued using a probability weighted average series of Black-Scholes-Merton models as a valuation technique with the following assumptions:

         
Fair Value of Warrants
 
   
No. of
Warrants
   
December 31,
2010
   
2011
Issuance
 
December 31,
2011
 
Risk-free interest rate
       
0.61%
   
 
0.12%
 
Expected volatility
       
120%
   
 
92%
 
Expected life (in years)
       
1.75 – 2.00
   
 
.75 – 1.00
 
Expected dividend yield
       
0%
   
 
0%
 
Fair Value:
                           
2009 Summer Warrants
   
1,870,000
   
$
804,100
     
 
$
332,998
 
2009 Wellfleet Warrants
   
100,000
     
129,000
     
   
17,807
 
2009 Fall Warrants
   
6,352,500
     
2,731,575
   
$
   
1,292,334
 
Total Fair Value
   
8,322,500
   
$
3,664,675
   
$
 
$
1,643,139
 

 

 
 
F-30

 
 

The risk-free interest rate is based on the yield available on U.S. Treasury securities.  The Company estimates volatility based on the historical volatility of its common stock.  The expected life warrants are based on the expiration date of the related warrants.  The expected dividend yield was based on the fact that the Company has not paid dividends to common shareholders in the past and does not expect to pay dividends to common shareholders in the future.
 
As of December 31, 2011, The Company re-measured the derivative liabilities and determined the fair value to be $1,585,932.  For the year ended December 31, 2011, the Company recorded an income on the change in the fair value of derivatives of $2,078,743.
 
8.     
Common Stock Transactions

Issuances of Common Stock-2011

During the year ended December 31, 2011 the Company issued an aggregate of 22,820,276 shares of its common stock as follows:
 
 
During 2011, the Company issued 2,800,000 shares of its common stock for services valued in the aggregate at $862,000. The Company valued the shares at the trading price at the date of the agreements ranging from $0.25 to $0.60 per share.

 
During 2011 the Company issued 19,861,478 shares of its common stock in exchange for conversion of $4,965,370 of Convertible Notes.  The Company valued the shares at $0.25 pursuant to the terms of the convertible note agreement.

 
During 2011, the Company issued 77,778 shares of its common stock for exercised options valued at $0.27 per share or $21,000.

 
During 2011, the Company issued 81,020 shares of its common stock for cashless exercise of warrants.

Issuances of Common Stock-2010

During the year ended December 31, 2010 the Company issued an aggregate of 20,163,798 shares of its common stock as follows:
 
 
During 2010, the Company issued 3,710,099 shares of its common stock for services valued in the aggregate at $1,385,137. The Company valued the shares at prices ranging from $0.43 to $0.48 per share.

 
During 2010, the Company issued 170,000 shares of its common stock to its employees as compensation valued in the aggregate $91,700.  The Company valued the shares at prices ranging from $0.52 to $0.55 per share.

 
During 2010, the Company issued 12,121 shares of its common stock to settle $4,121 of outstanding accounts payable.  The Company valued the shares at $0.34 per share.

 
During 2010, the Company issued 16,076,023 shares of its common stock (including 224,751 shares issued to induce conversion of certain notes valued at $119,118)  in exchange for conversion of $4,417,417 of Convertible Notes.  The Company valued the shares at prices ranging from $0.15 to $0.50.

 
During 2010, the Company issued 195,555 shares of its common stock for exercised options valued at $.027.
 
9.     
Stock options and warrants
 
The Company currently issues stock options to employees, directors and consultants under the 2004 Stock Option Plan (the Plan). The Company could issue options under the Plan to acquire up to 5,000,000 shares of common stock. In February 2006, the board approved an amendment to the Plan (approved by the Shareholders in May 2006), increasing the authorized shares by 2,000,000 shares to 7,000,000 shares. At December 31, 2011, 2,732,108 were available to be granted under the Plan. Prior to 2004, the Company granted 3,250,000 options outside the Plan to officers of the Company.

 
 
F-31

 
 

Employee options vest according to the terms of the specific grant and expire from 5 to 10 years from date of grant. Non-employee option grants to date are vested upon issuance. The weighted-average, remaining contractual life of employee options outstanding at December 31, 2011 was 8.5 years. Stock option activity for the years ended December 31, 2011 and 2010, which includes 3,250,000 options granted outside and prior to the adoption of the Plan, was as follows:
 
   
Weighted Avg.
Options
   
Weighted Avg.
Exercise Price
 
             
Options, January 1, 2004
   
13,250,000
   
$
0.11
 
Options granted              
   
1,172,652
     
1.03
 
Options exercised           
   
     
 
Options cancelled           
   
     
 
Options, December 31, 2004                                
   
14,422,652
     
0.18
 
Options granted                                                     
   
2,085,909
     
0.92
 
Options exercised                                                  
   
     
 
Options cancelled            
   
(10,000,000
)
   
0.10
 
Options, December 31, 2005                                 
   
6,508,561
     
0.53
 
Options granted                  
   
1,313,605
     
1.21
 
Options exercised               
   
(2,860,000
)
   
0.10
 
Options forfeited                 
   
(962,607
)
   
0.84
 
Options cancelled           
   
     
 
Options, December 31, 2006                                
   
3,999,559
     
0.99
 
Options granted                                                     
   
238,679
     
0.55
 
Options exercised                                                  
   
     
 
Options forfeited                                                    
   
(49,793
)
   
1.96
 
Options cancelled                                                   
   
     
 
Options, December 31, 2007                                    
   
4,188,445
   
$
0.95
 
Options granted                                                     
   
2,700,000
     
0.28
 
Options exercised                                                  
   
     
 
Options forfeited                                                    
   
(2,287,220
)
   
1.00
 
Options cancelled                                                   
   
     
 
Options, December 31, 2008                                  
   
4,601,225
   
$
0.53
 
Options granted                                                     
   
333,333
     
0.30
 
Options exercised                                                  
   
(83,333
   
0.27
 
Options forfeited                                                    
   
     
 
Options cancelled                                                   
   
     
 
Options, December 31, 2009                                
   
4,851,225
   
$
0.52
 
Options granted                                                     
   
181,818
     
0.55
 
Options exercised                                                  
   
(195,555
   
0.27
 
Options forfeited                                                    
   
     
 
Options cancelled                                                   
   
     
 
Options, December 31, 2010                                
   
4,837,488
   
$
0.52
 
Options granted                                                     
   
19,800,000
     
0.26
 
Options exercised                                                  
   
(77,778
   
0.27
 
Options forfeited                                                    
   
(310,000
   
0.76
 
Options cancelled                                                   
   
(181,818
   
0.55
 
Options, December 31, 2011                                
   
24,067,892
   
$
0.30
 

 

 
 
F-32

 
 

The weighted average exercise prices, remaining contractual lives for options granted, exercisable, and expected to vest under the Plan as of December 31, 2011 were as follows:
 
     
Outstanding Options
   
Exercisable Options
 
Option
Exercise Price
Per Share
   
Shares
   
Life
 (Years)
   
Weighted
 Average Exercise
 Price
   
Shares
   
Weighted
 Average Exercise
 Price
 
$ 0.21 - $ 0.99
     
23,740,346
   
8.6
   
$
0.29
     
6,140,346
   
$
0.40
 
$ 1.00 - $ 1.99
     
327,546
   
3.4
   
$
1.25
     
327,546
   
$
1.25
 
         
24,067,892
         
$
0.30
     
6,467,892
   
$
0.45
 
 
As of December 31, 2011 the market price of the Company’s stock was $0.37 per share. Future compensation expense on the options which were not exercisable at December 31, 2011 is $5,581,289. At December 31, 2011 the aggregate intrinsic value of the options outstanding was $2,501,667.
  
 During the year ended December 31, 2011, the Company granted 17,600,000 options to Cecil Bond Kyte, its chairman and chief executive officer. The options have an exercise price of $0.25 per share, vest over a five year period, and expire ten years from date of grant.   Twenty percent of the options shall vest on each of the first five anniversary dates.  In the event of a change of control of the Company, all unvested options shall vest on the date of the change of control.  During the year ended December 31, 2011, the Company amortized $1,252,942 of compensation cost based on the vesting of the options.  Future unamortized compensation expense on the outstanding options at December 31, 2011 is $5,581,289. 

During the year ended December 31, 2011, the Company granted 2,200,000 options to certain of its director and officers. The options have an exercise price of $0.30 per share, vest immediately and expire ten years from date of grant. The options were valued at $541,134 or $0.25 per share using Black-Scholes-Merton valuation model and were expensed at the time of grant.  The options have an exercise price of $0.30 per share, vesting immediately and expire in ten years from date of grant.
  
During the year ended December 31, 2011, the Company recognized amortization expense of $8,058 based upon its vesting of option granted to an employee in prior years.
   
Black-Scholes value of options
 
During the years ended December 31, 2011 and 2010, the Company valued options for pro-forma purposes at the grant date using the Black-Scholes-Merton valuation model with the following average assumptions:

   
2011
 
2010
                 
Expected life (years)
   
6.00
     
5.50
 
Risk free interest rate
   
1.95
%
   
3.63
%
Volatility                     
   
141.97
%
   
129.95
%
Expected dividend yield
   
0.00
%
   
0.00
%

The weighted average fair value for options granted in 2011 and 2010 were $0.37 and $0.53, respectively.

 

 
 
F-33

 
 

Warrants

The following table summarizes certain information about the Company’s stock purchase warrants (including the warrants discussed in Note 9).

   
Warrants
   
Weighted Avg.
Exercise Price
 
Warrants outstanding, January 1, 2004
   
14,252,414
     
0.48
 
Warrants granted
   
2,372,500
     
1.27
 
Warrants exercised
   
(960,500
)
   
0.20
 
Warrants cancelled
   
   —
     
  —
 
Warrants outstanding, December 31, 2004
   
15,664,414
     
0.62
 
Warrants granted
   
5,198,574
     
1.16
 
Warrants exercised
   
(50,500
)
   
0.99
 
Warrants cancelled
   
(20,000
)
   
1.50
 
Warrants outstanding, December 31, 2005
   
20,792,488
     
0.75
 
Warrants granted
   
3,624,894
     
1.28
 
Warrants exercised
   
(2,328,452
)
   
0.68
 
Warrants cancelled
   
(1,191,619
)
   
1.46
 
Warrants outstanding, December 31, 2006
   
20,897,311
   
$
0.81
 
Warrants granted
   
3,602,701
     
0.64
 
Warrants exercised
   
     
 
Warrants cancelled
   
(6,580,984
)
   
1.06
 
Warrants outstanding, December 31, 2007
   
17,919,028
   
$
0.67
 
Warrants granted
   
3,931,708
     
0.42
 
Warrants exercised
   
(1,064,650
   
0.50
 
Warrants cancelled
   
(10,386,083
)
   
0.56
 
Warrants outstanding, December 31, 2008
   
10,400,003
   
$
0.70
 
Warrants granted
   
5,247,276
     
0.36
 
Warrants exercised
   
     
 
Warrants cancelled
   
(2,300,515
)
   
0.95
 
Warrants outstanding, December 31, 2009
   
13,346,764
   
$
0.52
 
Warrants granted
   
14,058,032
     
0.32
 
Warrants exercised
   
     
 
Warrants cancelled
   
(4,425,728
)
   
0.53
 
Warrants outstanding, December 31, 2010
   
22,979,068
   
$
0.52
 
Warrants granted
   
29,781,916
     
0.30
 
Warrants exercised
   
(224,000
   
0.47
 
Warrants cancelled
   
(3,430,704
)
   
0.56
 
Warrants outstanding, December 31, 2011
   
49,106,280
   
$
0.32
 

 
 
F-34

 
 

In August 2011, the Company granted a warrant to an employee to purchase 2,000,000 shares of its common stock pursuant to an employment agreement.  The warrant is exercisable at $0.30/share, vests over five years and will expire in ten years from grant date.  Total fair value of the warrant was determined to be $486,202 at the date of grant using a Black-Scholes Merton valuation model with the following assumptions: risk-free interest rate of 2.05%; dividend yield of 0%; volatility of 126%; and an expected life of seven years.  During the year ended December 31, 2011, the Company recognized amortization expense of $69,457 based upon vesting of the warrants.
 
In December 2011, the Company granted a warrant to an employee to purchase 1,000,000 shares of its common stock pursuant to a separation agreement.  The warrant is exercisable at $0.30/share, vest immediately and will expire in ten years from grant date.  Total fair value of the warrant was determined to be $369,370 at the date of grant using a Black-Scholes Merton valuation model with the following assumptions: risk-free interest rate of 1.89%; dividend yield of 0%; volatility of 196%; and an expected life of ten years.  During the year ended December 31, 2011, the Company recognized the full value of the warrant.
 
During the year ended December 31, 2011, the Company granted warrants to consultants to purchase 1,850,000 shares of its common stock.  The warrants have an average exercise price of $0.31/share, vests over a period up to three years and will expire in one to ten years from grant date.  Total fair value of the warrant amounted to $463,898 using the Black-Scholes Merton valuation model with the following average assumptions: risk-free interest rate of 0.71%; dividend yield of 0%; volatility of 136%; and an expected life of four years.  During the year ended December 31, 2011, the Company recognized amortization expense of $411,888 based upon vesting of the warrants.
 
During the year ended December 31, 2011, the Company granted issued 24,931,916 warrants to acquire share of its common stock in connection of its issuance of convertible notes.  The warrant is exercisable at $0.25/share, fully vested, and will expire in two years for date of grant.  See Note 5.
      
At December 31, 2011 the price of the Company’s common stock was $0.37 per share and the aggregate intrinsic value of the warrants outstanding was $3,512,888.
 
     
Outstanding Warrants
   
Exercisable Warrants
 
Warrant
 Exercise Price Per Share
   
Shares
   
Life
 (Years)
   
Weighted
 Average Exercise
 Price
   
Shares
   
Weighted
 Average Exercise
 Price
 
$ 0.30 - $ 0.99
     
48,106,280
   
 1.9
   
$
0.30
     
46,106,280
   
$
0.30
 
$ 1.00 - $ 1.99
     
1,000,000
   
 1.5
   
$
1.00
     
1,000,000
   
$
1.00
 
         
49,106,280
         
$
0.32
     
47,106,280
   
$
0.32
 
 
Included in the table above are 8,322,500 warrants at an  exercise price of $0.25 per share.  Based upon these warrant agreements, the exercise price may be reduced if the Company sells equity to any person or entity at a price per share or conversion price or exercise price per share which shall be less than the Warrant exercise price in respect of the Warrant Shares then in effect.  The reset of the warrant exercise price gives rise to the characterization of these instruments as derivative liabilities.  (See note 7).
 
10.   
Commitments and contingencies

There is no other litigation of any significance with the exception of the matters that have arisen under, and are being handled in, the normal course of business.
   
Litigation Involving Former Executive Officer
 
As previously reported, on April 7, 2010, Bruce McKinnon, the former CEO of the Company, and the Company entered into an Agreement Re: Collection on Judgment (“Judgment”) (the “Settlement Agreement”),  wherein McKinnon, among other things, agreed to cease further collection efforts on the Judgment, and the Company, among other things, agreed to satisfy the Judgment for, and McKinnon agreed to accept as full and final satisfaction of the Judgment, subject to certain payment waivers described below, a total amount of $360,000, plus interest of ten percent (10%) per annum from March 15, 2010, on the unpaid balance until paid, payable as follows:  $30,000 on April 7, 2010; $85,000 on or before April 15, 2010; and, $15,000 per month commencing on June 1, 2010, until paid.   As of December 31, 2011, all payments were made on time and the balance has been paid in full.

Employment agreement

Agreement with Cecil Bond Kyte. On January 30, 2009, the Company entered into an employment agreement with Cecil Bond Kyte, pursuant to which he serves as our Chief Executive Officer.  The initial term of the agreement became effective on January 30, 2009 and expires on January 30, 2010 and renews automatically for addition one-year periods unless either party has given notice of non-extension prior to October 30, 2010.  The agreement provides for a base compensation of $200,000 per year.  Mr. Kyte is eligible to participate in the Company’s incentive and benefit plans, including eligibility to receive grants of stock options under the 2004 plan.
 
Mr. Kyte shall be eligible to receive an annual cash bonus in an amount equal to 2% of the Company’s net profit, if any, for its most recently completed fiscal year, computed in accordance with generally accepted accounting principles applied consistently with prior periods.  The bonus shall be payable, if at all, on the anniversary date of employment each year of the term; provided that no bonus shall be paid if the Executive is not, on such payment date, in the employ of the Company.
 
Mr. Kyte shall also receive an option (the “Option”) to purchase a number of shares (the “Option Shares”) of the Company’s common stock equal to the result of (A) 100,000 divided by (B) the closing price per share of the Company’s Common Stock on the first anniversary of the Effective Date.  The Option shall be an incentive stock option, shall be exercisable at the closing price per share on the first anniversary of the Effective Date, shall be exercisable for ten years from the date of grant and shall vest on the second anniversary of the Effective Date.


 
 
F-35

 
 

Amendment To  Kyte Employment Agreement

On March 1, 2011, the Board of Directors (the “Board”) of Save The World Air, Inc. (the “Company”) approved an amendment (the “Amendment”) to the employment agreement between the Company and the Company and Kyte have agreed to an amendment of the Employment Agreement, providing for non-cash performance compensation in the form of nonqualified stock options.

Kyte has agreed to continue to serve in the role of CEO of the Company through at least January 29, 2016
and in furtherance and consideration of the foregoing, the Board determined to amend the Employment Agreement and grant Kyte nonqualified stock options to acquire shares of common stock of the Company under the following terms and conditions:
 
Stock Option Grant of 17,600,000 Shares at an Exercise Price of  $0.25 per share exercisable for 10 years and will expire on January 30, 2021.  (see Note 9)
 
            Twenty percent (20%) of the Option shall vest on the first anniversary of the Effective Date; twenty percent (20%) on the second anniversary of the Effective Date; twenty percent (20%) on the third anniversary of the Effective Date; twenty percent (20%) on the fourth anniversary of the Effective Date; and, twenty percent (20%) on the fifth anniversary of the Effective Date;

Amendment #2 to Kyte Employment Agreement

This Second Amendment to Employment Agreement is made and entered into by and between Save The World Air, Inc. and Cecil Bond Kyte effective as of December 1, 2011 with reference to the following:
 
It is the desire of the Company and Executive to amend the Employment Agreement, pursuant to the terms and conditions of this 2nd Amendment.  Compensation of the Employment Agreement is hereby amended, as follows: Executive shall receive a base salary of $300,000 per year.  The Employment Agreement would remain in full force and effect through at least January 29, 2016, unless the Company determines to terminate the employment agreement.
 
Leases
 
In March 2009, the Company entered into a sublease agreement for its executive offices in Santa Barbara, California.  The term of the lease was for $3,520 per month from April 1, 2010 through December 31, 2010 and $3,630 per month from January 1, 2010 to December 31, 2010.  In November 2010, the Company  amended the lease agreement. Pursuant to the amendment, the term of the lease was for $5,830 per month from January 1, 2011 to December 31, 2013.

Total rent expense under this lease and other operating leases in effect during the years ended December 31, 2011 and 2010, was $138,840 and $112,320, respectively.  The following is a schedule by years of future minimum rental payments required under the non-cancellable operating leases as of December 31, 2011.

Years Ending December 31,
     
2011
 
$
69,960
 
2012
   
69,960
 
2013
   
69,960
 
         
Total         
 
$
209,880
 

 


 
 
F-36

 
 

11.   
Income taxes

The Company did not record an income tax provision for 2011 and 2010, other than $800 for the minimum state tax provision. A reconciliation of income taxes with the amounts computed at the statutory federal rate follows:

   
December 31,
 
   
2011
   
2010
 
             
Computed tax provision (benefit) at federal statutory rate (34%)
 
$
(1,175,000
)
 
$
(1,918,000
)
State income taxes, net of federal benefit
   
(305,000
)
   
(170,000
)
Permanent items
   
0
     
0
 
Valuation allowance
   
1,480,800
     
2,088,800
 
Income tax provision
 
$
800
   
$
800
 

The deferred tax assets and deferred tax liabilities recorded on the balance sheet are as follows:
 
   
December 31, 2011
   
December 31, 2010
 
Net operating loss carry forwards
   
13,700,000
     
12,200,000
 
Valuation allowance
   
(13,700,000
)
   
(12,200,000
Total deferred taxes net of valuation allowance
 
$
   
$
 
  
As of December 31, 2011, the Company had net operating losses available for carry forward for federal tax purposes of approximately $34 million expiring beginning in 2019. These carry forward benefits may be subject to annual limitations due to the ownership change limitations imposed by the Internal Revenue Code and similar state provisions. The annual limitation, if imposed, may result in the expiration of net operating losses before utilization.
 
As of December 31, 2011, the Company has recorded a $13,900,000 valuation allowance against a portion of its deferred tax assets, since at that time it was believed that such assets did not meet the more likely than not criteria to be recoverable through projected future profitable operations in the foreseeable future.

Effective January 1, 2007, the Company adopted FASB guidance that addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under this guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The FASB also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. As of December 31, 2011 and 2010, the Company does not have a liability for unrecognized tax benefits.
 
The Company files income tax returns in the U.S. federal jurisdiction and the state of California. The Company is subject to U.S. federal or state income tax examinations by tax authorities for years after 2002. During the periods open to examination, the Company has net operating loss and tax credit carry forwards for U.S. federal and state tax purposes that have attributes from closed periods. Since these net operating losses and tax credit carry forwards may be utilized in future periods, they remain subject to examination. The Company’s policy is to record interest and penalties on uncertain tax provisions as income tax expense. As of December 31, 2011, the Company has no accrued interest or penalties related to uncertain tax positions. The Company believes that it has not taken any uncertain tax positions that would impact its consolidated financial statements as of December 31, 2011 or 2010.
 
 

 
 
F-37

 
12.   
Subsequent events
 
2011 Fall#3 Offering

From December 19, 2011 through January 15, 2012, the Company  conducted a private offering (the “Fall#3 2011 Offering”) of up to $3,000,000 aggregate face amount of its convertible notes (the “Fall#3 2011  Notes”). A total of $1,020,734 aggregate face amount of the Fall#3 2011  Notes were sold for an aggregate purchase price of $927,940.  While the stated interest rate on the Fall#3 2011 Notes is 0%, the actual interest rate on the Fall#3 2011 Notes is 10% per annum. The Fall#3 2011 Notes mature on the first anniversary of their date of issuance. The Fall#3 2011 Notes are convertible, at the option of the noteholder, into 4,082,936 shares of common stock of the Company (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).

Each of the investors in the Fall#3 2011 Offering received, for no additional consideration, a warrant (the “Fall#3 2011 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 100% of the number of shares of common stock into which the Fall#3 2011 Notes are convertible (the “Warrant Shares”).  Each Fall#3 2011 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 4,082,936 Warrant Shares are initially issuable to date on exercise of the Fall#3 2011 Warrants.

2012 Winter Offering

From January 24, 2012 through February 3, 2012, the Company  conducted a private offering (the “Winter 2012 Offering”) of up to $2,000,000 aggregate face amount of its convertible notes (the “Winter 2012  Notes”). A total of $451,550 aggregate face amount of the Winter 2012  Notes were sold for an aggregate purchase price of $410,500.  While the stated interest rate on the Winter 2012 Notes is 0%, the actual interest rate on the Winter 2012 Notes is 10% per annum. The Winter 2012 Notes mature on the first anniversary of their date of issuance. The Winter 2012 Notes are convertible, at the option of the noteholder, into 1,806,200 shares of common stock of the Company (the “Conversion Shares”) at an initial conversion price of $0.25 per share (the “Conversion Price”).

Each of the investors in the Winter 2012 Offering received, for no additional consideration, a warrant (the “Winter 2012 Warrants”), entitling the holder to purchase a number of shares of the Company’s common stock equal to 100% of the number of shares of common stock into which the Winter 2012 Notes are convertible (the “Warrant Shares”).  Each Winter 2012 Warrant is exercisable on a cash basis only at an initial price of $0.30 per share, and is exercisable immediately upon issuance and for a period of two (2) years from the date of issuance. Up to 1,806,200 Warrant Shares are initially issuable to date on exercise of the Winter 2012 Warrants.

Increase in Outstanding Shares

During the period from January 1, 2012 through March 15, 2012, the Company issued 6,436,764 shares of its common stock.  This was comprised of the following:
 
The Company issued 5,936,764 shares of its common stock upon conversion of $1,484,191 of debt to its existing convertible note holders.

The Company issued 500,000 shares of its common stock per consulting agreement with Integra Consulting Group, LLC, valued at $150,000.  The shares were valued at the trading price at the date of the agreement.

Employment Agreement Chief Financial Officer

On February 1, 2012, the Company entered into a five year  employment agreement with Greggory M. Bigger as the Company’s Chief Financial Officer.  Pursuant to the agreement, Mr. Bigger will receive an annual salary of $120,000 and options to purchase 4,000,000 shares of common stock at $0.25 per share.  The options valued at $1,207,193 using the Black-Scholes Option Pricing model vest over five years and will expire on  February 1, 2022.
   
 
F-38